<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><?covid-19-tdm ?><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">71345</article-id><article-id pub-id-type="doi">10.7554/eLife.71345</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Epidemiology and Global Health</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Estimation and worldwide monitoring of the effective reproductive number of SARS-CoV-2</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" equal-contrib="yes" id="author-236199"><name><surname>Huisman</surname><given-names>Jana S</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1782-8109</contrib-id><email>jana.huisman@env.ethz.ch</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-243233"><name><surname>Scire</surname><given-names>Jérémie</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210906"><name><surname>Angst</surname><given-names>Daniel C</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6512-4595</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-243234"><name><surname>Li</surname><given-names>Jinzhou</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-1701"><name><surname>Neher</surname><given-names>Richard A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2525-1407</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-243237"><name><surname>Maathuis</surname><given-names>Marloes H</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-243236"><name><surname>Bonhoeffer</surname><given-names>Sebastian</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8052-3925</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib2">‡</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes" id="author-53628"><name><surname>Stadler</surname><given-names>Tanja</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6431-535X</contrib-id><email>tanja.stadler@bsse.ethz.ch</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib2">‡</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05a28rw58</institution-id><institution>Department of Environmental Systems Science, ETH Zurich, Swiss Federal Institute of Technology</institution></institution-wrap><addr-line><named-content content-type="city">Zurich</named-content></addr-line><country>Switzerland</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/002n09z45</institution-id><institution>Swiss Institute of Bioinformatics</institution></institution-wrap><addr-line><named-content content-type="city">Lausanne</named-content></addr-line><country>Switzerland</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05a28rw58</institution-id><institution>Department of Biosystems Science and Engineering, ETH Zurich, Swiss Federal Institute of Technology</institution></institution-wrap><addr-line><named-content content-type="city">Basel</named-content></addr-line><country>Switzerland</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05a28rw58</institution-id><institution>Department of Mathematics, ETH Zurich, Swiss Federal Institute of Technology</institution></institution-wrap><addr-line><named-content content-type="city">Zurich</named-content></addr-line><country>Switzerland</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02s6k3f65</institution-id><institution>Biozentrum, University of Basel</institution></institution-wrap><addr-line><named-content content-type="city">Basel</named-content></addr-line><country>Switzerland</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Davenport</surname><given-names>Miles P</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03r8z3t63</institution-id><institution>University of New South Wales</institution></institution-wrap><country>Australia</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Davenport</surname><given-names>Miles P</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03r8z3t63</institution-id><institution>University of New South Wales</institution></institution-wrap><country>Australia</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn><fn fn-type="con" id="equal-contrib2"><label>‡</label><p>These authors also contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>08</day><month>08</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e71345</elocation-id><history><date date-type="received" iso-8601-date="2021-06-17"><day>17</day><month>06</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2022-07-01"><day>01</day><month>07</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2020-11-30"><day>30</day><month>11</month><year>2020</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2020.11.26.20239368"/></event></pub-history><permissions><copyright-statement>© 2022, Huisman, Scire et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Huisman, Scire et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-71345-v2.pdf"/><abstract><p>The effective reproductive number <italic>R</italic><sub><italic>e</italic></sub> is a key indicator of the growth of an epidemic. Since the start of the SARS-CoV-2 pandemic, many methods and online dashboards have sprung up to monitor this number through time. However, these methods are not always thoroughly tested, correctly placed in time, or are overly confident during high incidence periods. Here, we present a method for timely estimation of <italic>R</italic><sub><italic>e</italic></sub>, applied to COVID-19 epidemic data from 170 countries. We thoroughly evaluate the method on simulated data, and present an intuitive web interface for interactive data exploration. We show that, in early 2020, in the majority of countries the estimated <italic>R</italic><sub><italic>e</italic></sub> dropped below 1 only after the introduction of major non-pharmaceutical interventions. For Europe the implementation of non-pharmaceutical interventions was broadly associated with reductions in the estimated <italic>R</italic><sub><italic>e</italic></sub>. Globally though, relaxing non-pharmaceutical interventions had more varied effects on subsequent <italic>R</italic><sub><italic>e</italic></sub> estimates. Our framework is useful to inform governments and the general public on the status of epidemics in their country, and is used as the official source of <italic>R</italic><sub><italic>e</italic></sub> estimates for SARS-CoV-2 in Switzerland. It further allows detailed comparison between countries and in relation to covariates such as implemented public health policies, mobility, behaviour, or weather data.</p></abstract><abstract abstract-type="plain-language-summary"><title>eLife digest</title><p>Over the past two and a half years, countries around the globe have struggled to control the transmission of the SARS-CoV-2 virus within their borders. To manage the situation, it is important to have an accurate picture of how fast the virus is spreading. This can be achieved by calculating the effective reproductive number (Re), which describes how many people, on average, someone with COVID-19 is likely to infect. If the Re is greater than one, the virus is infecting increasingly more people, but if it is smaller than one, the number of cases is declining.</p><p>Scientists use various strategies to estimate the Re, which each have their own strengths and weaknesses. One of the main difficulties is that infections are typically recorded only when people test positive for COVID-19, are hospitalized with the virus, or die. This means that the data provides a delayed representation of when infections are happening. Furthermore, changes in these records occur later than measures that change the infection dynamics. As a result, researchers need to take these delays into account when estimating Re.</p><p>Here, Huisman, Scire et al. have developed a new method for estimating the Re based on available data records, statistically taking into account the above-mentioned delays. An online dashboard with daily updates was then created so that policy makers and the population could monitor the values over time.</p><p>For over two years, Huisman, Scire et al. have been applying their tool and dashboard to COVID-19 data from 170 countries. They found that public health interventions, such as mask requirements and lockdowns, did help reduce the Re in Europe. But the effects were not uniform across the globe, likely because of variations in how restrictions were implemented and followed during the pandemic. In early 2020, the Re only dropped below one after countries put lockdowns or other severe measures in place.</p><p>The Re values added to the dashboard over the last two years have been used pro-actively to inform public health policies in Switzerland and to monitor the spread of SARS-CoV-2 in South Africa. The team has also recently released programming software based on this method that can be used to track future disease outbreaks, and extended the method to estimate the Re using SARS-CoV-2 levels in wastewater.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>SARS-CoV-2</kwd><kwd>public health surveillance</kwd><kwd>infectious disease</kwd><kwd>reproductive number</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Viruses</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001711</institution-id><institution>Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung</institution></institution-wrap></funding-source><award-id>31CA30_196267</award-id><principal-award-recipient><name><surname>Stadler</surname><given-names>Tanja</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001711</institution-id><institution>Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung</institution></institution-wrap></funding-source><award-id>200021_172603</award-id><principal-award-recipient><name><surname>Maathuis</surname><given-names>Marloes H</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001711</institution-id><institution>Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung</institution></institution-wrap></funding-source><award-id>310030B_176401</award-id><principal-award-recipient><name><surname>Bonhoeffer</surname><given-names>Sebastian</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001711</institution-id><institution>Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung</institution></institution-wrap></funding-source><award-id>407240-167121</award-id><principal-award-recipient><name><surname>Bonhoeffer</surname><given-names>Sebastian</given-names></name><name><surname>Stadler</surname><given-names>Tanja</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A new and throughly validated method for timely estimation of the effective reproductive number of SARS-CoV-2 aided in the public health response to the COVID-19 pandemic.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>During an infectious-disease outbreak, such as the SARS-CoV-2 pandemic, accurate monitoring of the epidemic situation is critical to the decision-making process of governments and public health authorities. The magnitude of an epidemic, as well as its spatial and temporal infection dynamics determine the exposure risk posed to citizens in the near and long-term future, the pressure on critical infrastructure like hospitals, and the overall burden of disease to society.</p><p>The effective reproductive number <inline-formula><mml:math id="inf1"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> is a key indicator to describe how efficiently a pathogen spreads in a given population at a given time (<xref ref-type="bibr" rid="bib6">Anderson and May, 1991</xref>; <xref ref-type="bibr" rid="bib12">Cauchemez et al., 2006</xref>; <xref ref-type="bibr" rid="bib64">Wallinga and Lipsitch, 2007</xref>). It quantifies the average number of secondary infections caused by a primary infected individual. It also has a natural threshold value of 1, below which the epidemic reduces in size <xref ref-type="bibr" rid="bib6">Anderson and May, 1991</xref>; <xref ref-type="bibr" rid="bib43">Nishiura and Chowell, 2009</xref>. <inline-formula><mml:math id="inf2"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> typically changes during the course of an epidemic as a result of the depletion of susceptible individuals, changed contact behaviour, seasonality of the pathogen, or the effect of pharmaceutical and non-pharmaceutical interventions (NPIs) (<xref ref-type="bibr" rid="bib6">Anderson and May, 1991</xref>; <xref ref-type="bibr" rid="bib14">Delamater et al., 2019</xref>; <xref ref-type="bibr" rid="bib53">Scire et al., 2020</xref>; <xref ref-type="bibr" rid="bib4">Ali et al., 2020</xref>; <xref ref-type="bibr" rid="bib19">Flaxman et al., 2020</xref>).</p><p>Different methods have been developed to estimate <inline-formula><mml:math id="inf3"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula>. They broadly fall into two categories: those based on compartmental models, (e.g. <xref ref-type="bibr" rid="bib14">Delamater et al., 2019</xref>; <xref ref-type="bibr" rid="bib34">Kucharski et al., 2020</xref>; <xref ref-type="bibr" rid="bib66">Zhou et al., 2020</xref>), and those that infer the number of secondary infections per infected individual directly, based on a time series of infection incidence, (e.g. <xref ref-type="bibr" rid="bib63">Wallinga and Teunis, 2004</xref>; <xref ref-type="bibr" rid="bib13">Cori et al., 2013</xref>). We focus on the latter class of methods as they rely on few, simple assumptions, are less prone to model misspecifications, and are well-suited for ongoing monitoring of the epidemic (<xref ref-type="bibr" rid="bib22">Gostic et al., 2020</xref>). In particular, we consider the EpiEstim method of <xref ref-type="bibr" rid="bib13">Cori et al., 2013</xref>.</p><p>The infection incidence based methods face the difficulty that infection events cannot be observed directly (<xref ref-type="bibr" rid="bib22">Gostic et al., 2020</xref>). These events can only be surmised with a certain time lag, e.g. when individuals show symptoms and are tested, via contact tracing, or via periodic testing of a cohort of individuals (<xref ref-type="bibr" rid="bib43">Nishiura and Chowell, 2009</xref>). To use these methods, one must thus employ a proxy for infection events (e.g. the observed incidence of confirmed cases, hospitalisations, or deaths). This proxy is either used directly in lieu of the infection incidence, or it is used as an indirect observation to infer past infections (<xref ref-type="bibr" rid="bib22">Gostic et al., 2020</xref>). It is important to relate <inline-formula><mml:math id="inf4"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates to the timing of infection events because this allows multiple proxies of infection events, with differing delays, to be used separately to monitor the same epidemic (<xref ref-type="bibr" rid="bib53">Scire et al., 2020</xref>). In addition, any factors that may affect transmission dynamics will do so at the time infections occurred. If <inline-formula><mml:math id="inf5"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> is placed properly on this timescale, it can be compared directly to external covariates like weather and interventions (<xref ref-type="bibr" rid="bib19">Flaxman et al., 2020</xref>; <xref ref-type="bibr" rid="bib57">Soltesz et al., 2020</xref>). However, depending on the method used to infer the timing of infections from the observed incidence time series, one can also introduce biases such as smoothing sudden changes in <inline-formula><mml:math id="inf6"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> (<xref ref-type="bibr" rid="bib22">Gostic et al., 2020</xref>; <xref ref-type="bibr" rid="bib20">Goldstein et al., 2009</xref>; <xref ref-type="bibr" rid="bib48">Petermann and Wyler, 2020</xref>).</p><p>Several methods, software packages, and online dashboards have been developed to monitor developments in <inline-formula><mml:math id="inf7"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> during the SARS-CoV-2 pandemic (e.g. <xref ref-type="bibr" rid="bib2">Abbott et al., 2020b</xref>; <xref ref-type="bibr" rid="bib58">Systrom et al., 2020</xref>; <xref ref-type="bibr" rid="bib59">Tebé et al., 2020</xref>; <xref ref-type="bibr" rid="bib54">Scott et al., 2020</xref>; <xref ref-type="bibr" rid="bib26">Hamouda, 2020</xref>; <xref ref-type="bibr" rid="bib50">Richter et al., 2020</xref>). A pipeline for the continuous estimation of <inline-formula><mml:math id="inf8"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> using infection incidence based methods should include four critical steps: (i) gathering and curating observable proxy data of infection incidence, (ii) reconstruction of the unobserved infection events, (iii) <inline-formula><mml:math id="inf9"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimation, and (iv) communication of the results, including uncertainty and potential biases. These four axes also define the differences between existing methods. The first step dictates e.g. the geographical scope of the <inline-formula><mml:math id="inf10"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates reported. During the SARS-CoV-2 epidemic, many local public health authorities have made case data publicly available. Depending on the data sources used, estimated <inline-formula><mml:math id="inf11"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> values span from the scale of a city, region, country, or the entire globe (<xref ref-type="bibr" rid="bib58">Systrom et al., 2020</xref>; <xref ref-type="bibr" rid="bib46">Pan et al., 2020</xref>; <xref ref-type="bibr" rid="bib51">Robert Koch-Institut, 2020</xref>). The second step, i.e. going from a noisy time series of indirect observations to an infection incidence time series, is technically challenging. Biases can be introduced easily, and accurately assessing the uncertainty around the inferred infection incidence is a challenge in itself (<xref ref-type="bibr" rid="bib22">Gostic et al., 2020</xref>). For the third step, i.e. to estimate <inline-formula><mml:math id="inf12"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> from a timeline of infection events, there are ready-to-use software packages (<xref ref-type="bibr" rid="bib13">Cori et al., 2013</xref>; <xref ref-type="bibr" rid="bib45">Obadia et al., 2012</xref>), which produce <inline-formula><mml:math id="inf13"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates along with an estimate of the uncertainty resulting from this step. Finally, the communication of results to the general public and decision makers is essential, but often overlooked. We present a pipeline, together with an online dashboard, for timely monitoring of <inline-formula><mml:math id="inf14"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula>. We use publicly available data gathered by different public health authorities. Wherever possible, we show results obtained from different types of case reports (confirmed cases, hospitalisations or deaths). This allows comparison across observation types and to balance the biases inherent in the different types. Results are updated daily, and can be found on <ext-link ext-link-type="uri" xlink:href="https://ibz-shiny.ethz.ch/covid-19-re-international/">https://ibz-shiny.ethz.ch/covid-19-re-international/</ext-link>. The results of this method have been used directly in public health policy making in Switzerland for the past 2 years, and were also communicated by the Federal Office of Public Health on <ext-link ext-link-type="uri" xlink:href="https://www.covid19.admin.ch/en/overview">https://www.covid19.admin.ch/en/overview</ext-link> during that time. Through continuous engagement with the public, scientific experts, and thorough evaluation on simulated scenarios, we have created a robust and transparent method of enduring relevance for the current and future epidemics.</p><p>Because <inline-formula><mml:math id="inf15"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates reflect changes in virus transmission dynamics, they can be used to assess the impact of public health interventions. Prior work on the relative impact of specific non-pharmaceutical interventions on <inline-formula><mml:math id="inf16"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> has shown conflicting results (<xref ref-type="bibr" rid="bib19">Flaxman et al., 2020</xref>; <xref ref-type="bibr" rid="bib16">Esra et al., 2020</xref>; <xref ref-type="bibr" rid="bib9">Banholzer et al., 2021</xref>; <xref ref-type="bibr" rid="bib57">Soltesz et al., 2020</xref>; <xref ref-type="bibr" rid="bib27">Haug et al., 2020</xref>; <xref ref-type="bibr" rid="bib33">Kohanovski et al., 2022</xref>). These differences can be attributed mostly to different model formulations (<xref ref-type="bibr" rid="bib57">Soltesz et al., 2020</xref>; <xref ref-type="bibr" rid="bib56">Sharma et al., 2020</xref>; <xref ref-type="bibr" rid="bib10">Banholzer et al., 2022</xref>), including differing assumptions on the independence of NPIs (<xref ref-type="bibr" rid="bib56">Sharma et al., 2020</xref>), differing timescales over which the effect of the NPI was analysed (<xref ref-type="bibr" rid="bib19">Flaxman et al., 2020</xref>; <xref ref-type="bibr" rid="bib27">Haug et al., 2020</xref>), whether the time point of the NPI was assumed fixed or allowed to vary (<xref ref-type="bibr" rid="bib33">Kohanovski et al., 2022</xref>), and differing geographical scope. There is a need to address whether the strength of measures and the speed of their implementation resulted in a larger and faster decrease of <inline-formula><mml:math id="inf17"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula>, and specifically whether highly restrictive lockdowns were necessary to achieve <inline-formula><mml:math id="inf18"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>&lt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mstyle></mml:math></inline-formula>. Further, it remains unclear how the impact of interventions differed across time and geographical regions. We add to this debate by using our <inline-formula><mml:math id="inf19"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates across geographical regions and timescales that include the lifting of many NPIs. While we cannot determine causal relationships, we use our method to assess likely associations.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>A pipeline to estimate the effective reproductive number of SARS-CoV-2</title><p>We have developed a pipeline to estimate the time-varying effective reproductive number of SARS-CoV-2 from observed COVID-19 case incidence time series (see Materials and Methods). The objective was to achieve stable estimates for multiple types of data, and with an adequate representation of uncertainty. At the core, we use the EpiEstim method (<xref ref-type="bibr" rid="bib13">Cori et al., 2013</xref>) to estimate <inline-formula><mml:math id="inf20"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> from a time series of infection incidence. To infer the infection incidence from a time series of (noisy) observations, we extended the deconvolution method by Goldstein et al. to deal with partially observed data and time-varying delay distributions (<xref ref-type="bibr" rid="bib22">Gostic et al., 2020</xref>; <xref ref-type="bibr" rid="bib20">Goldstein et al., 2009</xref>). We smooth the data prior to deconvolution to reduce numerical artefacts resulting from their weekly patterns and overall noisy nature. We compute point-wise 95% confidence intervals for the true <inline-formula><mml:math id="inf21"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> values, using the union of a block bootstrap method, designed to account for variation in the case observations, and the credible intervals from EpiEstim. As observed incidence data we use COVID-19 confirmed case data, hospital admissions, and deaths (with type specific delay distributions, see Materials and Methods). We publish separate <inline-formula><mml:math id="inf22"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates for each of these types of incidence data. The most recent <inline-formula><mml:math id="inf23"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimate lies further in the past than the most recent observed incidence data due to the delay between infection and case observation.</p></sec><sec id="s2-2"><title>Evaluation on simulated data</title><p>To evaluate our method, we used simulations of several epidemic scenarios (see Materials and Methods for more details). For each scenario, we specified an <inline-formula><mml:math id="inf24"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> time series. The specified <inline-formula><mml:math id="inf25"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> trajectories were parametrised in a piecewise linear fashion. To mimic the course of the COVID-19 outbreaks observed in many European countries in 2020 (<xref ref-type="bibr" rid="bib35">Lemaitre et al., 2020</xref>), we started with <inline-formula><mml:math id="inf26"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> values around 3, then dropped to a value below 1 (the ‘initial decrease’), stayed around 1 in summer and slightly above 1 (the ‘second wave’) in autumn (<xref ref-type="fig" rid="fig1">Figure 1</xref>). From each specified <inline-formula><mml:math id="inf27"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> trajectory, we stochastically simulated 100 time series of infections and their resulting case observations. To account for reporting effects and to better mimic observed COVID-19 case data from around the world, we added additional autocorrelated noise to the case observations.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Evaluation of the pipeline on simulated data.</title><p>(<bold>A</bold>) The specified <inline-formula><mml:math id="inf28"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> trajectory (black line) was used to stochastically simulate 100 trajectories of observed cases. From each trajectory, we estimated <inline-formula><mml:math id="inf29"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> (yellow boxplots) and constructed a 95% confidence interval (purple boxplots of the lower/upper endpoint). (<bold>B</bold>) Fraction of simulations for which the true <inline-formula><mml:math id="inf30"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> value was within the 95% confidence interval. The dashed red line indicates the nominal 95% coverage. (<bold>C</bold>) Root mean squared relative error for every time point. (<bold>D</bold>) Fraction of simulations for which <inline-formula><mml:math id="inf31"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> is estimated to be significantly above or below one, depending on the true value of <inline-formula><mml:math id="inf32"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71345-fig1-v2.tif"/></fig><p>We then used our method to infer the infection incidence and <inline-formula><mml:math id="inf33"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> from each simulated time series of case observations, and compared these to the true underlying <inline-formula><mml:math id="inf34"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> values (<xref ref-type="fig" rid="fig1">Figure 1</xref>). The results show that the method accurately estimates the effective reproductive number (<xref ref-type="fig" rid="fig1">Figure 1</xref>; metrics described in Materials and Methods). Across most time points, the 95% confidence interval includes the true <inline-formula><mml:math id="inf35"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> value (coverage; <xref ref-type="fig" rid="fig1">Figure 1B</xref>). The low root mean squared error (RMSE) indicates that our point estimates closely track the true <inline-formula><mml:math id="inf36"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> value (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Importantly, we correctly infer whether <inline-formula><mml:math id="inf37"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> is significantly above or below 1 in this scenario: we never infer that <inline-formula><mml:math id="inf38"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> is significantly above 1 when the true value is below 1, and only for two time points the estimates are significantly below 1 for some simulations when the true value is a little above 1 (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Due to the smoothing step prior to deconvolution, we slightly misestimate <inline-formula><mml:math id="inf39"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> during steep changes (see Appendix 2, and <xref ref-type="fig" rid="app3fig1">Appendix 3—figure 1</xref> for more scenarios). However, the inclusion of smoothing greatly improves the performance across scenarios with different types of observation noise (<xref ref-type="fig" rid="app3fig2">Appendix 3—figures 2</xref> and <xref ref-type="fig" rid="app3fig3">3</xref>). For a wide range of infection incidences, the 95% confidence interval is informative and covers the true value of <inline-formula><mml:math id="inf40"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> (<xref ref-type="fig" rid="app3fig4">Appendix 3—figures 4</xref> and <xref ref-type="fig" rid="app3fig5">5</xref>). Our block-bootstrapping method greatly improves coverage compared to the out-of-the-box EpiEstim method. Our method also outperforms the common approach of using a fixed delay to infer the infection incidence time series (<xref ref-type="fig" rid="app3fig6">Appendix 3—figure 6</xref>).</p><p>We further tested the impact of misspecifying the delay between infections and observations. Misspecifying the mean of the delay distribution between infection and case observation by up to 2 days does not have a strong effect on the <inline-formula><mml:math id="inf41"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates, whereas larger misspecifications by 5 or 10 days lead to a more substantial decrease in coverage (<xref ref-type="fig" rid="app3fig7">Appendix 3—figure 7</xref>). Correspondingly, allowing for time-varying delay distributions has a pronounced effect on the estimated <inline-formula><mml:math id="inf42"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> only when changes in the mean of the delay distribution are large (<xref ref-type="fig" rid="app3fig8">Appendix 3—figure 8</xref>). The impact of other model misspecifications, e.g. of the generation time interval, have been investigated by <xref ref-type="bibr" rid="bib22">Gostic et al., 2020</xref> for this class of methods.</p></sec><sec id="s2-3"><title>Stability of the <inline-formula><mml:math id="inf43"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates in an outbreak monitoring context</title><p>As our <inline-formula><mml:math id="inf44"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates for SARS-CoV-2 were directly policy relevant in Switzerland, we investigated their stability as new data becomes available (up to 21 additional days of data; <xref ref-type="fig" rid="fig2">Figure 2</xref>). With each new day of incidence data, it becomes possible to estimate <inline-formula><mml:math id="inf45"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> for an additional day in the past. The most recent available <inline-formula><mml:math id="inf46"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimate will be delayed with respect to the observed case incidence by at least the median delay from infection to observation to ensures sufficient information is available in the data (and can be delayed further if required; see below). As time passes and more observations become available, one can estimate more recent values of <inline-formula><mml:math id="inf47"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula>. Importantly, the estimated <inline-formula><mml:math id="inf48"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> for a day <inline-formula><mml:math id="inf49"><mml:mi>t</mml:mi></mml:math></inline-formula> is updated whenever additional data is added. This means that the <inline-formula><mml:math id="inf50"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> estimates initially change with each passing day before they settle on a long-term, stable value. In the analysis of Swiss COVID-19 case data in <xref ref-type="fig" rid="fig2">Figure 2B</xref>, <inline-formula><mml:math id="inf51"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates for Sept. 1 2020 to April 1 2021 based on data up to April 30 2021 are referred to as ‘stable <inline-formula><mml:math id="inf52"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates’. During rapid changes in the real <inline-formula><mml:math id="inf53"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula>, the initial estimates for <inline-formula><mml:math id="inf54"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> can occasionally under- or overshoot the long-term stable value. However, with our improved 95% confidence intervals (CI), the percentage of the first estimated CI for <inline-formula><mml:math id="inf55"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> that is contained within the stable CI is substantially improved compared to purely EpiEstim-based uncertainty intervals (<xref ref-type="fig" rid="fig2">Figure 2</xref>). This difference is particularly striking during periods of high case incidence (e.g. October 2020), when the EpiEstim uncertainty interval is very narrow.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Stability of the Swiss <inline-formula><mml:math id="inf56"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates based on confirmed COVID-19 cases, upon adding additional days of observations.</title><p>(<bold>A</bold>) Line segments correspond to 3 weeks of estimates made with the same input data (e.g. data up to December 1st). The segments were assigned an arbitrary colour for ease of distinction. For each day, <inline-formula><mml:math id="inf57"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates and associated 95% confidence intervals (CIs) are overlaid, from the first possible estimate for that day up to estimates including 3 additional weeks of data. The latter, always the left end of a line segment, corresponds to the stable estimate. (<bold>B</bold>) Percentage of the first estimated CI that is contained in the stable CI based on data from 30 April 2021. This percentage was calculated as the width of the intersection of both CIs, divided by the width of the first CI. The colour indicates whether the stable <inline-formula><mml:math id="inf58"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimate was contained in the first reported CI. In both rows, the left column shows uncertainty intervals from EpiEstim on the original data, and the right our improved 95% CIs. Both columns use the same pipeline, and differ only in the construction of the uncertainty intervals.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71345-fig2-v2.tif"/></fig><p>We complemented this analysis on empirical data with an assessment of the stability of <inline-formula><mml:math id="inf59"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates on synthetic data. Using the set-up described before, we simulated 4 <inline-formula><mml:math id="inf60"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> scenarios: a constant trend, a slow increase, a slow decrease, and an abrupt decrease in <inline-formula><mml:math id="inf61"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula>. Contrary to before, we estimated <inline-formula><mml:math id="inf62"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> repeatedly, adding an additional day to the simulation in each iteration (<xref ref-type="fig" rid="app4fig1">Appendix 4—figure 1</xref>). For each scenario, we compare ‘raw’ <inline-formula><mml:math id="inf63"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates to trajectories for which the 4 most recent <inline-formula><mml:math id="inf64"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates were removed. This analysis shows that the last few <inline-formula><mml:math id="inf65"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates can lay outside of the stabilized confidence interval, in particular when the real <inline-formula><mml:math id="inf66"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> trend is increasing. Instead, the truncated trajectories appear more stable as their most recent estimate has already been consolidated over 4 days. This highlights a trade-off between timeliness and accuracy when publishing <inline-formula><mml:math id="inf67"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates. On our online dashboard we present truncated <inline-formula><mml:math id="inf68"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates for Swiss cantons since these estimates were directly policy-relevant in Switzerland.</p></sec><sec id="s2-4"><title>Detailed data allows more precise analysis: the example of Switzerland</title><p>When detailed epidemiological data about individual cases is available (in the form of a line list), the precision of our method can be increased by relaxing the assumptions that (i) distributions of delays between infection and observation do not change through time and (ii) outbreaks occur in populations that are isolated at the country-level. In particular, we collaborated with the Federal Office of Public Health (FOPH) in Switzerland to relax these assumptions and further refine the monitoring of the Swiss SARS-CoV-2 epidemic.</p><p>The FOPH line list contains information on the delays between onset of symptoms and reporting - of a positive test, hospitalisation or death - for a substantial fraction of the reported cases. For each of these three types of case report, we estimate the time-varying empirical delay distribution for the delay from infection to reporting. We use this time-varying distribution as input to the deconvolution step, instead of the fixed delay distribution from the literature which is used for countries without an available line list (for details see Materials and Methods section 4.3). Each delay distribution is thus tailored to the specifics of the Swiss population and health system. Since each distribution varies through time, it reflects changes caused by e.g. improved contact tracing or overburdened health offices (see <xref ref-type="fig" rid="app4fig2">Appendix 4—figure 2</xref>; Appendix 1). Whenever available in the FOPH line list, we use the symptom onset date of patients as the date of observation and thus only deconvolve the incubation period to obtain a time series of infection dates. This was most relevant until early 2021, after which the date of symptom onset was rarely recorded anymore. For most days, the effect of these modifications on the <inline-formula><mml:math id="inf69"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> point estimates is slight (<xref ref-type="fig" rid="app4fig3">Appendix 4—figure 3</xref>; shown for confirmed case data), yet the difference for a particular day can be as big as 20%.</p><p>Using FOPH data on the fraction of cases infected abroad, we can correct our <inline-formula><mml:math id="inf70"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimate for imported cases. This is especially important in phases during which the local epidemic is seeded from abroad, and local transmission occurs at a low rate relative to case importation (<xref ref-type="fig" rid="app4fig4">Appendix 4—figure 4</xref>). This correction, which relies on EpiEstim (<xref ref-type="bibr" rid="bib13">Cori et al., 2013</xref>), treats imported cases as pure infectors, and not infectees. It further assumes that imported cases transmit at the same rate as local cases. When this is not the case, e.g. when strict quarantines are imposed on travellers or travellers have more contacts compared to the rest of the population, and when a large fraction of all cases are imported, this can bias results (<xref ref-type="bibr" rid="bib61">Tsang et al., 2021</xref>). Additionally, since we do not have data on the number of cases infected in Switzerland that are “exported&quot; to other countries, we cannot correct for exports. Thus, the estimated <inline-formula><mml:math id="inf71"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> value corrected for imports is a lower bound for the <inline-formula><mml:math id="inf72"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimate which would be obtained if we could account for the location of infection of all cases detected in Switzerland or exported out of the country.</p></sec><sec id="s2-5"><title>Comparison with existing methods</title><p>During the COVID-19 pandemic, research groups and local public health authorities around the world developed and used methods to estimate the effective reproductive number (<xref ref-type="bibr" rid="bib1">Abbott et al., 2020a</xref>; <xref ref-type="bibr" rid="bib54">Scott et al., 2020</xref>; <xref ref-type="bibr" rid="bib26">Hamouda, 2020</xref>; <xref ref-type="bibr" rid="bib50">Richter et al., 2020</xref>). To put our method into context, we compare against EpiNow2, a prominent R-package to estimate (<xref ref-type="bibr" rid="bib1">Abbott et al., 2020a</xref>), and the official <inline-formula><mml:math id="inf73"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates for Germany (developed by the <xref ref-type="bibr" rid="bib51">Robert Koch-Institut, 2020</xref>; RKI <xref ref-type="bibr" rid="bib26">Hamouda, 2020</xref>) and Austria (developed by the Austrian Agency for Health and Food Safety; AGES <xref ref-type="bibr" rid="bib50">Richter et al., 2020</xref>). A detailed comparison of the structure and features of these methods —with the addition of the epidemia R-package (<xref ref-type="bibr" rid="bib54">Scott et al., 2020</xref>)— can be found in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. To the best of our knowledge, our method is the only one that can account for variations through time in delay distributions and combine symptom onset data with case data.</p><p>We compiled publicly available <inline-formula><mml:math id="inf74"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates for Switzerland, Austria and Germany from these research groups and institutions (<xref ref-type="fig" rid="fig3">Figure 3</xref>; <xref ref-type="bibr" rid="bib3">Abbott et al., 2022</xref>; <xref ref-type="bibr" rid="bib29">Heiden, 2021</xref>; <xref ref-type="bibr" rid="bib62">TU Graz AGES, 2021</xref>). In this case the underlying truth is unknown, yet we can compare how well the point estimates and confidence intervals correspond between different methods. Both the RKI and AGES publish very narrow confidence intervals, which are unlikely to accurately capture the uncertainty around the estimates (similar to <xref ref-type="fig" rid="fig2">Figure 2</xref>). In addition, the trend of AGES estimates appear shifted closer to the present than our estimates (<xref ref-type="fig" rid="fig3">Figure 3</xref>). This is because AGES applies EpiEstim directly to observed case data, thus indirectly assuming that case confirmation occurs on the day of infection. The estimates from EpiNow2 and ours follow a qualitatively similar trend, although the EpiNow2 estimates are smoother and there is a small lag between both estimates, likely due to differences in the specified observation delay distribution. An in-depth comparison exploring the accuracy and stability of estimates produced by all available methods lies beyond the scope of this work, but would certainly be beneficial to give a full picture of the state-of-the-art of <inline-formula><mml:math id="inf75"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimation methods.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Comparison of published <inline-formula><mml:math id="inf76"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates for three countries.</title><p>Point estimates are presented with a solid line and 95% confidence intervals are presented as coloured ribbons.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71345-fig3-v2.tif"/></fig></sec><sec id="s2-6"><title>Monitoring <inline-formula><mml:math id="inf77"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> during the COVID-19 pandemic</title><p>We developed an online dashboard (<ext-link ext-link-type="uri" xlink:href="https://ibz-shiny.ethz.ch/covid-19-re-international/">https://ibz-shiny.ethz.ch/covid-19-re-international/</ext-link>) on which we present daily-updated results of this <inline-formula><mml:math id="inf78"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimation method applied to COVID-19 case data from 170 countries (<xref ref-type="fig" rid="fig4">Figure 4</xref>). For most countries, we include multiple observation sources, such as daily incidence of COVID-19 cases and deaths, and, when available, hospital admissions. We estimate <inline-formula><mml:math id="inf79"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> separately from each incidence type and make the estimates available for download, as an open resource for other researchers and the general public alike.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Example panels from the online dashboard.</title><p>(<bold>A</bold>) Swiss case incidence with evidence of weekly testing patterns (top row), <inline-formula><mml:math id="inf80"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates with associated 95% confidence intervals from four types of observation data (middle row), and timeline of stringency index and vaccination coverage (bottom row). (<bold>B</bold>) World map of incidence per 100’000 inhabitants over the last 14 days. One can also display the worldwide <inline-formula><mml:math id="inf81"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates instead. (<bold>C</bold>) Comparison of <inline-formula><mml:math id="inf82"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates across four countries (Austria, Chile, India and Morocco), with timelines of stringency indices and vaccination coverage. All panels were extracted on May 12, 2022. Dashboard url: <ext-link ext-link-type="uri" xlink:href="https://ibz-shiny.ethz.ch/covid-19-re-international">https://ibz-shiny.ethz.ch/covid-19-re-international</ext-link>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71345-fig4-v2.tif"/></fig><p>The online app allows for comparison through time within a single country, between multiple observation traces, and between multiple countries. The data download further allows users to put these estimates in relation to external covariates such as mobility, weather, or behavioural data. The map view enables comparison across larger geographical areas and additionally reports the cases per 100’000 inhabitants per 14 days. We additionally show the Oxford Stringency Index and vaccination coverage for context (<xref ref-type="bibr" rid="bib25">Hale et al., 2021</xref>; <xref ref-type="bibr" rid="bib52">Roser et al., 2020</xref>).</p></sec><sec id="s2-7"><title>The effect of lockdowns in spring 2020 on the estimated <inline-formula><mml:math id="inf83"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> of SARS-CoV-2</title><p>We assessed the association between non-pharmaceutical interventions (NPIs) and the estimated effective reproductive number <inline-formula><mml:math id="inf84"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> during the early stage of the COVID-19 pandemic. We selected 20 European countries for which the reported data was free of major gaps or spikes, and for which we could estimate <inline-formula><mml:math id="inf85"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> prior to the nationwide implementation of a lockdown in spring 2020. The dates of interventions were extracted from news reports (sources listed in <xref ref-type="table" rid="app6table2">Appendix 6—table 2</xref>), and ‘lockdown’ taken to refer to stay-at-home orders of differing intensity. Of the countries investigated, all except Sweden implemented a lockdown (19/20). Using case data, we inferred that <inline-formula><mml:math id="inf86"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> was significantly above one prior to the lockdown measures in nearly all countries with a lockdown (15/19; <xref ref-type="table" rid="table1">Table 1</xref>). Denmark, which had a complex outbreak consisting of two initial waves, and Germany, which experienced a cluster of early cases, had an estimated <inline-formula><mml:math id="inf87"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> significantly below one prior to this date. For countries with very short delays between the lockdown and the estimated date that <inline-formula><mml:math id="inf88"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>&lt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mstyle></mml:math></inline-formula> (e.g. Austria, Switzerland) we can not exclude the possibility that the ‘true’ <inline-formula><mml:math id="inf89"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> may have been below 1 prior to the lockdown since our pipeline introduces smoothing to the estimates (see Appendix 2). The results are remarkably consistent across the different observation types (<xref ref-type="table" rid="app6table1">Appendix 6—table 1</xref>). However, the 95% confidence intervals tend to be wider for the estimates based on death incidence data because the number of deaths is much smaller than the number of cases, and the relative noise in observations tends to be higher.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Investigating the relation between the date of ‘lockdown’ and the date when the estimated <inline-formula><mml:math id="inf90"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> based on case reports dropped below 1.</title><p>Based on news reports, we report when a country implemented stay-at-home orders (a ‘lockdown’). The column ‘<inline-formula><mml:math id="inf91"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mi>R</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>&lt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mstyle></mml:math></inline-formula>’ indicates when the <inline-formula><mml:math id="inf92"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> point estimate first dropped below 1. The column ‘CI includes 1’ details the corresponding time interval where the 95% confidence interval included 1. Of the investigated countries that implemented a nationwide lockdown, four (Denmark, Germany, the Netherlands, Slovenia) had 95% confidence intervals that included 1 or were below before a nationwide lockdown was implemented. The column ‘Time until <inline-formula><mml:math id="inf93"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mi>R</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>&lt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mstyle></mml:math></inline-formula>’ indicates the number of days between the lockdown and the date that the <inline-formula><mml:math id="inf94"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> point estimate dropped below 1.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Country</th><th align="left" valign="bottom">Lockdown</th><th align="left" valign="bottom">Re &lt;1</th><th align="left" valign="bottom">CI includes 1</th><th align="left" valign="bottom">Time until Re &lt;1</th></tr></thead><tbody><tr><td align="left" valign="bottom">Austria</td><td align="char" char="ndash" valign="bottom">16–30</td><td align="char" char="ndash" valign="bottom">20–30</td><td align="char" char="." valign="bottom">[20-03, 20-03]</td><td align="char" char="." valign="bottom">4 days</td></tr><tr><td align="left" valign="bottom">Belgium</td><td align="char" char="ndash" valign="bottom">18–30</td><td align="char" char="ndash" valign="bottom">30–30</td><td align="char" char="." valign="bottom">[25-03, 03-04]</td><td align="char" char="." valign="bottom">12 days</td></tr><tr><td align="left" valign="bottom">Denmark</td><td align="char" char="ndash" valign="bottom">18–30</td><td align="char" char="ndash" valign="bottom">≤10–03</td><td align="left" valign="bottom">[≤10–03, 20–06]</td><td align="char" char="." valign="bottom">–8 days</td></tr><tr><td align="left" valign="bottom">Finland</td><td align="char" char="ndash" valign="bottom">16–30</td><td align="char" char="hyphen" valign="bottom">01-Feb</td><td align="char" char="." valign="bottom">[29-03, 30-04]</td><td align="char" char="." valign="bottom">17 days</td></tr><tr><td align="left" valign="bottom">France</td><td align="char" char="ndash" valign="bottom">17–30</td><td align="char" char="ndash" valign="bottom">27–30</td><td align="char" char="." valign="bottom">[23-03, 07-04]</td><td align="char" char="." valign="bottom">10 days</td></tr><tr><td align="left" valign="bottom">Germany</td><td align="char" char="ndash" valign="bottom">22–30</td><td align="char" char="ndash" valign="bottom">18–30</td><td align="char" char="." valign="bottom">[17-03, 19-03]</td><td align="char" char="." valign="bottom">–4 days</td></tr><tr><td align="left" valign="bottom">Ireland</td><td align="char" char="ndash" valign="bottom">27–30</td><td align="char" char="ndash" valign="bottom">01–100</td><td align="char" char="." valign="bottom">[04–04, 15–04]</td><td align="char" char="." valign="bottom">12 days</td></tr><tr><td align="left" valign="bottom">Italy</td><td align="char" char="ndash" valign="bottom">01–300</td><td align="char" char="ndash" valign="bottom">18–30</td><td align="char" char="." valign="bottom">[17-03, 19-03]</td><td align="char" char="." valign="bottom">8 days</td></tr><tr><td align="left" valign="bottom">Netherlands</td><td align="char" char="ndash" valign="bottom">23–30</td><td align="char" char="hyphen" valign="bottom">01-Jan</td><td align="char" char="." valign="bottom">[22-03, 10-04]</td><td align="char" char="." valign="bottom">13 days</td></tr><tr><td align="left" valign="bottom">Norway</td><td align="char" char="ndash" valign="bottom">14–30</td><td align="char" char="ndash" valign="bottom">21–30</td><td align="char" char="." valign="bottom">[17-03, 19-03]</td><td align="char" char="." valign="bottom">7 days</td></tr><tr><td align="left" valign="bottom">Poland</td><td align="char" char="ndash" valign="bottom">25–30</td><td align="char" char="hyphen" valign="bottom">01-Jan</td><td align="char" char="." valign="bottom">[31-03, 17-04]</td><td align="char" char="." valign="bottom">8 days</td></tr><tr><td align="left" valign="bottom">Portugal</td><td align="char" char="ndash" valign="bottom">16–30</td><td align="char" char="ndash" valign="bottom">28–30</td><td align="char" char="." valign="bottom">[23-03, 15-04]</td><td align="char" char="." valign="bottom">12 days</td></tr><tr><td align="left" valign="bottom">Romania</td><td align="char" char="ndash" valign="bottom">24–30</td><td align="char" char="hyphen" valign="bottom">01-Jun</td><td align="char" char="." valign="bottom">[31-03, 29-04]</td><td align="char" char="." valign="bottom">13 days</td></tr><tr><td align="left" valign="bottom">Russian Federation</td><td align="char" char="ndash" valign="bottom">30–30</td><td align="char" char="hyphen" valign="bottom">01-Apr</td><td align="char" char="." valign="bottom">[01–05, 08–05]</td><td align="char" char="." valign="bottom">35 days</td></tr><tr><td align="left" valign="bottom">Slovenia</td><td align="char" char="ndash" valign="bottom">20–30</td><td align="char" char="ndash" valign="bottom">23–30</td><td align="left" valign="bottom">[≤13–03, 26–03]</td><td align="char" char="." valign="bottom">3 days</td></tr><tr><td align="left" valign="bottom">Spain</td><td align="char" char="ndash" valign="bottom">14–30</td><td align="char" char="ndash" valign="bottom">26–30</td><td align="char" char="." valign="bottom">[25-03, 26-03]</td><td align="char" char="." valign="bottom">12 days</td></tr><tr><td align="left" valign="bottom">Sweden</td><td align="left" valign="bottom"/><td align="char" char="hyphen" valign="bottom">01-Jan</td><td align="left" valign="bottom">[06–03,≥03-05-2021]</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Switzerland</td><td align="char" char="ndash" valign="bottom">17–30</td><td align="char" char="ndash" valign="bottom">22–30</td><td align="char" char="." valign="bottom">[20-03, 22-03]</td><td align="char" char="." valign="bottom">5 days</td></tr><tr><td align="left" valign="bottom">Turkey</td><td align="char" char="ndash" valign="bottom">21–30</td><td align="char" char="hyphen" valign="bottom">01-Aug</td><td align="char" char="." valign="bottom">[01–04, 13–04]</td><td align="char" char="." valign="bottom">18 days</td></tr><tr><td align="left" valign="bottom">United Kingdom</td><td align="char" char="ndash" valign="bottom">24–30</td><td align="char" char="ndash" valign="bottom">30–30</td><td align="char" char="." valign="bottom">[28-03, 20-04]</td><td align="char" char="." valign="bottom">6 days</td></tr></tbody></table></table-wrap><p>To consider the association between NPIs and the estimated <inline-formula><mml:math id="inf95"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> for countries outside of Europe, we used the stringency index (SI) of the Blavatnik School of Government (<xref ref-type="bibr" rid="bib24">Hale et al., 2020</xref>) to describe the public health response in different countries (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). This is a compound measure describing e.g. whether a state has closed borders, schools, or workplaces. For example, a country with widespread information campaigns, partially closed borders, closed schools, and a ban on public events and gatherings with more than 10 people would have an SI slightly above 50. As reference date, we used the date when a country first exceeded a stringency index of 50 (<inline-formula><mml:math id="inf96"><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mo>⁢</mml:mo><mml:mi>I</mml:mi><mml:mo>⁢</mml:mo><mml:mn>50</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula>). Then, we investigated whether the estimated <inline-formula><mml:math id="inf97"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> was significantly above 1 prior to the reference date (i.e. the lower bound of the 95% confidence interval was above 1). We excluded countries without <inline-formula><mml:math id="inf98"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates before the reference date <inline-formula><mml:math id="inf99"><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mo>⁢</mml:mo><mml:mi>I</mml:mi><mml:mo>⁢</mml:mo><mml:mn>50</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula>. Worldwide, for 35 out of the 42 countries which fulfilled the criteria for inclusion (list in Appendix 6), <inline-formula><mml:math id="inf100"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> was significantly above 1 prior to <inline-formula><mml:math id="inf101"><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi>S</mml:mi><mml:mo>⁢</mml:mo><mml:mi>I</mml:mi><mml:mo>⁢</mml:mo><mml:mn>50</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula>. As a sensitivity analysis, we performed the same calculation with a different reference date <inline-formula><mml:math id="inf102"><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mo>⁢</mml:mo><mml:mi>a</mml:mi><mml:mo>⁢</mml:mo><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>, defined as the date with the biggest increase in SI in the preceding 7 days. The results were very similar, with 38/45 countries significantly above one before <inline-formula><mml:math id="inf103"><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mo>⁢</mml:mo><mml:mi>a</mml:mi><mml:mo>⁢</mml:mo><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> (Appendix 6).</p></sec><sec id="s2-8"><title>Insights into continent-specific impacts of NPIs</title><p>To further investigate the association between non-pharmaceutical interventions and changes in the estimated reproductive number of SARS-CoV-2, we extended our analysis beyond the first 2020 epidemic wave. We included both the implementation and lifting of NPIs until May 3rd 2021 (increases and decreases in stringency). For each week and each country, we calculated the change in stringency index over the preceding week (<inline-formula><mml:math id="inf104"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo>⁢</mml:mo><mml:mi>S</mml:mi><mml:mo>⁢</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mrow><mml:mi>S</mml:mi><mml:mo>⁢</mml:mo><mml:mi>I</mml:mi><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mo>-</mml:mo><mml:mrow><mml:mi>S</mml:mi><mml:mo>⁢</mml:mo><mml:mi>I</mml:mi><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>7</mml:mn></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:mrow></mml:math></inline-formula>) and the corresponding change in the estimated <inline-formula><mml:math id="inf105"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> (during the same week <inline-formula><mml:math id="inf106"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo>⁢</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>R</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>R</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover><mml:mi>e</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mo>-</mml:mo><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>R</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover><mml:mi>e</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>7</mml:mn></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:mrow></mml:math></inline-formula>, 1 week later <inline-formula><mml:math id="inf107"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo>⁢</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>R</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mn>7</mml:mn></mml:mrow></mml:mrow></mml:msub></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>R</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover><mml:mi>e</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mn>7</mml:mn></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mo>-</mml:mo><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>R</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover><mml:mi>e</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:mrow></mml:math></inline-formula>, or 2 weeks later <inline-formula><mml:math id="inf108"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo>⁢</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>R</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover><mml:mrow><mml:mi>e</mml:mi><mml:mo>,</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mn>14</mml:mn></mml:mrow></mml:mrow></mml:msub></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>R</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover><mml:mi>e</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mn>14</mml:mn></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mo>-</mml:mo><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>R</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover><mml:mi>e</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:mrow></mml:math></inline-formula>). If NPIs were effective, we expect increases in stringency to be associated with decreases in the estimated <inline-formula><mml:math id="inf109"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> and vice versa. We do find such an association for increases in stringency e.g. in Europe. In Europe we also see that large increases in stringency are associated with larger decreases in <inline-formula><mml:math id="inf110"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> 7–14 days after the change in SI. However, the association between decreases in stringency and changes in <inline-formula><mml:math id="inf111"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> is heterogeneous on all continents (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). This suggests that reversing non-pharmaceutical interventions had a different effect than introducing them.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>The association between the implementation or lifting of non-pharmaceutical interventions and changes in <inline-formula><mml:math id="inf112"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> until May 2021.</title><p>(<bold>A</bold>) The change in the estimated <inline-formula><mml:math id="inf113"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> at the same time as (<inline-formula><mml:math id="inf114"><mml:mrow><mml:mi>R</mml:mi><mml:mo mathvariant="normal">⁢</mml:mo><mml:mrow><mml:mo mathvariant="normal" stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo mathvariant="normal" stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) or following (<inline-formula><mml:math id="inf115"><mml:mrow><mml:mi>R</mml:mi><mml:mo mathvariant="normal">⁢</mml:mo><mml:mrow><mml:mo mathvariant="normal" stretchy="false">(</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo mathvariant="normal">+</mml:mo><mml:mn mathvariant="normal">7</mml:mn></mml:mrow><mml:mo mathvariant="normal" stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="inf116"><mml:mrow><mml:mi>R</mml:mi><mml:mo mathvariant="normal">⁢</mml:mo><mml:mrow><mml:mo mathvariant="normal" stretchy="false">(</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo mathvariant="normal">+</mml:mo><mml:mn mathvariant="normal">14</mml:mn></mml:mrow><mml:mo mathvariant="normal" stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>) the implementation (above x-axis) or lifting (below x-axis) of NPIs in a given week. (<bold>B</bold>) The change in the estimated <inline-formula><mml:math id="inf117"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> related to the change in mobility in the same week. The error bars indicate the Q1 and Q3 quartiles.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71345-fig5-v2.tif"/></fig><p>We repeated the same analysis for Europe, comparing against various measures of Google mobility data (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Increased mobility in residential areas, and decreased mobility at workplaces or grocery stores is associated with decreases in <inline-formula><mml:math id="inf118"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula>.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>We have developed a pipeline to estimate the effective reproductive number <inline-formula><mml:math id="inf119"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> of SARS-CoV-2 for both timely monitoring and retrospective investigation. We evaluated our estimates on simulated data. We showed that the inferred <inline-formula><mml:math id="inf120"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> curve can be over-smoothed on simulated data, but that this disadvantage is outweighed by the increased stability of the estimates. Overall, we show that the relative error in the <inline-formula><mml:math id="inf121"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates is small.</p><p>During the ongoing SARS-CoV-2 pandemic, <inline-formula><mml:math id="inf122"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates are of interest to health authorities, politicians, decision makers, the media and the general public. Because of this broad interest and the importance of <inline-formula><mml:math id="inf123"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates, it is crucial to communicate both the results as well as the associated uncertainty and caveats in an open, transparent and accessible way. This is why we display daily updated results on an online dashboard, accessible at <ext-link ext-link-type="uri" xlink:href="https://ibz-shiny.ethz.ch/covid-19-re-international/">https://ibz-shiny.ethz.ch/covid-19-re-international/</ext-link>. The dashboard shows <inline-formula><mml:math id="inf124"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates in the form of time series for each included country or region, and a global map containing the latest <inline-formula><mml:math id="inf125"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates and normalised incidence. For all countries, we further display a timeline of the stringency index of the Blavatnik School of Government (<xref ref-type="bibr" rid="bib25">Hale et al., 2021</xref>), and current vaccination coverage.</p><p>A unique advantage of the monitoring method we have developed is the parallel use of different types of observation data, all reflecting the same underlying infection process (<xref ref-type="bibr" rid="bib53">Scire et al., 2020</xref>). Wherever we have data of sufficient quality, we estimate <inline-formula><mml:math id="inf126"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> separately based on confirmed cases, hospitalisations and death reports. The advantages and disadvantages of the different observation types are discussed in the Appendix 1. Comparing estimates from several types of data is a powerful way to evaluate the sensitivity of the results to the type of observations they were derived from. More generally, the method is applicable to any other type of incidence data, such as admissions to intensive care units or excess death data. We have also extended this method to make use of daily measurements of SARS-CoV-2 viral concentrations in wastewater (<xref ref-type="bibr" rid="bib31">Huisman et al., 2022</xref>). The potential limitations of our <inline-formula><mml:math id="inf127"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimation method are discussed in detail in the Appendix 1.</p><p>Any decision to implement, remove or otherwise adjust measures aimed at infection control will be informed by epidemiological, social and economic factors (<xref ref-type="bibr" rid="bib55">Sebhatu et al., 2020</xref>). We can aid this decision making process by investigating the association between adjustments of public-health measures and the estimated <inline-formula><mml:math id="inf128"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula>. In particular, the merits of nation-wide lockdowns in the context of the COVID-19 pandemic have been heavily discussed, both in the scientific literature and the public sphere (<xref ref-type="bibr" rid="bib19">Flaxman et al., 2020</xref>; <xref ref-type="bibr" rid="bib27">Haug et al., 2020</xref>; <xref ref-type="bibr" rid="bib9">Banholzer et al., 2021</xref>; <xref ref-type="bibr" rid="bib57">Soltesz et al., 2020</xref>; <xref ref-type="bibr" rid="bib32">Karberg, 2020</xref>). Analyses showing that <inline-formula><mml:math id="inf129"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates had dropped below 1 before the strictest measures were enforced were frequently used to claim that a lockdown was not necessary (<xref ref-type="bibr" rid="bib32">Karberg, 2020</xref>). We showed that this argumentation cannot be applied universally: for 15 out of 20 European countries, we found that the estimated <inline-formula><mml:math id="inf130"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> was significantly above 1 prior to the lockdown in spring of 2020. Interestingly, the result we obtain for Germany critically depends on whether we use symptom onset data, or more widely available case reports.</p><p>Extending our analysis beyond the first wave, we find differences between continents in the association between changes in the stringency of NPIs and changes in <inline-formula><mml:math id="inf131"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula>. This could reflect differences in the speed with which lockdowns were put into practice (<xref ref-type="bibr" rid="bib33">Kohanovski et al., 2022</xref>), the de facto lockdown stringency, or socio-cultural aspects (<xref ref-type="bibr" rid="bib55">Sebhatu et al., 2020</xref>; <xref ref-type="bibr" rid="bib39">Mbow et al., 2020</xref>). It is often argued that, especially in countries with a large informal business sector, there may be a difference between the official containment measures and those adhered to or implemented de facto (<xref ref-type="bibr" rid="bib39">Mbow et al., 2020</xref>). However, for continents where we find no significant correlation, this could also be because a large fraction of NPIs were implemented at a time for which we could not estimate changes in <inline-formula><mml:math id="inf132"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula>. Many African countries had early and strict government responses, often prior to the first detected cases. These are thought to have delayed the virus in establishing a foothold on the continent (<xref ref-type="bibr" rid="bib39">Mbow et al., 2020</xref>).</p><p>Importantly, our analysis suggests that reversing non-pharmaceutical interventions may have a very different effect than introducing them. This could be because the situation is not fully reverted: due to increased public awareness, testing, contact tracing, and quarantine measures still in place. In addition, the epidemic situation - in terms of number of infected individuals - is likely different when measures are implemented or lifted.</p><p>Our analysis could be confounded by economic, social, and psychological factors motivating the implementation or release of measures. With the current stringency measures we cannot account for diversity in adherence to NPIs across geographic regions and through time. Cultural norms, defiance towards public authorities, &quot;lockdown fatigue&quot;, and economic pressures are all among the factors that may determine whether NPIs are in fact adhered to. In addition, there is increasing evidence that weather may be a factor influencing <inline-formula><mml:math id="inf133"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> through its effect on people’s behaviour and on properties of the virus (<xref ref-type="bibr" rid="bib42">Morris et al., 2021</xref>). In the future, our tools to estimate <inline-formula><mml:math id="inf134"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> could be used to explore associations of these many factors with <inline-formula><mml:math id="inf135"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates, with the aim of identifying minimal sets of factors that may ensure an <inline-formula><mml:math id="inf136"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>&lt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mstyle></mml:math></inline-formula> for a particular location.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Overview of the software pipeline</title><p>The software pipeline we developed allows the estimation of <inline-formula><mml:math id="inf137"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> from different proxies for the infection incidence, such as the time series of confirmed cases, hospitalisations or deaths. It provides a separate estimate of the <inline-formula><mml:math id="inf138"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> trajectory through time for each proxy. In a first step, we smooth the case observations and deconvolve the smoothed observations by the type-specific delay distribution to obtain an estimate of the infection incidence time series. Second, we use the package EpiEstim to estimate the effective reproductive number Re from this infection incidence. We assess the uncertainty in the estimates using the union of a block bootstrap method, designed to account for variation in the case observations, and the credible intervals from EpiEstim.</p></sec><sec id="s4-2"><title>Smoothing the case observations</title><p>To reduce the influence of weekly patterns in case reporting data, as well as reporting irregularities, we smooth the observed incidence data prior to deconvolution. To smooth the incidence data, we use local polynomial regression (LOESS) with 1st order polynomials and tricubic weights. The smoothing parameter alpha is set such that we include 21 days of data in the local neighbourhood of each point. After smoothing, we normalise to the original total number of cases. Here we use smoothing parameter 21 because it performs best overall in our simulations. We investigated the effect of this tuning parameter in simulations, see <xref ref-type="fig" rid="app5fig5">Appendix 5—figure 5</xref>.</p></sec><sec id="s4-3"><title>Estimating the infection incidence through deconvolution</title><p>To recover the non-observed time series of infection incidence, we deconvolve the smoothed observed time series of COVID-19 case incidence with a delay distribution specific to the type of case detection (case confirmation, hospital admission, death). To this end, we extended the deconvolution method of <xref ref-type="bibr" rid="bib20">Goldstein et al., 2009</xref>, which is itself an adaptation of the Richardson-Lucy algorithm (<xref ref-type="bibr" rid="bib49">Richardson, 1972</xref>; <xref ref-type="bibr" rid="bib38">Lucy, 1974</xref>) (essentially an expectation maximisation algorithm), to deal with zero-incidence case observations and time-varying delay distributions.</p><p>Formally, the method infers a deconvolved output time series <inline-formula><mml:math id="inf139"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>N</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> from an input time series <inline-formula><mml:math id="inf140"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>D</mml:mi><mml:mo stretchy="false">¯</mml:mo></mml:mover><mml:mi>K</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>D</mml:mi><mml:mo stretchy="false">¯</mml:mo></mml:mover><mml:mi>N</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>, where <inline-formula><mml:math id="inf141"><mml:mrow><mml:mi>K</mml:mi><mml:mo>≥</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="inf142"><mml:msub><mml:mover accent="true"><mml:mi>D</mml:mi><mml:mo stretchy="false">¯</mml:mo></mml:mover><mml:mi>i</mml:mi></mml:msub></mml:math></inline-formula> indicates the smoothed number of observations on day <inline-formula><mml:math id="inf143"><mml:mi>i</mml:mi></mml:math></inline-formula> (e.g. confirmed cases, hospitalisations, or deaths). Let <inline-formula><mml:math id="inf144"><mml:msubsup><mml:mi>m</mml:mi><mml:mi>l</mml:mi><mml:mi>j</mml:mi></mml:msubsup></mml:math></inline-formula> be the probability that an infection on day <inline-formula><mml:math id="inf145"><mml:mi>j</mml:mi></mml:math></inline-formula> takes <inline-formula><mml:math id="inf146"><mml:mrow><mml:mi>l</mml:mi><mml:mo>≥</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></inline-formula> days to be observed. If no line list data is available, <inline-formula><mml:math id="inf147"><mml:mrow><mml:msubsup><mml:mi>m</mml:mi><mml:mi>l</mml:mi><mml:mi>j</mml:mi></mml:msubsup><mml:mo>=</mml:mo><mml:msub><mml:mi>m</mml:mi><mml:mi>l</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> and no time-variation of the delay distribution is assumed. Let <italic>q</italic><sub><italic>j</italic></sub> be the probability that an infection that occurred on day <inline-formula><mml:math id="inf148"><mml:mi>j</mml:mi></mml:math></inline-formula> is observed during the time-window of observations, i.e. is counted towards <inline-formula><mml:math id="inf149"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>D</mml:mi><mml:mo stretchy="false">¯</mml:mo></mml:mover><mml:mi>K</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>D</mml:mi><mml:mo stretchy="false">¯</mml:mo></mml:mover><mml:mi>N</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>. Then:<disp-formula id="equ1"><label>(1)</label><mml:math id="m1"><mml:mtable columnspacing="5pt" displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:msub><mml:mi>q</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:mi/><mml:mo>=</mml:mo><mml:mrow><mml:mstyle displaystyle="false"><mml:msubsup><mml:mo largeop="true" symmetric="true">∑</mml:mo><mml:mrow><mml:mi>l</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mi>K</mml:mi><mml:mo>-</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:mrow><mml:mrow><mml:mi>N</mml:mi><mml:mo>-</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msubsup></mml:mstyle><mml:mpadded width="+1.7pt"><mml:msubsup><mml:mi>m</mml:mi><mml:mi>l</mml:mi><mml:mi>j</mml:mi></mml:msubsup></mml:mpadded></mml:mrow></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula></p><p>Let <inline-formula><mml:math id="inf150"><mml:msub><mml:mi>E</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math></inline-formula> be the expected number of observed cases on day <inline-formula><mml:math id="inf151"><mml:mi>i</mml:mi></mml:math></inline-formula>, for a given infection incidence <inline-formula><mml:math id="inf152"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>:<disp-formula id="equ2"><label>(2)</label><mml:math id="m2"><mml:mrow><mml:mtable columnalign="right left" rowspacing="4pt" columnspacing="1em"><mml:mtr><mml:mtd><mml:msub><mml:mi>E</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mtd><mml:mtd><mml:mo>=</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:mtable columnalign="left left" rowspacing=".2em" columnspacing="1em" displaystyle="false"><mml:mtr><mml:mtd><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:munderover><mml:msub><mml:mi>λ</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mspace width="thinmathspace"/><mml:msubsup><mml:mi>m</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>−</mml:mo><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup></mml:mtd><mml:mtd><mml:mtext>for</mml:mtext><mml:mspace width="1em"/><mml:mi>K</mml:mi><mml:mo>≥</mml:mo><mml:mi>i</mml:mi><mml:mo>≥</mml:mo><mml:mi>N</mml:mi></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mn>0</mml:mn></mml:mtd><mml:mtd><mml:mtext>for</mml:mtext><mml:mspace width="1em"/><mml:mn>0</mml:mn><mml:mo>&lt;</mml:mo><mml:mi>i</mml:mi><mml:mo>&lt;</mml:mo><mml:mi>K</mml:mi><mml:mspace width="thinmathspace"/><mml:mo>.</mml:mo></mml:mtd></mml:mtr></mml:mtable><mml:mo fence="true" stretchy="true" symmetric="true"/></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p><p>The deconvolution algorithm uses expectation maximisation (<xref ref-type="bibr" rid="bib15">Dempster et al., 1977</xref>) to find a final infection incidence estimate, which has the highest likelihood of explaining the observed input time series. To do so, it starts from an initial guess of the infection incidence time series <inline-formula><mml:math id="inf153"><mml:mrow><mml:msup><mml:mi mathvariant="normal">Λ</mml:mi><mml:mn>0</mml:mn></mml:msup><mml:mo>=</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msubsup><mml:mi>λ</mml:mi><mml:mn>1</mml:mn><mml:mn>0</mml:mn></mml:msubsup><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msubsup><mml:mi>λ</mml:mi><mml:mi>N</mml:mi><mml:mn>0</mml:mn></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, used to compute <inline-formula><mml:math id="inf154"><mml:msubsup><mml:mi>E</mml:mi><mml:mi>i</mml:mi><mml:mn>0</mml:mn></mml:msubsup></mml:math></inline-formula> according to <xref ref-type="disp-formula" rid="equ2">equation 2</xref>, and updates the estimate in each iteration <inline-formula><mml:math id="inf155"><mml:mi>n</mml:mi></mml:math></inline-formula> according to the following formula:<disp-formula id="equ3"><label>(3)</label><mml:math id="m3"><mml:msubsup><mml:mi>λ</mml:mi><mml:mi>j</mml:mi><mml:mrow><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:mrow><mml:mrow><mml:mi/><mml:mo>=</mml:mo><mml:mrow><mml:mstyle displaystyle="true"><mml:mfrac><mml:msubsup><mml:mi>λ</mml:mi><mml:mi>j</mml:mi><mml:mi>n</mml:mi></mml:msubsup><mml:msub><mml:mi>q</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mfrac></mml:mstyle><mml:mo>⋅</mml:mo><mml:mrow><mml:mstyle displaystyle="true"><mml:munderover><mml:mo largeop="true" movablelimits="false" symmetric="true">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mi>K</mml:mi></mml:mrow><mml:mi>N</mml:mi></mml:munderover></mml:mstyle><mml:mpadded width="+1.7pt"><mml:mstyle displaystyle="true"><mml:mfrac><mml:mrow><mml:msubsup><mml:mi>m</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>-</mml:mo><mml:mi>j</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msubsup><mml:mo>⁢</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>D</mml:mi><mml:mo stretchy="false">¯</mml:mo></mml:mover><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:msubsup><mml:mi>E</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:msubsup></mml:mfrac></mml:mstyle></mml:mpadded></mml:mrow></mml:mrow></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula></p><p>The iteration proceeds until a termination criterion is reached. Here, we follow Goldstein et al. and iterate until the <inline-formula><mml:math id="inf156"><mml:msup><mml:mi>χ</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:math></inline-formula> statistic drops below 1 (<xref ref-type="bibr" rid="bib20">Goldstein et al., 2009</xref>):<disp-formula id="equ4"><label>(4)</label><mml:math id="m4"><mml:msup><mml:mi>χ</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mrow><mml:mrow><mml:mi/><mml:mo>=</mml:mo><mml:mrow><mml:mstyle displaystyle="true"><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mrow><mml:mi>N</mml:mi><mml:mo>-</mml:mo><mml:mi>K</mml:mi></mml:mrow><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfrac></mml:mstyle><mml:mo>⁢</mml:mo><mml:mrow><mml:mstyle displaystyle="true"><mml:munderover><mml:mo largeop="true" movablelimits="false" symmetric="true">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mi>K</mml:mi></mml:mrow><mml:mi>N</mml:mi></mml:munderover></mml:mstyle><mml:mpadded width="+1.7pt"><mml:mstyle displaystyle="true"><mml:mfrac><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msubsup><mml:mi>E</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:msubsup><mml:mo>-</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>D</mml:mi><mml:mo stretchy="false">¯</mml:mo></mml:mover><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:msubsup><mml:mi>E</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi></mml:msubsup></mml:mfrac></mml:mstyle></mml:mpadded></mml:mrow></mml:mrow></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula></p><p>or 100 iterations have been reached.</p><p>Convergence is typically fast and the stopping criterion based on the <inline-formula><mml:math id="inf157"><mml:msup><mml:mi>χ</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:math></inline-formula> statistic is reached in a few iterations. Due to the smoothing prior to deconvolution, this is the case for the vast majority of the empirical data we analyzed. In some cases, e.g. when the observed incidence is especially noisy, convergence is slower and the threshold of 100 iterations is reached (on 26.5.2022, this was the case for 13 of the countries analyzed).</p><p>For the initial estimate of the incidence time series <inline-formula><mml:math id="inf158"><mml:msup><mml:mi mathvariant="normal">Λ</mml:mi><mml:mn>0</mml:mn></mml:msup></mml:math></inline-formula>, we shift the observation time series backwards in time by the mode of the delay distribution μ <xref ref-type="bibr" rid="bib20">Goldstein et al., 2009</xref>. However, this leaves a gap of unspecified values at the start and end of the time series <inline-formula><mml:math id="inf159"><mml:msub><mml:mi mathvariant="normal">Λ</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math></inline-formula>. Contrary to Goldstein et al., we augment the shifted time series with the first observed value (<inline-formula><mml:math id="inf160"><mml:msub><mml:mover accent="true"><mml:mi>D</mml:mi><mml:mo stretchy="false">¯</mml:mo></mml:mover><mml:mi>K</mml:mi></mml:msub></mml:math></inline-formula>) on the left, and with the last observed value (<inline-formula><mml:math id="inf161"><mml:msub><mml:mover accent="true"><mml:mi>D</mml:mi><mml:mo stretchy="false">¯</mml:mo></mml:mover><mml:mi>N</mml:mi></mml:msub></mml:math></inline-formula>) on the right, to avoid initialising with a zero-value anywhere. If a day is initialised with zero incidence, it will also have zero incidence in the final estimate (compare <xref ref-type="disp-formula" rid="equ3">equation (3)</xref>), which would be a potential source of bias.</p><p>We note that the Richardson-Lucy deconvolution algorithm accounts for ‘right truncation’, i.e. that not all infections are observed within the given observation time window (due to delay until symptoms/reporting), through the <italic>q</italic><sub><italic>j</italic></sub> indices.</p></sec><sec id="s4-4"><title>Use of line list data</title><p>When information on the time variation of delays between symptom onset and observation is available (e.g. through a line list), this can be taken into account directly during the deconvolution step. In this case, we perform the deconvolution in two separate steps: first with the time-varying empirical onset-to-observation distributions, and then with the constant-through-time incubation period distribution. For those cases where symptom onset data is available, we only deconvolve with the incubation period distribution.</p><p>The <inline-formula><mml:math id="inf162"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msubsup><mml:mi>m</mml:mi><mml:mn>0</mml:mn><mml:mi>j</mml:mi></mml:msubsup><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msubsup><mml:mi>m</mml:mi><mml:msub><mml:mi>l</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mo>⁢</mml:mo><mml:mi>a</mml:mi><mml:mo>⁢</mml:mo><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mi>j</mml:mi></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> time-varying delay distributions from onset of symptoms to observation are determined as follows: for each date <inline-formula><mml:math id="inf163"><mml:mi>j</mml:mi></mml:math></inline-formula>, at least 300 of the most recent recorded delays between symptom onset and observation, with onset date before <inline-formula><mml:math id="inf164"><mml:mi>j</mml:mi></mml:math></inline-formula>, are taken into account; <inline-formula><mml:math id="inf165"><mml:msub><mml:mi>l</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mo>⁢</mml:mo><mml:mi>a</mml:mi><mml:mo>⁢</mml:mo><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> being the highest observed delay. To avoid biases caused by the intensity of testing and reporting varying throughout the week, recorded delays are included in full weeks going in the past, until at least 00 delays are included.</p><p>As the incidence data is right-truncated, we have to fix the distribution for the reporting delay (<inline-formula><mml:math id="inf166"><mml:msubsup><mml:mi>m</mml:mi><mml:mi>l</mml:mi><mml:mi>j</mml:mi></mml:msubsup></mml:math></inline-formula>) after a certain day <inline-formula><mml:math id="inf167"><mml:mi>j</mml:mi></mml:math></inline-formula>, so that delay distributions are not downward biased for infection dates close to the present. Let <inline-formula><mml:math id="inf168"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>m</mml:mi><mml:mo stretchy="false">¯</mml:mo></mml:mover><mml:mn>0</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>m</mml:mi><mml:mo stretchy="false">¯</mml:mo></mml:mover><mml:msub><mml:mi>l</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mo>⁢</mml:mo><mml:mi>a</mml:mi><mml:mo>⁢</mml:mo><mml:mi>x</mml:mi></mml:mrow></mml:msub></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> be the empirical probability density function of the delay (aggregated over the entire window of observations) and <inline-formula><mml:math id="inf169"><mml:mi>n</mml:mi></mml:math></inline-formula> the 99th percentile of this distribution (<inline-formula><mml:math id="inf170"><mml:mi>n</mml:mi></mml:math></inline-formula> is the smallest integer for which <inline-formula><mml:math id="inf171"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:munderover><mml:msub><mml:mrow><mml:mover><mml:mi>m</mml:mi><mml:mo stretchy="false">¯</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>≥</mml:mo><mml:mn>0.99</mml:mn></mml:mrow></mml:mstyle></mml:math></inline-formula>). For infection dates <inline-formula><mml:math id="inf172"><mml:mi>z</mml:mi></mml:math></inline-formula> that are closer to the present than <inline-formula><mml:math id="inf173"><mml:mi>n</mml:mi></mml:math></inline-formula> (i.e. <inline-formula><mml:math id="inf174"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>N</mml:mi><mml:mo>−</mml:mo><mml:mi>z</mml:mi><mml:mo>&lt;</mml:mo><mml:mi>n</mml:mi></mml:mrow></mml:mstyle></mml:math></inline-formula>, where <inline-formula><mml:math id="inf175"><mml:mi>N</mml:mi></mml:math></inline-formula> is the index of the last available data point), we fix <inline-formula><mml:math id="inf176"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msubsup><mml:mi>m</mml:mi><mml:mn>0</mml:mn><mml:mi>z</mml:mi></mml:msubsup><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msubsup><mml:mi>m</mml:mi><mml:msub><mml:mi>l</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mo>⁢</mml:mo><mml:mi>a</mml:mi><mml:mo>⁢</mml:mo><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mi>z</mml:mi></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> to be equal to <inline-formula><mml:math id="inf177"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msubsup><mml:mi>m</mml:mi><mml:mn>0</mml:mn><mml:mrow><mml:mi>N</mml:mi><mml:mo>-</mml:mo><mml:mi>n</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msubsup><mml:mi>m</mml:mi><mml:msub><mml:mi>l</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mo>⁢</mml:mo><mml:mi>a</mml:mi><mml:mo>⁢</mml:mo><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mi>N</mml:mi><mml:mo>-</mml:mo><mml:mi>n</mml:mi></mml:mrow></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>.</p></sec><sec id="s4-5"><title>Estimating the effective reproductive number Re</title><p>Once we have obtained an estimate for the time series of infection incidence, we use the method developed by <xref ref-type="bibr" rid="bib13">Cori et al., 2013</xref>, implemented in the EpiEstim R package, to estimate <inline-formula><mml:math id="inf178"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula>.</p><p>Disease transmission is modelled with a Poisson process. At time <inline-formula><mml:math id="inf179"><mml:mi>t</mml:mi></mml:math></inline-formula>, an individual infected at time <inline-formula><mml:math id="inf180"><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:math></inline-formula> causes new infections at a rate <inline-formula><mml:math id="inf181"><mml:mrow><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mo>⋅</mml:mo><mml:msub><mml:mi>w</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>, where <italic>w</italic><sub><italic>s</italic></sub> is the value of the infectivity profile <inline-formula><mml:math id="inf182"><mml:mi>s</mml:mi></mml:math></inline-formula> days after infection. The infectivity profile sums to 1, and can be approximated by the (discretised) serial interval distribution (<xref ref-type="bibr" rid="bib13">Cori et al., 2013</xref>). The likelihood of the incidence <inline-formula><mml:math id="inf183"><mml:msub><mml:mi>I</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></inline-formula> at time <inline-formula><mml:math id="inf184"><mml:mi>t</mml:mi></mml:math></inline-formula> is thus given by:<disp-formula id="equ5"><label>(5)</label><mml:math id="m5"><mml:mtable columnspacing="5pt" displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>P</mml:mi><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo lspace="2.5pt" rspace="2.5pt" stretchy="false">|</mml:mo><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:mi/><mml:mo>=</mml:mo><mml:mpadded width="+1.7pt"><mml:mstyle displaystyle="false"><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>⁢</mml:mo><mml:msub><mml:mi mathvariant="normal">Λ</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:msup><mml:mo>⁢</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>-</mml:mo><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>⁢</mml:mo><mml:msub><mml:mi mathvariant="normal">Λ</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>!</mml:mo></mml:mrow></mml:mfrac></mml:mstyle></mml:mpadded></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula><disp-formula id="equ6"><label>(6)</label><mml:math id="m6"><mml:mtable columnspacing="5pt" displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mtext>where</mml:mtext><mml:mo mathsize="70%" mathvariant="italic" separator="true" stretchy="false">    </mml:mo><mml:msub><mml:mi mathvariant="normal">Λ</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:mi/><mml:mo>=</mml:mo><mml:mrow><mml:mstyle displaystyle="false"><mml:msubsup><mml:mo largeop="true" symmetric="true">∑</mml:mo><mml:mrow><mml:mi>s</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>t</mml:mi></mml:msubsup></mml:mstyle><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>⁢</mml:mo><mml:mpadded width="+1.7pt"><mml:msub><mml:mi>w</mml:mi><mml:mi>s</mml:mi></mml:msub></mml:mpadded></mml:mrow></mml:mrow></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula></p><p>The <inline-formula><mml:math id="inf185"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> inference is performed in a Bayesian framework, and an analytical solution can be derived for the posterior distribution of <inline-formula><mml:math id="inf186"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> (see <xref ref-type="bibr" rid="bib13">Cori et al., 2013</xref>; Web Appendix 1). We choose a gamma distributed prior on <inline-formula><mml:math id="inf187"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> with mean 1, and standard deviation 5.</p><p>For the gradually-changing <inline-formula><mml:math id="inf188"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates, we assume <inline-formula><mml:math id="inf189"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> is constant over a sliding window of 3 days (<inline-formula><mml:math id="inf190"><mml:mrow><mml:mi>τ</mml:mi><mml:mo>=</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:math></inline-formula> in EpiEstim), i.e. the reported <inline-formula><mml:math id="inf191"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimate for day <inline-formula><mml:math id="inf192"><mml:mi>T</mml:mi></mml:math></inline-formula> summarises the average <inline-formula><mml:math id="inf193"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> over a 3 day period ending on day <inline-formula><mml:math id="inf194"><mml:mi>T</mml:mi></mml:math></inline-formula>. In addition to these smooth estimates, we provide step-wise estimates of <inline-formula><mml:math id="inf195"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> on our dashboard. In the step-wise analysis, <inline-formula><mml:math id="inf196"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> is assumed to be constant on a number of intervals spanning the entire epidemic time window. These intervals are determined by dates at which public health interventions were implemented, altered, or lifted. All results reported here are based on the smooth <inline-formula><mml:math id="inf197"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates. In both cases, we use the mean of the posterior distribution of <inline-formula><mml:math id="inf198"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> as the point estimate.</p></sec><sec id="s4-6"><title>Estimating the uncertainty intervals</title><p>To account for the uncertainty in the case observations, we construct 95% bootstrap confidence intervals for <inline-formula><mml:math id="inf199"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula>. We first re-sample case observations as follows: given the original case observations <inline-formula><mml:math id="inf200"><mml:mrow><mml:mrow><mml:mrow><mml:msub><mml:mi>D</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow><mml:mo>=</mml:mo><mml:mi>K</mml:mi></mml:mrow><mml:mo>,</mml:mo><mml:mrow><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:mi>N</mml:mi></mml:mrow></mml:mrow></mml:math></inline-formula>, we apply the LOESS with smoothing parameter 21 days on the log-transformed data <inline-formula><mml:math id="inf201"><mml:mrow><mml:mi>l</mml:mi><mml:mo>⁢</mml:mo><mml:mi>o</mml:mi><mml:mo>⁢</mml:mo><mml:mi>g</mml:mi><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msub><mml:mi>D</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> to obtain the smoothed value <inline-formula><mml:math id="inf202"><mml:msub><mml:mover accent="true"><mml:mi>μ</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover><mml:mi>t</mml:mi></mml:msub></mml:math></inline-formula> and additive residuals <italic>e</italic><sub><italic>t</italic></sub>. Here we use log-transformation to stabilise the variance of the residuals because it is the best overall choice among the transformations we tried. We compare to the commonly used square root transformation in <xref ref-type="fig" rid="app5fig1">Appendix 5—figure 1</xref>.</p><p>After obtaining the residuals <italic>e</italic><sub><italic>t</italic></sub>, we resample them to get bootstrap residuals <inline-formula><mml:math id="inf203"><mml:msubsup><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mo>*</mml:mo></mml:msubsup></mml:math></inline-formula> and obtain the bootstrap case observations by<disp-formula id="equ7"><label>(7)</label><mml:math id="m7"><mml:mtable columnspacing="5pt" displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mrow><mml:msubsup><mml:mi>D</mml:mi><mml:mi>t</mml:mi><mml:mo>*</mml:mo></mml:msubsup><mml:mo>=</mml:mo><mml:mrow><mml:mi>max</mml:mi><mml:mo>⁡</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mrow><mml:mi>exp</mml:mi><mml:mo>⁡</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>μ</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover><mml:mi>t</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msubsup><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mo>*</mml:mo></mml:msubsup></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>,</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:mtd><mml:mtd/></mml:mtr></mml:mtable></mml:math></disp-formula></p><p>We now discuss how we obtain a set of bootstrapped residuals <inline-formula><mml:math id="inf204"><mml:msubsup><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mo>*</mml:mo></mml:msubsup></mml:math></inline-formula>, <inline-formula><mml:math id="inf205"><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mi>K</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:mi>N</mml:mi></mml:mrow></mml:mrow></mml:math></inline-formula>. Since the empirical residuals of most countries are autocorrelated (see <xref ref-type="fig" rid="app5fig2">Appendix 5—figure 2</xref>), we use an overlapping block bootstrap. Specifically, given the original residuals <inline-formula><mml:math id="inf206"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mi>K</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mi>N</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>, we start by taking a random block of <inline-formula><mml:math id="inf207"><mml:mi>b</mml:mi></mml:math></inline-formula> consecutive residuals, which we denote by <inline-formula><mml:math id="inf208"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msubsup><mml:mi>e</mml:mi><mml:mn>1</mml:mn><mml:mrow><mml:mi/><mml:mo>*</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msubsup><mml:mi>e</mml:mi><mml:mi>b</mml:mi><mml:mrow><mml:mi/><mml:mo>*</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>. To account for weekly patterns in the case observations, we need to match the day of the week to the original case observations. That is, we keep the longest subvector <inline-formula><mml:math id="inf209"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msubsup><mml:mi>e</mml:mi><mml:msub><mml:mi>m</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mrow><mml:mi/><mml:mo>*</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msubsup><mml:mi>e</mml:mi><mml:mi>b</mml:mi><mml:mrow><mml:mi/><mml:mo>*</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> of <inline-formula><mml:math id="inf210"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msubsup><mml:mi>e</mml:mi><mml:mn>1</mml:mn><mml:mrow><mml:mi/><mml:mo>*</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msubsup><mml:mi>e</mml:mi><mml:mi>b</mml:mi><mml:mrow><mml:mi/><mml:mo>*</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> such that <inline-formula><mml:math id="inf211"><mml:msubsup><mml:mi>e</mml:mi><mml:msub><mml:mi>m</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mrow><mml:mi/><mml:mo>*</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup></mml:math></inline-formula> has the same day of the week as <inline-formula><mml:math id="inf212"><mml:msub><mml:mi>e</mml:mi><mml:mi>K</mml:mi></mml:msub></mml:math></inline-formula> (e.g., both correspond to Fridays). We then randomly take a new block of <inline-formula><mml:math id="inf213"><mml:mi>b</mml:mi></mml:math></inline-formula> consecutive residuals, which we denote by <inline-formula><mml:math id="inf214"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msubsup><mml:mi>e</mml:mi><mml:mn>1</mml:mn><mml:mrow><mml:mi/><mml:mo>*</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msubsup><mml:mi>e</mml:mi><mml:mi>b</mml:mi><mml:mrow><mml:mi/><mml:mo>*</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>. We keep its longest part <inline-formula><mml:math id="inf215"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msubsup><mml:mi>e</mml:mi><mml:msub><mml:mi>m</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mrow><mml:mi/><mml:mo>*</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msubsup><mml:mi>e</mml:mi><mml:mi>b</mml:mi><mml:mrow><mml:mi/><mml:mo>*</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> such that <inline-formula><mml:math id="inf216"><mml:msubsup><mml:mi>e</mml:mi><mml:msub><mml:mi>m</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mrow><mml:mi/><mml:mo>*</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></inline-formula> has the day of the week that follows on that of <inline-formula><mml:math id="inf217"><mml:msubsup><mml:mi>e</mml:mi><mml:mi>b</mml:mi><mml:mrow><mml:mi/><mml:mo>*</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup></mml:math></inline-formula> (e.g. if <inline-formula><mml:math id="inf218"><mml:msubsup><mml:mi>e</mml:mi><mml:mi>b</mml:mi><mml:mrow><mml:mi/><mml:mo>*</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup></mml:math></inline-formula> corresponds to a Tuesday, then <inline-formula><mml:math id="inf219"><mml:msubsup><mml:mi>e</mml:mi><mml:msub><mml:mi>m</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mrow><mml:mi/><mml:mo>*</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></inline-formula> must correspond to a Wednesday). We then glue these two sampled blocks together to get <inline-formula><mml:math id="inf220"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msubsup><mml:mi>e</mml:mi><mml:msub><mml:mi>m</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mrow><mml:mi/><mml:mo>*</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msubsup><mml:mi>e</mml:mi><mml:mi>b</mml:mi><mml:mrow><mml:mi/><mml:mo>*</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:msubsup><mml:mi>e</mml:mi><mml:msub><mml:mi>m</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mrow><mml:mi/><mml:mo>*</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msubsup><mml:mi>e</mml:mi><mml:mi>b</mml:mi><mml:mrow><mml:mi/><mml:mo>*</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>. We repeat this process of adding blocks until the length of the re-sampled residuals is at least as large as that of the original residuals. If it is longer, we simply cut off the last part of the re-sampled residuals so that its length is the same. Finally, we re-index the re-sampled residuals as <inline-formula><mml:math id="inf221"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msubsup><mml:mi>e</mml:mi><mml:mi>K</mml:mi><mml:mo>*</mml:mo></mml:msubsup><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msubsup><mml:mi>e</mml:mi><mml:mi>N</mml:mi><mml:mo>*</mml:mo></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>. We present a concrete example in Appendix 2.</p><p>Choosing an optimal block size <inline-formula><mml:math id="inf222"><mml:mi>b</mml:mi></mml:math></inline-formula> for the block bootstrap method is generally difficult. To capture week effects, we need a block size of at least 7. We tried different sizes and found that <inline-formula><mml:math id="inf223"><mml:mrow><mml:mi>b</mml:mi><mml:mo>=</mml:mo><mml:mn>10</mml:mn></mml:mrow></mml:math></inline-formula> tended to work well in various simulation settings (<xref ref-type="fig" rid="app5fig6">Appendix 5—figure 6</xref>).</p><p>Given a set of bootstrap case observations <inline-formula><mml:math id="inf224"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msubsup><mml:mi>D</mml:mi><mml:mi>K</mml:mi><mml:mo>*</mml:mo></mml:msubsup><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msubsup><mml:mi>D</mml:mi><mml:mi>N</mml:mi><mml:mo>*</mml:mo></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>, we apply our method to obtain an estimate for <inline-formula><mml:math id="inf225"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>. For ease of notation, we now denote this by <inline-formula><mml:math id="inf226"><mml:mrow><mml:msup><mml:mover accent="true"><mml:mi>θ</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover><mml:mo>*</mml:mo></mml:msup><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>. By repeating the above steps 100 times, we obtain <inline-formula><mml:math id="inf227"><mml:mrow><mml:mrow><mml:msubsup><mml:mover accent="true"><mml:mi>θ</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover><mml:mn>1</mml:mn><mml:mo>*</mml:mo></mml:msubsup><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mover accent="true"><mml:mi>θ</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover><mml:mn>100</mml:mn><mml:mo>*</mml:mo></mml:msubsup><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:math></inline-formula>. Then, we construct a Normal based bootstrap confidence interval for each time point <inline-formula><mml:math id="inf228"><mml:mi>t</mml:mi></mml:math></inline-formula> by:<disp-formula id="equ8"><label>(8)</label><mml:math id="m8"><mml:mtable columnspacing="5pt" displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mrow><mml:mrow><mml:mover accent="true"><mml:mi>θ</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mo>-</mml:mo><mml:mrow><mml:msub><mml:mi>q</mml:mi><mml:mi>z</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mstyle displaystyle="false"><mml:mfrac><mml:mi>α</mml:mi><mml:mn>2</mml:mn></mml:mfrac></mml:mstyle></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>⁢</mml:mo><mml:mover accent="true"><mml:mrow><mml:mi>s</mml:mi><mml:mo>⁢</mml:mo><mml:mi>d</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mover accent="true"><mml:mi>θ</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover><mml:mo>*</mml:mo></mml:msup><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mrow><mml:mo rspace="7.5pt">,</mml:mo><mml:mrow><mml:mrow><mml:mover accent="true"><mml:mi>θ</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:msub><mml:mi>q</mml:mi><mml:mi>z</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mstyle displaystyle="false"><mml:mfrac><mml:mi>α</mml:mi><mml:mn>2</mml:mn></mml:mfrac></mml:mstyle></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>⁢</mml:mo><mml:mover accent="true"><mml:mrow><mml:mi>s</mml:mi><mml:mo>⁢</mml:mo><mml:mi>d</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msup><mml:mover accent="true"><mml:mi>θ</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover><mml:mo>*</mml:mo></mml:msup><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mrow><mml:mo stretchy="false">]</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mtd><mml:mtd/></mml:mtr></mml:mtable></mml:math></disp-formula></p><p>where <inline-formula><mml:math id="inf229"><mml:mrow><mml:mover accent="true"><mml:mi>θ</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> denotes the estimated <inline-formula><mml:math id="inf230"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> based on the original case observations, <inline-formula><mml:math id="inf231"><mml:mrow><mml:msub><mml:mi>q</mml:mi><mml:mi>z</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mfrac><mml:mi>α</mml:mi><mml:mn>2</mml:mn></mml:mfrac></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> denotes the <inline-formula><mml:math id="inf232"><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mfrac><mml:mi>α</mml:mi><mml:mn>2</mml:mn></mml:mfrac></mml:mrow></mml:math></inline-formula> quantile of the standard normal distribution, and <inline-formula><mml:math id="inf233"><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>s</mml:mi><mml:mo>⁢</mml:mo><mml:mi>d</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msup><mml:mover accent="true"><mml:mi>θ</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover><mml:mo>*</mml:mo></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> denotes the empirical standard deviation of <inline-formula><mml:math id="inf234"><mml:mrow><mml:mrow><mml:msubsup><mml:mover accent="true"><mml:mi>θ</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover><mml:mn>1</mml:mn><mml:mo>*</mml:mo></mml:msubsup><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:mrow><mml:msubsup><mml:mover accent="true"><mml:mi>θ</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover><mml:mn>100</mml:mn><mml:mo>*</mml:mo></mml:msubsup><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:math></inline-formula>. In this paper, we aim at a confidence interval level of 95%, so <inline-formula><mml:math id="inf235"><mml:mrow><mml:mi>α</mml:mi><mml:mo>=</mml:mo><mml:mn>0.05</mml:mn></mml:mrow></mml:math></inline-formula>. We use the Normal based bootstrap interval because we found that it performed best overall with respect to coverage in our simulations, when compared to other common choices like quantile and reversed-quantile bootstrap confidence intervals (<xref ref-type="fig" rid="app3fig3">Appendix 3—figure 3</xref>).</p><p>The above bootstrap method implicitly assumes that the variance of the residuals <italic>e</italic><sub><italic>t</italic></sub> is constant over time <inline-formula><mml:math id="inf236"><mml:mi>t</mml:mi></mml:math></inline-formula> and does not depend on the value of the log-transformed data <inline-formula><mml:math id="inf237"><mml:mrow><mml:mi>log</mml:mi><mml:mo>⁡</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msub><mml:mi>D</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>. This assumption roughly holds when the case incidence is high. During periods of low case incidence (e.g. deaths or regional data in summer 2020 in Switzerland), this assumption is no longer appropriate. Therefore, to be conservative and rather err on the side of too wide uncertainty intervals, we also consider the credible interval of <inline-formula><mml:math id="inf238"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> which is obtained by taking the 0.025 and 0.975 quantiles from the posterior distribution of <inline-formula><mml:math id="inf239"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> using EpiEstim based on the original data <inline-formula><mml:math id="inf240"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:mi>K</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:mi>N</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>. The final reported interval is then the union of the credible interval and the 95% bootstrap confidence interval. Based on our experience, the credible interval is typically wider during periods of very low case incidence and will then be reported. But at high case numbers, the bootstrap confidence interval will tend to be much wider than the credible interval and will be the reported one.</p><p>Finally, we point out that the choices of transformation, block size, smoothing parameters and type of bootstrap confidence interval in this paper might not be universal. The best choice can be different for different data sets (e.g., data sets from different countries).</p></sec><sec id="s4-7"><title>Data</title><p>We gather case incidence data directly from public health authorities. Whenever accessible, we rely on data from local authorities. Otherwise, we use data from ‘Our World in Data’ since the European Centre for Disease Control (ECDC) has stopped its daily updates (December 2020) (<xref ref-type="bibr" rid="bib52">Roser et al., 2020</xref>; <xref ref-type="bibr" rid="bib18">European Centre for Disease Prevention and Control (ECDC), 2022</xref>). A table summarising the incidence data sources is available in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. Information on the start and end of interventions, or major changes in testing policy, are obtained from media reports and the websites of public health authorities. The stringency index of the Blavatnik School of Government is accessed from their publicly available github repository (<xref ref-type="bibr" rid="bib24">Hale et al., 2020</xref>). The vaccination coverage is taken from ‘Our World in Data’ (<xref ref-type="bibr" rid="bib52">Roser et al., 2020</xref>).</p><p>We parametrise the discretised infectivity profile <italic>w</italic><sub><italic>s</italic></sub> using COVID-19 serial interval estimates from the literature (<xref ref-type="bibr" rid="bib44">Nishiura et al., 2020</xref>). For a review of published serial interval estimates, see Griffin et al. (<xref ref-type="bibr" rid="bib23">Griffin et al., 2020</xref>). The incubation period is parametrised by a gamma distribution with mean 5.3 days and SD 3.2 days (<xref ref-type="bibr" rid="bib36">Linton et al., 2020</xref>). For countries for which we do not have access to line list data, i.e. all except Switzerland, Germany and Hong Kong at the time of writing, we assume delays from symptom onset to observation to be gamma-distributed, with parameters taken from the literature. <xref ref-type="table" rid="table2">Table 2</xref> summarises the distributions used in our pipeline.</p><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>Gamma distributions used in the pipeline: serial interval, incubation period, and the delay distributions assumed for each observation type.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Distribution</th><th align="left" valign="bottom">Mean (days)</th><th align="left" valign="bottom">SD (days)</th><th align="left" valign="bottom">Reference</th></tr></thead><tbody><tr><td align="left" valign="bottom">Serial interval</td><td align="char" char="." valign="bottom">4.8</td><td align="char" char="." valign="bottom">2.3</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib44">Nishiura et al., 2020</xref></td></tr><tr><td align="left" valign="bottom">Infection to onset of symptoms</td><td align="char" char="." valign="bottom">5.3</td><td align="char" char="." valign="bottom">3.2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib36">Linton et al., 2020</xref></td></tr><tr><td align="left" valign="bottom">Onset of symptoms to case confirmation</td><td align="char" char="." valign="bottom">5.5</td><td align="char" char="." valign="bottom">3.8</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib11">Bi et al., 2020</xref></td></tr><tr><td align="left" valign="bottom">Onset of symptoms to hospital admission</td><td align="char" char="." valign="bottom">5.1</td><td align="char" char="." valign="bottom">4.2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib47">Pellis et al., 2021</xref></td></tr><tr><td align="left" valign="bottom">Onset of symptoms to death</td><td align="char" char="." valign="bottom">15.0</td><td align="char" char="." valign="bottom">6.9</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib36">Linton et al., 2020</xref></td></tr></tbody></table></table-wrap><p>For Switzerland, Germany and Hong Kong, we use line lists to build time-varying empirical distributions on delays between symptom onset and case confirmation, hospitalisation or death. During the deconvolution step we use the empirical delay distribution of the last 300 recorded cases prior to the infection date. Moreover, for the fraction of cases for which the date of onset of symptoms is known, we use the onset date directly instead of deconvolving a delay from onset to reporting, allowing for more precise estimation of the infection date. For Switzerland, line lists contain information on which cases were infected abroad. By considering imported cases and locally-transmitted cases separately in the deconvolution step, we obtain two separate time series, one for local infections and one for imported infections. <italic>EpiEstim</italic> can then estimate a corrected <inline-formula><mml:math id="inf241"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> that excludes infections incurred abroad from the local transmission dynamics.</p><p>For comparison between methods, epiforecasts.io <inline-formula><mml:math id="inf242"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates were collected from <ext-link ext-link-type="uri" xlink:href="https://github.com/epiforecasts/covid-rt-estimates/blob/master/national/cases/summary/rt.csv">https://github.com/epiforecasts/covid-rt-estimates/blob/master/national/cases/summary/rt.csv</ext-link>, accessing file versions from December 5 2020, March 15, June 24, October 1, November 10 2021 and January 10 2022. Robert Koch Institute estimates were collected from <ext-link ext-link-type="uri" xlink:href="https://raw.githubusercontent.com/robert-koch-institut/SARS-CoV-2-Nowcasting_und_-R-Schaetzung/main/Nowcast_R_aktuell.csv">https://raw.githubusercontent.com/robert-koch-institut/SARS-CoV-2-Nowcasting_und_-R-Schaetzung/main/Nowcast_R_aktuell.csv</ext-link>, last accessed on January 10 2022. AGES estimates were collected from <ext-link ext-link-type="uri" xlink:href="https://www.ages.at/fileadmin/AGES2015/Wissen-Aktuell/COVID19/R_eff.csv">https://www.ages.at/fileadmin/AGES2015/Wissen-Aktuell/COVID19/R_eff.csv</ext-link>, last accessed on January 10 2022.</p></sec><sec id="s4-8"><title>Simulations</title><p>In the simulations, we start by specifying different <inline-formula><mml:math id="inf243"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> trajectories. To assess a range of scenarios, we parametrise <inline-formula><mml:math id="inf244"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> as a piecewise linear trajectory, where we fix its plateau values and the time-points at which its slope changes. From each <inline-formula><mml:math id="inf245"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> trajectory, we stochastically simulate 100 time series of infections and their corresponding case observations. We then use our pipeline to estimate <inline-formula><mml:math id="inf246"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> from each of these 100 times series and compare it to the true underlying value of <inline-formula><mml:math id="inf247"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>.</p><p>Assuming <italic>I</italic><sub>0</sub> infected individuals on the first day, the infection incidence is simulated forward in time. The infection incidence on day <inline-formula><mml:math id="inf248"><mml:mi>t</mml:mi></mml:math></inline-formula> is drawn from a Poisson distribution, corresponding to <xref ref-type="disp-formula" rid="equ6">equation (6)</xref>, using the specified <inline-formula><mml:math id="inf249"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> time series and the discretised serial interval for SARS-CoV-2 (<xref ref-type="bibr" rid="bib44">Nishiura et al., 2020</xref>) as the infectivity profile (see <xref ref-type="bibr" rid="bib13">Cori et al., 2013</xref>; Web Appendix 11). These simulated infections are convolved with the observation type-specific delay distribution (<xref ref-type="bibr" rid="bib36">Linton et al., 2020</xref>) to obtain the raw observation time series <inline-formula><mml:math id="inf250"><mml:msub><mml:mover accent="true"><mml:mi>D</mml:mi><mml:mo stretchy="false">~</mml:mo></mml:mover><mml:mi>t</mml:mi></mml:msub></mml:math></inline-formula>.</p><p>Since the raw observation time series <inline-formula><mml:math id="inf251"><mml:msub><mml:mover accent="true"><mml:mi>D</mml:mi><mml:mo stretchy="false">~</mml:mo></mml:mover><mml:mi>t</mml:mi></mml:msub></mml:math></inline-formula> are too smooth compared to the real data (<xref ref-type="fig" rid="app5fig4">Appendix 5—figure 4</xref>), we add noise to obtain our final simulated observation time series <inline-formula><mml:math id="inf252"><mml:msub><mml:mi>D</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></inline-formula>. The additional noise accounts for aspects of the observation process that are not covered by the delay distribution, such as weekend and holiday effects, the random and occasional delay in the recording of confirmed cases, and irregular components such as confirmed cases that are imported from abroad.</p><p>To obtain a realistic noise model for <inline-formula><mml:math id="inf253"><mml:msub><mml:mi>D</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></inline-formula>, we considered the empirical noise observed in real SARS-CoV-2 case data. For most countries the residuals are autocorrelated (<xref ref-type="fig" rid="app5fig2">Appendix 5—figure 2</xref>), which led us to fit ARIMA models to the observed residuals. We considered five simulation settings with different noise models obtained based on the confirmed case data from five countries (Switzerland, China, France, New Zealand, United States of America). Specifically, we first apply the LOESS smoother with smoothing parameter 21 days on the log-transformed confirmed case data to obtain additive residuals. We then chose the ARIMA model by fitting ARIMA models of various orders and assessing the resulting ACF and PACF plots of their residuals. This leads to five ARIMA models: ARIMA(2,0,1)(0,1,1), ARIMA(1,0,1)(0,0,0), ARIMA(0,0,6)(0,1,1), ARIMA(4,0,1)(1,0,0), and ARIMA(4,0,0)(0,0,0), based on the data from CHE, CHN, FRA, NZL, and USA, respectively. The final observation time series <inline-formula><mml:math id="inf254"><mml:mrow><mml:msub><mml:mi>D</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>D</mml:mi><mml:mo stretchy="false">~</mml:mo></mml:mover><mml:mi>t</mml:mi></mml:msub><mml:mo>⋅</mml:mo><mml:mrow><mml:mi>exp</mml:mi><mml:mo>⁡</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:mrow></mml:math></inline-formula>, where <italic>e</italic><sub><italic>t</italic></sub> is simulated from the fitted ARIMA model. We present the simulated observations with the noise model based on CHE data in <xref ref-type="fig" rid="app5fig4">Appendix 5—figure 4</xref>. We emphasize that the ARIMA model is only used in simulations to obtain simulated observations that look roughly realistic. Our main approach to obtain the estimated <inline-formula><mml:math id="inf255"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> and the related confidence intervals does not require fitting an ARIMA model. In particular, the block bootstrap method is fully non-parametric.</p><p>In the case of time-varying delay distributions, we assume that the mean of the delay distribution decreases by a fixed amount (1/20) each day, to a minimum of 2 days (e.g. for the confirmed cases this results in a range from 5.5 to 2). When estimating with a time-varying delay distribution, we draw observations from the true distributions, similar to line list information recorded by public health authorities. To assess the added value of the deconvolution method, we further compare against a method where we estimate the infection time series by shifting the observations back by the mean of the delay distribution (termed ‘fixed shift method’).</p><p>To quantify the performance of our method on the simulated scenarios, we compute the root mean squared error (RMSE) at time point <inline-formula><mml:math id="inf256"><mml:mi>j</mml:mi></mml:math></inline-formula>:<disp-formula id="equ9"><label>(9)</label><mml:math id="m9"><mml:mtable columnspacing="5pt" displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>R</mml:mi><mml:mo>⁢</mml:mo><mml:mi>M</mml:mi><mml:mo>⁢</mml:mo><mml:mi>S</mml:mi><mml:mo>⁢</mml:mo><mml:mi>E</mml:mi><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>j</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:mi/><mml:mo>=</mml:mo><mml:mpadded width="+1.7pt"><mml:msqrt><mml:mrow><mml:mstyle displaystyle="false"><mml:mfrac><mml:mn>1</mml:mn><mml:mi>M</mml:mi></mml:mfrac></mml:mstyle><mml:mo>⁢</mml:mo><mml:mrow><mml:mstyle displaystyle="false"><mml:msubsup><mml:mo largeop="true" symmetric="true">∑</mml:mo><mml:mrow><mml:mi>m</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>M</mml:mi></mml:msubsup></mml:mstyle><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>R</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover><mml:mi>e</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>j</mml:mi><mml:mo>,</mml:mo><mml:mi>m</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mo>-</mml:mo><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>j</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mrow></mml:msqrt></mml:mpadded></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula></p><p>where <inline-formula><mml:math id="inf257"><mml:mi>M</mml:mi></mml:math></inline-formula> is the total number of simulations, <inline-formula><mml:math id="inf258"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>R</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover><mml:mi>e</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>j</mml:mi><mml:mo>,</mml:mo><mml:mi>m</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> the estimated <inline-formula><mml:math id="inf259"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> and <inline-formula><mml:math id="inf260"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>j</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> the true <inline-formula><mml:math id="inf261"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> at time <inline-formula><mml:math id="inf262"><mml:mi>j</mml:mi></mml:math></inline-formula>, for simulation <inline-formula><mml:math id="inf263"><mml:mi>m</mml:mi></mml:math></inline-formula>.</p><p>For each simulation we also compute the 95% confidence interval (CI) of our estimates across 100 bootstrap replicates. The empirical coverage indicates the fraction of simulations for which our CI includes the true <inline-formula><mml:math id="inf264"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> value.</p></sec><sec id="s4-9"><title>Implementation and method availability</title><p>Daily updated results of our method on global COVID-19 data are available online on <ext-link ext-link-type="uri" xlink:href="https://ibz-shiny.ethz.ch/covid-19-re-international/">https://ibz-shiny.ethz.ch/covid-19-re-international/</ext-link>.</p><p>The source code of the software pipeline is openly accessible at <ext-link ext-link-type="uri" xlink:href="https://github.com/covid-19-Re/shiny-dailyRe">https://github.com/covid-19-Re/shiny-dailyRe</ext-link>; <xref ref-type="bibr" rid="bib7">Angst, 2022</xref>, and the code necessary to reproduce the figures and analyses presented in this paper is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/covid-19-Re/paper-code">https://github.com/covid-19-Re/paper-code</ext-link>; <xref ref-type="bibr" rid="bib30">Huisman, 2022</xref>.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf3"><p>Reviewing editor, <italic>eLife</italic></p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Data curation, Software, Validation, Investigation, Visualization, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Software, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Resources, Supervision, Investigation, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Resources, Supervision, Funding acquisition, Validation, Investigation, Methodology, Project administration, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>A table summarising the sources of incidence data.</title></caption><media xlink:href="elife-71345-supp1-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>A table comparing the structure and features of different methods to estimate Re.</title></caption><media xlink:href="elife-71345-supp2-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media xlink:href="elife-71345-transrepform1-v2.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>The source code of the pipeline is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/covid-19-Re/shiny-dailyRe">https://github.com/covid-19-Re/shiny-dailyRe</ext-link> (copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:70ee49555dae46c2c82193f4422452671d205a2e;origin=https://github.com/covid-19-Re/shiny-dailyRe;visit=swh:1:snp:3bcbd05db762cacef0e48b74e75a71e9560201a1;anchor=swh:1:rev:012c2892381ed8e246843556ca6ee502f134a6e0">swh:1:rev:012c2892381ed8e246843556ca6ee502f134a6e0</ext-link>); this includes a script to download the required incidence data from public sources. The resulting estimates (updated daily) are available at: <ext-link ext-link-type="uri" xlink:href="https://github.com/covid-19-Re/dailyRe-Data">https://github.com/covid-19-Re/dailyRe-Data</ext-link>. The code and data (such as case, hospitalization and death occurence data) necessary to reproduce the figures in the paper is at <ext-link ext-link-type="uri" xlink:href="https://github.com/covid-19-Re/paper-code">https://github.com/covid-19-Re/paper-code</ext-link> (copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:8533c92011c5e311fb7cb3f65d80fcbfd5961bfd;origin=https://github.com/covid-19-Re/paper-code;visit=swh:1:snp:583a1175c809ed920485a278e8fbc7d1132d91ac;anchor=swh:1:rev:edbe2e7a9ca3c5183772e94909d36fbe23e124cb">swh:1:rev:edbe2e7a9ca3c5183772e94909d36fbe23e124cb</ext-link>). Note that for Switzerland we use delay distributions from a line list provided to us by the Federal Office of Public Health (FOPH), with one row per infected individual including patient information. Due to privacy concerns, we are not allowed to share this original data. To obtain access to these records, interested individuals should contact the FOPH directly.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Angst</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>dailyRe-Data</data-title><source>GitHub</source><pub-id pub-id-type="accession" xlink:href="https://github.com/covid-19-Re/dailyRe-Data">dailyRe-Data</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank the Federal Office of Public Health Switzerland for access to their line list data, and Jūlija Pečerska for help in finding governmental datasets on COVID-19. We thank members of the modelling group of the Swiss National Covid-19 science task force for helpful discussions, and Markus Petermann and Daniel Wyler for their comments and suggestions. This work was supported by the Swiss National Science Foundation (SNSF) through grant number 31CA30_196267 (to TS), 200021_172603 (to MHM), 310030B_176401 (to SB), and NRP72 grant 407240–167121 (to SB and TS).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Abbott</surname><given-names>S</given-names></name><name><surname>Hellewell</surname><given-names>J</given-names></name><name><surname>Sherratt</surname><given-names>K</given-names></name><name><surname>Gostic</surname><given-names>K</given-names></name><name><surname>Hickson</surname><given-names>J</given-names></name><name><surname>Badr</surname><given-names>HS</given-names></name><name><surname>DeWitt</surname><given-names>M</given-names></name><name><surname>Thompson</surname><given-names>R</given-names></name><name><surname>Funk</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020a</year><data-title>EpiNow2: estimate real-time case counts and time-varying epidemiological parameters</data-title><source>Zenodo</source><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5281/zenodo.5036949">https://doi.org/10.5281/zenodo.5036949</ext-link></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbott</surname><given-names>S</given-names></name><name><surname>Hellewell</surname><given-names>J</given-names></name><name><surname>Thompson</surname><given-names>RN</given-names></name><name><surname>Sherratt</surname><given-names>K</given-names></name><name><surname>Gibbs</surname><given-names>HP</given-names></name><name><surname>Bosse</surname><given-names>NI</given-names></name><name><surname>Munday</surname><given-names>JD</given-names></name><name><surname>Meakin</surname><given-names>S</given-names></name><name><surname>Doughty</surname><given-names>EL</given-names></name><name><surname>Chun</surname><given-names>JY</given-names></name><name><surname>Chan</surname><given-names>YWD</given-names></name><name><surname>Finger</surname><given-names>F</given-names></name><name><surname>Campbell</surname><given-names>P</given-names></name><name><surname>Endo</surname><given-names>A</given-names></name><name><surname>Pearson</surname><given-names>CAB</given-names></name><name><surname>Gimma</surname><given-names>A</given-names></name><name><surname>Russell</surname><given-names>T</given-names></name><name><surname>Flasche</surname><given-names>S</given-names></name><name><surname>Kucharski</surname><given-names>AJ</given-names></name><name><surname>Eggo</surname><given-names>RM</given-names></name><name><surname>Funk</surname><given-names>S</given-names></name><collab>CMMID COVID modelling group</collab></person-group><year iso-8601-date="2020">2020b</year><article-title>Estimating the time-varying reproduction number of SARS-cov-2 using national and subnational case counts</article-title><source>Wellcome Open Research</source><volume>5</volume><elocation-id>112</elocation-id><pub-id pub-id-type="doi">10.12688/wellcomeopenres.16006.2</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Abbott</surname><given-names>S</given-names></name><name><surname>Hellewell</surname><given-names>J</given-names></name><name><surname>Thompson</surname><given-names>RN</given-names></name><name><surname>Sherratt</surname><given-names>K</given-names></name><name><surname>Gibbs</surname><given-names>HP</given-names></name><name><surname>Bosse</surname><given-names>NI</given-names></name><name><surname>Munday</surname><given-names>JD</given-names></name><name><surname>Meakin</surname><given-names>S</given-names></name><name><surname>Doughty</surname><given-names>EL</given-names></name><name><surname>Chun</surname><given-names>JY</given-names></name><name><surname>Chan</surname><given-names>YWD</given-names></name><name><surname>Finger</surname><given-names>F</given-names></name><name><surname>Campbell</surname><given-names>P</given-names></name><name><surname>Endo</surname><given-names>A</given-names></name><name><surname>Pearson</surname><given-names>CAB</given-names></name><name><surname>Gimma</surname><given-names>A</given-names></name><name><surname>Russell</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Temporal variation in transmission during the covid-19 outbreak</article-title><ext-link ext-link-type="uri" xlink:href="https://epiforecasts.io/covid/">https://epiforecasts.io/covid/</ext-link><date-in-citation iso-8601-date="2022-05-10">May 10, 2022</date-in-citation></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>ST</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Lau</surname><given-names>EHY</given-names></name><name><surname>Xu</surname><given-names>X-K</given-names></name><name><surname>Du</surname><given-names>Z</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Leung</surname><given-names>GM</given-names></name><name><surname>Cowling</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Serial interval of SARS-cov-2 was shortened over time by nonpharmaceutical interventions</article-title><source>Science</source><volume>369</volume><fpage>1106</fpage><lpage>1109</lpage><pub-id pub-id-type="doi">10.1126/science.abc9004</pub-id><pub-id pub-id-type="pmid">32694200</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alimohamadi</surname><given-names>Y</given-names></name><name><surname>Taghdir</surname><given-names>M</given-names></name><name><surname>Sepandi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Estimate of the basic reproduction number for COVID-19: A systematic review and meta-analysis</article-title><source>Journal of Preventive Medicine and Public Health = Yebang Uihakhoe Chi</source><volume>53</volume><fpage>151</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.3961/jpmph.20.076</pub-id><pub-id pub-id-type="pmid">32498136</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>RM</given-names></name><name><surname>May</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="1991">1991</year><source>Infectious Diseases of Humans: Dynamics and Control</source><publisher-loc>Oxford</publisher-loc><publisher-name>Oxford University Press</publisher-name></element-citation></ref><ref id="bib7"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Angst</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Shiny-dailyre</data-title><version designator="swh:1:rev:012c2892381ed8e246843556ca6ee502f134a6e0">swh:1:rev:012c2892381ed8e246843556ca6ee502f134a6e0</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://github.com/covid-19-Re/shiny-dailyRe">https://github.com/covid-19-Re/shiny-dailyRe</ext-link></element-citation></ref><ref id="bib8"><element-citation publication-type="web"><person-group person-group-type="author"><collab>Apple</collab></person-group><year iso-8601-date="2021">2021</year><article-title>COVID-19 Mobility Trends Reports</article-title><ext-link ext-link-type="uri" xlink:href="https://covid19.apple.com/mobility">https://covid19.apple.com/mobility</ext-link><date-in-citation iso-8601-date="2021-05-06">May 6, 2021</date-in-citation></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banholzer</surname><given-names>N</given-names></name><name><surname>van Weenen</surname><given-names>E</given-names></name><name><surname>Lison</surname><given-names>A</given-names></name><name><surname>Cenedese</surname><given-names>A</given-names></name><name><surname>Seeliger</surname><given-names>A</given-names></name><name><surname>Kratzwald</surname><given-names>B</given-names></name><name><surname>Tschernutter</surname><given-names>D</given-names></name><name><surname>Salles</surname><given-names>JP</given-names></name><name><surname>Bottrighi</surname><given-names>P</given-names></name><name><surname>Lehtinen</surname><given-names>S</given-names></name><name><surname>Feuerriegel</surname><given-names>S</given-names></name><name><surname>Vach</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Estimating the effects of non-pharmaceutical interventions on the number of new infections with COVID-19 during the first epidemic wave</article-title><source>PLOS ONE</source><volume>16</volume><elocation-id>e0252827</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0252827</pub-id><pub-id pub-id-type="pmid">34077448</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Banholzer</surname><given-names>N</given-names></name><name><surname>Lison</surname><given-names>A</given-names></name><name><surname>Özcelik</surname><given-names>D</given-names></name><name><surname>Stadler</surname><given-names>T</given-names></name><name><surname>Feuerriegel</surname><given-names>S</given-names></name><name><surname>Vach</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The Methodologies to Assess the Effects of Non-Pharmaceutical Interventions during COVID-19: A Systematic Review</article-title><source>medRxiv</source><pub-id pub-id-type="doi">10.1101/2022.04.14.22273858</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bi</surname><given-names>Q</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Mei</surname><given-names>S</given-names></name><name><surname>Ye</surname><given-names>C</given-names></name><name><surname>Zou</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Wei</surname><given-names>L</given-names></name><name><surname>Truelove</surname><given-names>SA</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Cheng</surname><given-names>C</given-names></name><name><surname>Tang</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>B</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>T</given-names></name><name><surname>Lessler</surname><given-names>J</given-names></name><name><surname>Feng</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in shenzhen, china: a retrospective cohort study</article-title><source>The Lancet. Infectious Diseases</source><volume>20</volume><fpage>911</fpage><lpage>919</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(20)30287-5</pub-id><pub-id pub-id-type="pmid">32353347</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cauchemez</surname><given-names>S</given-names></name><name><surname>Boëlle</surname><given-names>PY</given-names></name><name><surname>Thomas</surname><given-names>G</given-names></name><name><surname>Valleron</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Estimating in real time the efficacy of measures to control emerging communicable diseases</article-title><source>American Journal of Epidemiology</source><volume>164</volume><fpage>591</fpage><lpage>597</lpage><pub-id pub-id-type="doi">10.1093/aje/kwj274</pub-id><pub-id pub-id-type="pmid">16887892</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cori</surname><given-names>A</given-names></name><name><surname>Ferguson</surname><given-names>NM</given-names></name><name><surname>Fraser</surname><given-names>C</given-names></name><name><surname>Cauchemez</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A new framework and software to estimate time-varying reproduction numbers during epidemics</article-title><source>American Journal of Epidemiology</source><volume>178</volume><fpage>1505</fpage><lpage>1512</lpage><pub-id pub-id-type="doi">10.1093/aje/kwt133</pub-id><pub-id pub-id-type="pmid">24043437</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delamater</surname><given-names>PL</given-names></name><name><surname>Street</surname><given-names>EJ</given-names></name><name><surname>Leslie</surname><given-names>TF</given-names></name><name><surname>Yang</surname><given-names>YT</given-names></name><name><surname>Jacobsen</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Complexity of the basic reproduction number (R0)</article-title><source>Emerging Infectious Diseases</source><volume>25</volume><elocation-id>171901</elocation-id><pub-id pub-id-type="doi">10.3201/eid2501.171901</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dempster</surname><given-names>AP</given-names></name><name><surname>Laird</surname><given-names>NM</given-names></name><name><surname>Rubin</surname><given-names>DB</given-names></name></person-group><year iso-8601-date="1977">1977</year><article-title>Maximum likelihood from incomplete data via the <italic>em</italic> algorithm</article-title><source>Journal of the Royal Statistical Society</source><volume>39</volume><fpage>1</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1111/j.2517-6161.1977.tb01600.x</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Esra</surname><given-names>R</given-names></name><name><surname>Jamieson</surname><given-names>L</given-names></name><name><surname>Fox</surname><given-names>MP</given-names></name><name><surname>Letswalo</surname><given-names>D</given-names></name><name><surname>Ngcobo</surname><given-names>N</given-names></name><name><surname>Mngadi</surname><given-names>S</given-names></name><name><surname>Estill</surname><given-names>J</given-names></name><name><surname>Meyer-Rath</surname><given-names>G</given-names></name><name><surname>Keiser</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Evaluating the Impact of Non-Pharmaceutical Interventions for SARS-CoV-2 on a Global Scale</article-title><source>medRxiv</source><pub-id pub-id-type="doi">10.1101/2020.07.30.20164939</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esteve</surname><given-names>A</given-names></name><name><surname>Permanyer</surname><given-names>I</given-names></name><name><surname>Boertien</surname><given-names>D</given-names></name><name><surname>Vaupel</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>National age and coresidence patterns shape COVID-19 vulnerability</article-title><source>PNAS</source><volume>117</volume><fpage>16118</fpage><lpage>16120</lpage><pub-id pub-id-type="doi">10.1073/pnas.2008764117</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="web"><person-group person-group-type="author"><collab>European Centre for Disease Prevention and Control (ECDC)</collab></person-group><year iso-8601-date="2022">2022</year><article-title>Daily number of new reported cases of COVID-19 by country worldwide</article-title><ext-link ext-link-type="uri" xlink:href="https://opendata.ecdc.europa.eu/covid19/casedistribution/csv">https://opendata.ecdc.europa.eu/covid19/casedistribution/csv</ext-link><date-in-citation iso-8601-date="2020-10-02">October 2, 2020</date-in-citation></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flaxman</surname><given-names>S</given-names></name><name><surname>Mishra</surname><given-names>S</given-names></name><name><surname>Gandy</surname><given-names>A</given-names></name><name><surname>Unwin</surname><given-names>HJT</given-names></name><name><surname>Mellan</surname><given-names>TA</given-names></name><name><surname>Coupland</surname><given-names>H</given-names></name><name><surname>Whittaker</surname><given-names>C</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Berah</surname><given-names>T</given-names></name><name><surname>Eaton</surname><given-names>JW</given-names></name><name><surname>Monod</surname><given-names>M</given-names></name><collab>Imperial College COVID-19 Response Team</collab><name><surname>Ghani</surname><given-names>AC</given-names></name><name><surname>Donnelly</surname><given-names>CA</given-names></name><name><surname>Riley</surname><given-names>S</given-names></name><name><surname>Vollmer</surname><given-names>MAC</given-names></name><name><surname>Ferguson</surname><given-names>NM</given-names></name><name><surname>Okell</surname><given-names>LC</given-names></name><name><surname>Bhatt</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Estimating the effects of non-pharmaceutical interventions on covid-19 in europe</article-title><source>Nature</source><volume>584</volume><fpage>257</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2405-7</pub-id><pub-id pub-id-type="pmid">32512579</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldstein</surname><given-names>E</given-names></name><name><surname>Dushoff</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Plotkin</surname><given-names>JB</given-names></name><name><surname>Earn</surname><given-names>DJD</given-names></name><name><surname>Lipsitch</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Reconstructing influenza incidence by deconvolution of daily mortality time series</article-title><source>PNAS</source><volume>106</volume><fpage>21825</fpage><lpage>21829</lpage><pub-id pub-id-type="doi">10.1073/pnas.0902958106</pub-id><pub-id pub-id-type="pmid">20080801</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="web"><person-group person-group-type="author"><collab>Google</collab></person-group><year iso-8601-date="2021">2021</year><article-title>COVID-19 Community Mobility Reports</article-title><ext-link ext-link-type="uri" xlink:href="https://www.google.com/covid19/mobility">https://www.google.com/covid19/mobility</ext-link><date-in-citation iso-8601-date="2021-05-06">May 6, 2021</date-in-citation></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gostic</surname><given-names>KM</given-names></name><name><surname>McGough</surname><given-names>L</given-names></name><name><surname>Baskerville</surname><given-names>EB</given-names></name><name><surname>Abbott</surname><given-names>S</given-names></name><name><surname>Joshi</surname><given-names>K</given-names></name><name><surname>Tedijanto</surname><given-names>C</given-names></name><name><surname>Kahn</surname><given-names>R</given-names></name><name><surname>Niehus</surname><given-names>R</given-names></name><name><surname>Hay</surname><given-names>JA</given-names></name><name><surname>De Salazar</surname><given-names>PM</given-names></name><name><surname>Hellewell</surname><given-names>J</given-names></name><name><surname>Meakin</surname><given-names>S</given-names></name><name><surname>Munday</surname><given-names>JD</given-names></name><name><surname>Bosse</surname><given-names>NI</given-names></name><name><surname>Sherrat</surname><given-names>K</given-names></name><name><surname>Thompson</surname><given-names>RN</given-names></name><name><surname>White</surname><given-names>LF</given-names></name><name><surname>Huisman</surname><given-names>JS</given-names></name><name><surname>Scire</surname><given-names>J</given-names></name><name><surname>Bonhoeffer</surname><given-names>S</given-names></name><name><surname>Stadler</surname><given-names>T</given-names></name><name><surname>Wallinga</surname><given-names>J</given-names></name><name><surname>Funk</surname><given-names>S</given-names></name><name><surname>Lipsitch</surname><given-names>M</given-names></name><name><surname>Cobey</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Practical considerations for measuring the effective reproductive number, rt</article-title><source>PLOS Computational Biology</source><volume>16</volume><elocation-id>1008409</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1008409</pub-id><pub-id pub-id-type="pmid">33301457</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffin</surname><given-names>J</given-names></name><name><surname>Casey</surname><given-names>M</given-names></name><name><surname>Collins</surname><given-names>Á</given-names></name><name><surname>Hunt</surname><given-names>K</given-names></name><name><surname>McEvoy</surname><given-names>D</given-names></name><name><surname>Byrne</surname><given-names>A</given-names></name><name><surname>McAloon</surname><given-names>C</given-names></name><name><surname>Barber</surname><given-names>A</given-names></name><name><surname>Lane</surname><given-names>EA</given-names></name><name><surname>More</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Rapid review of available evidence on the serial interval and generation time of COVID-19</article-title><source>BMJ Open</source><volume>10</volume><elocation-id>e040263</elocation-id><pub-id pub-id-type="doi">10.1136/bmjopen-2020-040263</pub-id><pub-id pub-id-type="pmid">33234640</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hale</surname><given-names>T</given-names></name><name><surname>Webster</surname><given-names>S</given-names></name><name><surname>Petherick</surname><given-names>A</given-names></name><name><surname>Phillips</surname><given-names>T</given-names></name><name><surname>Kira</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><source>Oxford COVID-19 Government Response Tracker</source><publisher-name>Blavatnik School of Government</publisher-name></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hale</surname><given-names>T</given-names></name><name><surname>Angrist</surname><given-names>N</given-names></name><name><surname>Goldszmidt</surname><given-names>R</given-names></name><name><surname>Kira</surname><given-names>B</given-names></name><name><surname>Petherick</surname><given-names>A</given-names></name><name><surname>Phillips</surname><given-names>T</given-names></name><name><surname>Webster</surname><given-names>S</given-names></name><name><surname>Cameron-Blake</surname><given-names>E</given-names></name><name><surname>Hallas</surname><given-names>L</given-names></name><name><surname>Majumdar</surname><given-names>S</given-names></name><name><surname>Tatlow</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A global panel database of pandemic policies (oxford COVID-19 government response tracker)</article-title><source>Nature Human Behaviour</source><volume>5</volume><fpage>529</fpage><lpage>538</lpage><pub-id pub-id-type="doi">10.1038/s41562-021-01079-8</pub-id><pub-id pub-id-type="pmid">33686204</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Hamouda</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Schätzung der aktuellen entwicklung der sars-cov-2-epidemie in deutschland–nowcasting</data-title><source>Zenodo</source><ext-link ext-link-type="uri" xlink:href="https://zenodo.org/record/5712013#.Ywb3-nZBw2w">https://zenodo.org/record/5712013#.Ywb3-nZBw2w</ext-link></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haug</surname><given-names>N</given-names></name><name><surname>Geyrhofer</surname><given-names>L</given-names></name><name><surname>Londei</surname><given-names>A</given-names></name><name><surname>Dervic</surname><given-names>E</given-names></name><name><surname>Desvars-Larrive</surname><given-names>A</given-names></name><name><surname>Loreto</surname><given-names>V</given-names></name><name><surname>Pinior</surname><given-names>B</given-names></name><name><surname>Thurner</surname><given-names>S</given-names></name><name><surname>Klimek</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Ranking the effectiveness of worldwide COVID-19 government interventions</article-title><source>Nature Human Behaviour</source><volume>4</volume><fpage>1303</fpage><lpage>1312</lpage><pub-id pub-id-type="doi">10.1038/s41562-020-01009-0</pub-id><pub-id pub-id-type="pmid">33199859</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hauser</surname><given-names>A</given-names></name><name><surname>Counotte</surname><given-names>MJ</given-names></name><name><surname>Margossian</surname><given-names>CC</given-names></name><name><surname>Konstantinoudis</surname><given-names>G</given-names></name><name><surname>Low</surname><given-names>N</given-names></name><name><surname>Althaus</surname><given-names>CL</given-names></name><name><surname>Riou</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Estimation of SARS-cov-2 mortality during the early stages of an epidemic: A modeling study in hubei, china, and six regions in europe</article-title><source>PLOS Medicine</source><volume>17</volume><elocation-id>1003189</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.1003189</pub-id><pub-id pub-id-type="pmid">32722715</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Heiden</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Sars-cov-2-nowcasting und -r-schaetzung</data-title><source>Zenodo</source><ext-link ext-link-type="uri" xlink:href="https://zenodo.org/record/5712013#.YvpNmXZBzIU">https://zenodo.org/record/5712013#.YvpNmXZBzIU</ext-link></element-citation></ref><ref id="bib30"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Huisman</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Paper-code</data-title><version designator="swh:1:rev:edbe2e7a9ca3c5183772e94909d36fbe23e124cb">swh:1:rev:edbe2e7a9ca3c5183772e94909d36fbe23e124cb</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://github.com/covid-19-Re/paper-code">https://github.com/covid-19-Re/paper-code</ext-link></element-citation></ref><ref id="bib31"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Huisman</surname><given-names>JS</given-names></name><name><surname>Scire</surname><given-names>J</given-names></name><name><surname>Caduff</surname><given-names>L</given-names></name><name><surname>Fernandez-Cassi</surname><given-names>X</given-names></name><name><surname>Ganesanandamoorthy</surname><given-names>P</given-names></name><name><surname>Kull</surname><given-names>A</given-names></name><name><surname>Scheidegger</surname><given-names>A</given-names></name><name><surname>Stachler</surname><given-names>E</given-names></name><name><surname>Boehm</surname><given-names>AB</given-names></name><name><surname>Hughes</surname><given-names>B</given-names></name><name><surname>Knudson</surname><given-names>A</given-names></name><name><surname>Topol</surname><given-names>A</given-names></name><name><surname>Wigginton</surname><given-names>KR</given-names></name><name><surname>Wolfe</surname><given-names>MK</given-names></name><name><surname>Kohn</surname><given-names>T</given-names></name><name><surname>Ort</surname><given-names>C</given-names></name><name><surname>Stadler</surname><given-names>T</given-names></name><name><surname>Julian</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Wastewater-Based Estimation of the Effective Reproductive Number of Sars-Cov-2</article-title><source>medRxiv</source><pub-id pub-id-type="doi">10.1101/2021.04.29.21255961</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Karberg</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Der “überflüssige” Lockdown? Tagesspiegel</article-title><ext-link ext-link-type="uri" xlink:href="https://www.tagesspiegel.de/wissen/der-ueberfluessige-lockdown-ja-der-r-wert-sank-schon-vor-der-kontaktsperre-aber-/25767642.html">https://www.tagesspiegel.de/wissen/der-ueberfluessige-lockdown-ja-der-r-wert-sank-schon-vor-der-kontaktsperre-aber-/25767642.html</ext-link><date-in-citation iso-8601-date="2020-10-22">October 22, 2020</date-in-citation></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohanovski</surname><given-names>I</given-names></name><name><surname>Obolski</surname><given-names>U</given-names></name><name><surname>Ram</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Inferring the effective start dates of non-pharmaceutical interventions during covid-19 outbreaks</article-title><source>International Journal of Infectious Diseases</source><volume>117</volume><fpage>361</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2021.12.364</pub-id><pub-id pub-id-type="pmid">34986406</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kucharski</surname><given-names>AJ</given-names></name><name><surname>Russell</surname><given-names>TW</given-names></name><name><surname>Diamond</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Edmunds</surname><given-names>J</given-names></name><name><surname>Funk</surname><given-names>S</given-names></name><name><surname>Eggo</surname><given-names>RM</given-names></name><name><surname>Sun</surname><given-names>F</given-names></name><name><surname>Jit</surname><given-names>M</given-names></name><name><surname>Munday</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Early dynamics of transmission and control of COVID-19: a mathematical modelling study</article-title><source>The Lancet. Infectious Diseases</source><volume>20</volume><fpage>553</fpage><lpage>558</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(20)30144-4</pub-id><pub-id pub-id-type="pmid">32171059</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemaitre</surname><given-names>JC</given-names></name><name><surname>Perez-Saez</surname><given-names>J</given-names></name><name><surname>Azman</surname><given-names>AS</given-names></name><name><surname>Rinaldo</surname><given-names>A</given-names></name><name><surname>Fellay</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Assessing the impact of non-pharmaceutical interventions on SARS-cov-2 transmission in switzerland</article-title><source>Swiss Medical Weekly</source><volume>150</volume><elocation-id>w20295</elocation-id><pub-id pub-id-type="doi">10.4414/smw.2020.20295</pub-id><pub-id pub-id-type="pmid">32472939</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linton</surname><given-names>NM</given-names></name><name><surname>Kobayashi</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Hayashi</surname><given-names>K</given-names></name><name><surname>Akhmetzhanov</surname><given-names>AR</given-names></name><name><surname>Jung</surname><given-names>S-M</given-names></name><name><surname>Yuan</surname><given-names>B</given-names></name><name><surname>Kinoshita</surname><given-names>R</given-names></name><name><surname>Nishiura</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Incubation period and other epidemiological characteristics of 2019 novel coronavirus infections with right truncation: A statistical analysis of publicly available case data</article-title><source>Journal of Clinical Medicine</source><volume>9</volume><elocation-id>E538</elocation-id><pub-id pub-id-type="doi">10.3390/jcm9020538</pub-id><pub-id pub-id-type="pmid">32079150</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lloyd-Smith</surname><given-names>JO</given-names></name><name><surname>Schreiber</surname><given-names>SJ</given-names></name><name><surname>Kopp</surname><given-names>PE</given-names></name><name><surname>Getz</surname><given-names>WM</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Superspreading and the effect of individual variation on disease emergence</article-title><source>Nature</source><volume>438</volume><fpage>355</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1038/nature04153</pub-id><pub-id pub-id-type="pmid">16292310</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucy</surname><given-names>LB</given-names></name></person-group><year iso-8601-date="1974">1974</year><article-title>An iterative technique for the rectification of observed distributions</article-title><source>The Astronomical Journal</source><volume>79</volume><elocation-id>745</elocation-id><pub-id pub-id-type="doi">10.1086/111605</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mbow</surname><given-names>M</given-names></name><name><surname>Lell</surname><given-names>B</given-names></name><name><surname>Jochems</surname><given-names>SP</given-names></name><name><surname>Cisse</surname><given-names>B</given-names></name><name><surname>Mboup</surname><given-names>S</given-names></name><name><surname>Dewals</surname><given-names>BG</given-names></name><name><surname>Jaye</surname><given-names>A</given-names></name><name><surname>Dieye</surname><given-names>A</given-names></name><name><surname>Yazdanbakhsh</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>COVID-19 in africa: dampening the storm?</article-title><source>Science</source><volume>369</volume><fpage>624</fpage><lpage>626</lpage><pub-id pub-id-type="doi">10.1126/science.abd3902</pub-id><pub-id pub-id-type="pmid">32764055</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyerowitz-Katz</surname><given-names>G</given-names></name><name><surname>Merone</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates</article-title><source>International Journal of Infectious Diseases</source><volume>101</volume><fpage>138</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2020.09.1464</pub-id><pub-id pub-id-type="pmid">33007452</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Minder</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Counting Bodies and Pointing Fingers as Spain Tallies Coronavirus Dead</article-title><ext-link ext-link-type="uri" xlink:href="https://www.nytimes.com/2020/04/16/world/europe/coronoavirus-spain-death-toll.html">https://www.nytimes.com/2020/04/16/world/europe/coronoavirus-spain-death-toll.html</ext-link><date-in-citation iso-8601-date="2021-10-22">October 22, 2021</date-in-citation></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>DH</given-names></name><name><surname>Yinda</surname><given-names>KC</given-names></name><name><surname>Gamble</surname><given-names>A</given-names></name><name><surname>Rossine</surname><given-names>FW</given-names></name><name><surname>Huang</surname><given-names>Q</given-names></name><name><surname>Bushmaker</surname><given-names>T</given-names></name><name><surname>Fischer</surname><given-names>RJ</given-names></name><name><surname>Matson</surname><given-names>MJ</given-names></name><name><surname>Van Doremalen</surname><given-names>N</given-names></name><name><surname>Vikesland</surname><given-names>PJ</given-names></name><name><surname>Marr</surname><given-names>LC</given-names></name><name><surname>Munster</surname><given-names>VJ</given-names></name><name><surname>Lloyd-Smith</surname><given-names>JO</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Mechanistic theory predicts the effects of temperature and humidity on inactivation of SARS-cov-2 and other enveloped viruses</article-title><source>eLife</source><volume>10</volume><elocation-id>e65902</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.65902</pub-id><pub-id pub-id-type="pmid">33904403</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Nishiura</surname><given-names>H</given-names></name><name><surname>Chowell</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2009">2009</year><chapter-title>The effective reproduction number as a prelude to statistical estimation of time-dependent epidemic trends</chapter-title><person-group person-group-type="editor"><name><surname>Bettencourt</surname><given-names>Lu</given-names></name><name><surname>Castillo-Chavez</surname><given-names>Carlos</given-names></name></person-group><source>Mathematical and Statistical Estimation Approaches in Epidemiology</source><volume>Vol 1</volume><publisher-loc>Dordrecht, Netherlands</publisher-loc><publisher-name>Springer</publisher-name><fpage>103</fpage><lpage>121</lpage></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishiura</surname><given-names>H</given-names></name><name><surname>Linton</surname><given-names>NM</given-names></name><name><surname>Akhmetzhanov</surname><given-names>AR</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Serial interval of novel coronavirus (COVID-19) infections</article-title><source>International Journal of Infectious Diseases</source><volume>93</volume><fpage>284</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2020.02.060</pub-id><pub-id pub-id-type="pmid">32145466</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obadia</surname><given-names>T</given-names></name><name><surname>Haneef</surname><given-names>R</given-names></name><name><surname>Boëlle</surname><given-names>PY</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The R0 package: a toolbox to estimate reproduction numbers for epidemic outbreaks</article-title><source>BMC Medical Informatics and Decision Making</source><volume>12</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1186/1472-6947-12-147</pub-id><pub-id pub-id-type="pmid">23249562</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Guo</surname><given-names>H</given-names></name><name><surname>Hao</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>He</surname><given-names>N</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Wei</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Association of public health interventions with the epidemiology of the COVID-19 outbreak in wuhan, china</article-title><source>JAMA</source><volume>323</volume><fpage>1915</fpage><lpage>1923</lpage><pub-id pub-id-type="doi">10.1001/jama.2020.6130</pub-id><pub-id pub-id-type="pmid">32275295</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pellis</surname><given-names>L</given-names></name><name><surname>Scarabel</surname><given-names>F</given-names></name><name><surname>Stage</surname><given-names>HB</given-names></name><name><surname>Overton</surname><given-names>CE</given-names></name><name><surname>Chappell</surname><given-names>LHK</given-names></name><name><surname>Fearon</surname><given-names>E</given-names></name><name><surname>Bennett</surname><given-names>E</given-names></name><name><surname>Lythgoe</surname><given-names>KA</given-names></name><name><surname>House</surname><given-names>TA</given-names></name><name><surname>Hall</surname><given-names>I</given-names></name><collab>University of Manchester COVID-19 Modelling Group</collab></person-group><year iso-8601-date="2021">2021</year><article-title>Challenges in control of covid-19: short doubling time and long delay to effect of interventions</article-title><source>Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences</source><volume>376</volume><elocation-id>20200264</elocation-id><pub-id pub-id-type="doi">10.1098/rstb.2020.0264</pub-id><pub-id pub-id-type="pmid">34053267</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petermann</surname><given-names>M</given-names></name><name><surname>Wyler</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A pitfall in estimating the e ective reproductive number rt for COVID-19</article-title><source>Swiss Medical Weekly</source><volume>150</volume><elocation-id>w20307</elocation-id><pub-id pub-id-type="doi">10.4414/smw.2020.20307</pub-id><pub-id pub-id-type="pmid">32658987</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname><given-names>WH</given-names></name></person-group><year iso-8601-date="1972">1972</year><article-title>Bayesian-based iterative method of image restoration*</article-title><source>Journal of the Optical Society of America</source><volume>62</volume><elocation-id>55</elocation-id><pub-id pub-id-type="doi">10.1364/JOSA.62.000055</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Richter</surname><given-names>L</given-names></name><name><surname>Schmid</surname><given-names>D</given-names></name><name><surname>Stadlober</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Methodenbeschreibung für die Schätzung von epidemiologischen Parametern des COVID19 Ausbruchs, Österreich. AGES- Österreichische Agentur für Gesundheit und Ernährungssicherheit</article-title><ext-link ext-link-type="uri" xlink:href="https://graz.pure.elsevier.com/de/publications/methodenbeschreibung-f%C3%BCr-die-sch%C3%A4tzung-von-epidemiologischen-para">https://graz.pure.elsevier.com/de/publications/methodenbeschreibung-f%C3%BCr-die-sch%C3%A4tzung-von-epidemiologischen-para</ext-link><date-in-citation iso-8601-date="2020-04-20">April 20, 2020</date-in-citation></element-citation></ref><ref id="bib51"><element-citation publication-type="web"><person-group person-group-type="author"><collab>Robert Koch-Institut</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Täglicher Lagebericht des RKI zur Coronavirus-Krankheit-2019 (COVID-19)</article-title><ext-link ext-link-type="uri" xlink:href="https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsberichte/Maerz_2022/2022-03-09-de.pdf?__blob=publicationFile">https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsberichte/Maerz_2022/2022-03-09-de.pdf?__blob=publicationFile</ext-link><date-in-citation iso-8601-date="2020-11-16">November 16, 2020</date-in-citation></element-citation></ref><ref id="bib52"><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Roser</surname><given-names>M</given-names></name><name><surname>Hannah Ritchie</surname><given-names>EOO</given-names></name><name><surname>Hasell</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Coronavirus Pandemic (COVID-19). Our World in Data</article-title><ext-link ext-link-type="uri" xlink:href="https://ourworldindata.org/coronavirus">https://ourworldindata.org/coronavirus</ext-link><date-in-citation iso-8601-date="2022-01-10">January 10, 2022</date-in-citation></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scire</surname><given-names>J</given-names></name><name><surname>Nadeau</surname><given-names>S</given-names></name><name><surname>Vaughan</surname><given-names>T</given-names></name><name><surname>Brupbacher</surname><given-names>G</given-names></name><name><surname>Fuchs</surname><given-names>S</given-names></name><name><surname>Sommer</surname><given-names>J</given-names></name><name><surname>Koch</surname><given-names>KN</given-names></name><name><surname>Misteli</surname><given-names>R</given-names></name><name><surname>Mundorff</surname><given-names>L</given-names></name><name><surname>Götz</surname><given-names>T</given-names></name><name><surname>Eichenberger</surname><given-names>T</given-names></name><name><surname>Quinto</surname><given-names>C</given-names></name><name><surname>Savic</surname><given-names>M</given-names></name><name><surname>Meienberg</surname><given-names>A</given-names></name><name><surname>Burkard</surname><given-names>T</given-names></name><name><surname>Mayr</surname><given-names>M</given-names></name><name><surname>Meier</surname><given-names>CA</given-names></name><name><surname>Widmer</surname><given-names>A</given-names></name><name><surname>Kuehl</surname><given-names>R</given-names></name><name><surname>Egli</surname><given-names>A</given-names></name><name><surname>Hirsch</surname><given-names>HH</given-names></name><name><surname>Bassetti</surname><given-names>S</given-names></name><name><surname>Nickel</surname><given-names>CH</given-names></name><name><surname>Rentsch</surname><given-names>KS</given-names></name><name><surname>Kübler</surname><given-names>W</given-names></name><name><surname>Bingisser</surname><given-names>R</given-names></name><name><surname>Battegay</surname><given-names>M</given-names></name><name><surname>Tschudin-Sutter</surname><given-names>S</given-names></name><name><surname>Stadler</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Reproductive number of the COVID-19 epidemic in switzerland with a focus on the cantons of basel-stadt and basel-landschaft</article-title><source>Swiss Medical Weekly</source><volume>150</volume><elocation-id>w20271</elocation-id><pub-id pub-id-type="doi">10.4414/smw.2020.20271</pub-id><pub-id pub-id-type="pmid">32365217</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>JA</given-names></name><name><surname>Gandy</surname><given-names>A</given-names></name><name><surname>Mishra</surname><given-names>S</given-names></name><name><surname>Unwin</surname><given-names>J</given-names></name><name><surname>Flaxman</surname><given-names>S</given-names></name><name><surname>Bhatt</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Epidemia: modeling of epidemics using hierarchical bayesian models</data-title><version designator="version 1.0.0">version 1.0.0</version><source>R Package</source></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sebhatu</surname><given-names>A</given-names></name><name><surname>Wennberg</surname><given-names>K</given-names></name><name><surname>Arora-Jonsson</surname><given-names>S</given-names></name><name><surname>Lindberg</surname><given-names>SI</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Explaining the homogeneous diffusion of COVID-19 nonpharmaceutical interventions across heterogeneous countries</article-title><source>PNAS</source><volume>117</volume><fpage>21201</fpage><lpage>21208</lpage><pub-id pub-id-type="doi">10.1073/pnas.2010625117</pub-id><pub-id pub-id-type="pmid">32788356</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>M</given-names></name><name><surname>Mindermann</surname><given-names>S</given-names></name><name><surname>Brauner</surname><given-names>JM</given-names></name><name><surname>Leech</surname><given-names>G</given-names></name><name><surname>Stephenson</surname><given-names>AB</given-names></name><name><surname>Gavenčiak</surname><given-names>T</given-names></name><name><surname>Kulveit</surname><given-names>J</given-names></name><name><surname>Teh</surname><given-names>YW</given-names></name><name><surname>Chindelevitch</surname><given-names>L</given-names></name><name><surname>Gal</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>On the Robustness of Effectiveness Estimation of Nonpharmaceutical Interventions against COVID-19 Transmission</article-title><source>arXiv</source><ext-link ext-link-type="uri" xlink:href="https://arxiv.org/abs/2007.13454v1">https://arxiv.org/abs/2007.13454v1</ext-link></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soltesz</surname><given-names>K</given-names></name><name><surname>Gustafsson</surname><given-names>F</given-names></name><name><surname>Timpka</surname><given-names>T</given-names></name><name><surname>Jaldén</surname><given-names>J</given-names></name><name><surname>Jidling</surname><given-names>C</given-names></name><name><surname>Heimerson</surname><given-names>A</given-names></name><name><surname>Schön</surname><given-names>TB</given-names></name><name><surname>Spreco</surname><given-names>A</given-names></name><name><surname>Ekberg</surname><given-names>J</given-names></name><name><surname>Dahlström</surname><given-names>Ö</given-names></name><name><surname>Bagge Carlson</surname><given-names>F</given-names></name><name><surname>Jöud</surname><given-names>A</given-names></name><name><surname>Bernhardsson</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The effect of interventions on COVID-19</article-title><source>Nature</source><volume>588</volume><fpage>E26</fpage><lpage>E28</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-3025-y</pub-id><pub-id pub-id-type="pmid">33361787</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Systrom</surname><given-names>K</given-names></name><name><surname>Vladek</surname><given-names>T</given-names></name><name><surname>Krieger</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Rt covid live</article-title><ext-link ext-link-type="uri" xlink:href="https://github.com/rtcovidlive/covid-model">https://github.com/rtcovidlive/covid-model</ext-link><date-in-citation iso-8601-date="2022-01-10">January 10, 2022</date-in-citation></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tebé</surname><given-names>C</given-names></name><name><surname>Valls</surname><given-names>J</given-names></name><name><surname>Satorra</surname><given-names>P</given-names></name><name><surname>Tobías</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>COVID19-world: a shiny application to perform comprehensive country-specific data visualization for SARS-cov-2 epidemic</article-title><source>BMC Medical Research Methodology</source><volume>20</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1186/s12874-020-01121-9</pub-id><pub-id pub-id-type="pmid">32958001</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Tokyay</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Turkey hits record COVID-19 cases after change in reporting</article-title><ext-link ext-link-type="uri" xlink:href="https://www.arabnews.com/node/1768881/middle-east">https://www.arabnews.com/node/1768881/middle-east</ext-link><date-in-citation iso-8601-date="2021-04-26">April 26, 2021</date-in-citation></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsang</surname><given-names>TK</given-names></name><name><surname>Wu</surname><given-names>P</given-names></name><name><surname>Lau</surname><given-names>EHY</given-names></name><name><surname>Cowling</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Accounting for imported cases in estimating the time-varying reproductive number of coronavirus disease 2019 in hong kong</article-title><source>The Journal of Infectious Diseases</source><volume>224</volume><fpage>783</fpage><lpage>787</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiab299</pub-id><pub-id pub-id-type="pmid">34086944</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="web"><person-group person-group-type="author"><collab>TU Graz AGES</collab></person-group><year iso-8601-date="2021">2021</year><article-title>Epidemiologische parameter des covid19 ausbruchs, update 11.11.2021, österreich, 2020/2021</article-title><ext-link ext-link-type="uri" xlink:href="https://wissenaktuell.ages.at/download/0/0/7951f8dc4672000514e611c70195db45c55a65f2/fileadmin/AGES2015/Wissen-Aktuell/COVID19/Update_Epidemiologische_Parameter_des_COVID19_Ausbruchs_2021-11-19.pdf">https://wissenaktuell.ages.at/download/0/0/7951f8dc4672000514e611c70195db45c55a65f2/fileadmin/AGES2015/Wissen-Aktuell/COVID19/Update_Epidemiologische_Parameter_des_COVID19_Ausbruchs_2021-11-19.pdf</ext-link><date-in-citation iso-8601-date="2022-01-10">January 10, 2022</date-in-citation></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallinga</surname><given-names>J</given-names></name><name><surname>Teunis</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures</article-title><source>American Journal of Epidemiology</source><volume>160</volume><fpage>509</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1093/aje/kwh255</pub-id><pub-id pub-id-type="pmid">15353409</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallinga</surname><given-names>J</given-names></name><name><surname>Lipsitch</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>How generation intervals shape the relationship between growth rates and reproductive numbers</article-title><source>Proceedings. Biological Sciences</source><volume>274</volume><fpage>599</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.1098/rspb.2006.3754</pub-id><pub-id pub-id-type="pmid">17476782</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Kandula</surname><given-names>S</given-names></name><name><surname>Huynh</surname><given-names>M</given-names></name><name><surname>Greene</surname><given-names>SK</given-names></name><name><surname>Wye</surname><given-names>GV</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Chan</surname><given-names>HT</given-names></name><name><surname>McGibbon</surname><given-names>E</given-names></name><name><surname>Yeung</surname><given-names>A</given-names></name><name><surname>Olson</surname><given-names>D</given-names></name><name><surname>Fine</surname><given-names>A</given-names></name><name><surname>Shaman</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Estimating the Infection Fatality Risk of COVID-19 in New York City during the Spring 2020 Pandemic Wave</article-title><source>medRxiv</source><pub-id pub-id-type="doi">10.1101/2020.06.27.20141689</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Liao</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>K</given-names></name><name><surname>Bai</surname><given-names>W</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Preliminary prediction of the basic reproduction number of the wuhan novel coronavirus 2019-ncov</article-title><source>Journal of Evidence-Based Medicine</source><volume>13</volume><fpage>3</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1111/jebm.12376</pub-id><pub-id pub-id-type="pmid">32048815</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><sec sec-type="appendix" id="s8"><title>Observation types and the influence of testing</title><p>Here, we briefly discuss the benefits and potential biases of the three types of observations we used. The most commonly used proxy for infection incidence is the incidence of confirmed cases. It is the least indirect way of observing infection events. However, it generally assumes that (i) the proportion of infected individuals that is tested, and (ii) the distribution of the delay between infection and testing are constant through time. Unfortunately, these assumptions do not generally hold.</p><p>As long as the sampling proportion is constant throughout the considered time period, the <inline-formula><mml:math id="inf265"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates of EpiEstim are not affected by under-sampling (<xref ref-type="bibr" rid="bib13">Cori et al., 2013</xref>). During the COVID-19 epidemic, many countries initially restricted testing to only severe cases, before switching to a more extensive testing effort after curbing the first epidemic wave and ramping up testing capacity (<xref ref-type="bibr" rid="bib52">Roser et al., 2020</xref>). Changes in testing strategy as well as bottlenecks in testing capacity can result in a varying fraction of infected individuals that are confirmed positive, and variation in the delay between infection and test confirmation. These variations can bias <inline-formula><mml:math id="inf266"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates, as the increase or decrease in case numbers between consecutive time points will be attributed to a change in infection incidence, rather than a change in testing.</p><p>However, it is important to note that the ‘memory’ inherent in the <inline-formula><mml:math id="inf267"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimate is dictated by the infectivity profile <italic>w</italic><sub><italic>s</italic></sub>. An event at time <inline-formula><mml:math id="inf268"><mml:mi>t</mml:mi></mml:math></inline-formula> which changes the proportion of true infection incidence observed per day, e.g. a change in testing policy, will bias the <inline-formula><mml:math id="inf269"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimate for a number of days given by <italic>w</italic><sub><italic>s</italic></sub> (compare Materials and Methods, <xref ref-type="disp-formula" rid="equ6">equation 6</xref>). For SARS-CoV-2 the time needed to reach the 95% quantile of <italic>w</italic><sub><italic>s</italic></sub> is 9days. We do not observe the infection incidence directly, but if the deconvolution is assumed to be perfect, the intuition for the number of days of biased <inline-formula><mml:math id="inf270"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates still holds.</p><p>It is further possible to investigate the influence of testing intensity, by applying the <inline-formula><mml:math id="inf271"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimation method separately to a case incidence time series which is adjusted for the intensity of the testing effort. We have added this analysis to our online dashboard (where we show the number of confirmed cases / number of tests, normalised by the mean number of tests). However, one should note that such a normalisation does not take into account that the probability of test positivity might also change with the number of tests (e.g. by prioritising likely cases at low numbers of tests).</p><p>In contrast, the incidence of hospital admittance and deaths are likely based primarily on the severity of the symptoms, and mostly unaffected by changes in testing strategies, or the magnitude of the epidemic. This makes them valuable complementary observations of infection events (<xref ref-type="bibr" rid="bib20">Goldstein et al., 2009</xref>). However, also here biases can occur. First, only a small fraction of all infections results in hospitalisation or death (a meta-analysis found an average infection fatality ratio for SARS-CoV-2 of 0.68% <xref ref-type="bibr" rid="bib40">Meyerowitz-Katz and Merone, 2020</xref>). This fraction varies with the risk group of the infected population (<xref ref-type="bibr" rid="bib40">Meyerowitz-Katz and Merone, 2020</xref>; <xref ref-type="bibr" rid="bib28">Hauser et al., 2020</xref>; <xref ref-type="bibr" rid="bib17">Esteve et al., 2020</xref>; <xref ref-type="bibr" rid="bib65">Yang et al., 2020</xref>), introducing potential biases in <inline-formula><mml:math id="inf272"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimations when outbreaks occur in particularly age-stratified settings. Also, new variants may result in different hospitalisation or fatality rates. Second, if a country’s health infrastructure becomes overburdened and hospitals are forced to triage or delay admission, we expect the fraction of hospital admissions to decrease, and deaths to increase. Third, the likelihood to die from an infection may change through time as new treatment strategies are developed or if hospitals are overburdened. Additionally, guidelines used to record COVID-19 as the cause of death have changed through time for some countries (<xref ref-type="bibr" rid="bib41">Minder, 2020</xref>). Lastly, the delay between infection and hospitalisation or death is expected to be longer than the delay until case confirmation, with the result that these <inline-formula><mml:math id="inf273"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates are less timely. One should note that these observation type specific biases could also be seen as a source of information. The types simply describe a different epidemic if very structured populations with highly different mortality rates are captured (e.g. in elderly homes).</p><p>It is important to note that all analyses here are focused on the period before vaccination mediated immunity became widespread. Since vaccinations change the fraction of infections that eventually become hospitalised or die, they may introduce temporary biases for the <inline-formula><mml:math id="inf274"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimated from hospitalisation and death incidence. We have added the metric of vaccination coverage to the online dashboard, so one can estimate when these effects start to become important.</p><sec sec-type="appendix" id="s8-1"><title>Method Limitations</title><p>The <inline-formula><mml:math id="inf275"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimation method we present in the main text relies on several assumptions. Here we highlight the limitations that occur when these assumptions are violated.</p><p>First, the geographical scale of the <inline-formula><mml:math id="inf276"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates is determined by the incidence data itself. The <inline-formula><mml:math id="inf277"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> value calculated for a country represents an average, summarised across multiple local epidemics unfolding in different regions. <inline-formula><mml:math id="inf278"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> values need not be identical in different local epidemics across a country or administrative region. In particular, in times of very low pathogen transmission, single super-spreading events can significantly increase the estimated <inline-formula><mml:math id="inf279"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> of the entire country (<xref ref-type="bibr" rid="bib37">Lloyd-Smith et al., 2005</xref>).</p><p>Second, in our deconvolution step we account for an incubation period and a delay from symptom onset to case observation. Implicitly, we thus assume that all reported cases come from symptomatic individuals. This is certainly true for hospitalised and deceased patients, but does not have to hold for all confirmed cases. Similar to the testing intensity (discussed in Section B.1), this would not bias our estimates as long as the fraction of asymptomatic or presymptomatic individuals is constant through time. However, the fraction of asymptomatic individuals could vary with the population structure and age-stratification. The fraction of tested presymptomatic individuals could vary with the testing strategy and the intensity of the testing effort.</p><p>Third, in our current analysis we assume a single serial interval distribution for all geographic locations and all times. However, behaviour, population contact structure, and cultural differences in dealing with infection symptoms, will cause geographic and temporal variations in the serial interval. In particular, the implementation of non-pharmaceutical interventions can significantly shorten the serial interval (<xref ref-type="bibr" rid="bib4">Ali et al., 2020</xref>). Misspecification of the serial interval will lead to larger errors in <inline-formula><mml:math id="inf280"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates further away from one (<xref ref-type="bibr" rid="bib22">Gostic et al., 2020</xref>).</p><p>Lastly, our estimates of the effective reproductive number <inline-formula><mml:math id="inf281"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> are subject to changes in data reporting. There are frequent changes in the way in which public health offices update their observed incidence data: the number of variables shared (e.g. Brasil, the UK excluded testing information), their frequency (e.g. Swiss cantons moved to weekly data updates when daily numbers became low), the amount of data consolidation (i.e. to which extent values reported for a given day change in subsequent days), and what constitutes a COVID-19 case (<xref ref-type="bibr" rid="bib41">Minder, 2020</xref>; <xref ref-type="bibr" rid="bib60">Tokyay, 2020</xref>). These variables have all changed during the epidemic, frequently in response to political pressure or the magnitude of the local epidemic and the resulting workload at the public health offices (<xref ref-type="bibr" rid="bib41">Minder, 2020</xref>). This affects the timeliness of our estimates, and can cause the estimated <inline-formula><mml:math id="inf282"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> to change a bit between days.</p></sec></sec></app><app id="appendix-2"><title>Appendix 2</title><sec sec-type="appendix" id="s9"><title>Discretisation of delay distributions</title><p>When approximating delay distributions by gamma distributions, we discretise these in the following fashion:<disp-formula id="equ10"><label>(10)</label><mml:math id="m10"><mml:mrow><mml:msub><mml:mi>m</mml:mi><mml:mi>l</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:mtable columnspacing="5pt" displaystyle="true" rowspacing="0pt"><mml:mtr><mml:mtd columnalign="left"><mml:mrow><mml:mstyle displaystyle="false"><mml:msubsup><mml:mo largeop="true" symmetric="true">∫</mml:mo><mml:mn>0</mml:mn><mml:mn>0.5</mml:mn></mml:msubsup></mml:mstyle><mml:mrow><mml:mi>f</mml:mi><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo rspace="5.3pt" stretchy="false">)</mml:mo></mml:mrow><mml:mo>⁢</mml:mo><mml:mrow><mml:mo rspace="0pt">d</mml:mo><mml:mi>x</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mpadded lspace="10pt" width="+10pt"><mml:mi>l</mml:mi></mml:mpadded><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="left"><mml:mrow><mml:mstyle displaystyle="false"><mml:msubsup><mml:mo largeop="true" symmetric="true">∫</mml:mo><mml:mrow><mml:mi>l</mml:mi><mml:mo>-</mml:mo><mml:mn>0.5</mml:mn></mml:mrow><mml:mrow><mml:mi>l</mml:mi><mml:mo>+</mml:mo><mml:mn>0.5</mml:mn></mml:mrow></mml:msubsup></mml:mstyle><mml:mrow><mml:mi>f</mml:mi><mml:mo>⁢</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo rspace="5.3pt" stretchy="false">)</mml:mo></mml:mrow><mml:mo>⁢</mml:mo><mml:mrow><mml:mo rspace="0pt">d</mml:mo><mml:mi>x</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:mpadded lspace="10pt" width="+10pt"><mml:mi>l</mml:mi></mml:mpadded><mml:mo>∈</mml:mo><mml:mrow><mml:mo stretchy="false">{</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo rspace="4.2pt" stretchy="false">}</mml:mo></mml:mrow></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math></disp-formula></p><p>where <inline-formula><mml:math id="inf283"><mml:mi>f</mml:mi></mml:math></inline-formula> is either the probability density function (p.d.f) of the gamma-distributed delay distribution, or the p.d.f of the convolution of two independent gamma-distributed delay distributions. The former applies when line list data is available, and the observed data is deconvolved with the gamma-distributed incubation period separately from the empirical delay distribution of symptom onset to observation. The latter applies whenever the observed case data is jointly deconvolved with the incubation period and the delay between symptom onset and observation.</p><p>Because the probability density function of a convolution of two independent gamma distributions does not admit a simple form in the general case, we approximate the p.d.f by drawing a million independent pairs of samples, one from each gamma distribution, summing the pairs, and computing the empirical cumulative distribution function of the sampled distribution.</p><sec sec-type="appendix" id="s9-1"><title>The effect of smoothing on our ability to infer when Re =1</title><p>Our LOESS smoothing roughly spreads sudden changes in <inline-formula><mml:math id="inf284"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> over 20 days in the estimated <inline-formula><mml:math id="inf285"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula>. Whether this is a substantial problem depends on the smoothness of the true <inline-formula><mml:math id="inf286"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> that we are trying to estimate. Direct observations of behavioural changes, specifically changes in mobility, suggest the true <inline-formula><mml:math id="inf287"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> is quite smooth: for instance it took 2–3 weeks for mobility to drop to its lowest level in response to government interventions in Switzerland (<xref ref-type="bibr" rid="bib8">Apple, 2021</xref>; <xref ref-type="bibr" rid="bib21">Google, 2021</xref>).</p><p>However, to get a rough feeling for the impact smoothing would have on our estimates and downstream analysis in case the true <inline-formula><mml:math id="inf288"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> does change abruptly, we can use a simple analysis using a linear approximation. In the case of a step-wise change from <italic>R</italic><sub>0</sub> to <italic>R</italic><sub>1</sub> (with <inline-formula><mml:math id="inf289"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>) at time <italic>t</italic><sub>0</sub>, the estimated smooth <inline-formula><mml:math id="inf290"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> will start decreasing about 10 days prior to <italic>t</italic><sub>0</sub>, and take another 10 days after to reach the terminal value (<xref ref-type="fig" rid="app2fig1">Appendix 2—figure 1</xref>). When inferring the day that a certain threshold value was reached (e.g. <inline-formula><mml:math id="inf291"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula>) we will be off by a number of days <inline-formula><mml:math id="inf292"><mml:mi>s</mml:mi></mml:math></inline-formula>, dictated by <italic>R</italic><sub>0</sub> and <italic>R</italic><sub>1</sub>. Specifically, the delay <inline-formula><mml:math id="inf293"><mml:mi>s</mml:mi></mml:math></inline-formula> is greater if the turning point <inline-formula><mml:math id="inf294"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>⁢</mml:mo><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow><mml:mn>2</mml:mn></mml:mfrac></mml:mrow></mml:math></inline-formula> is further above 1, or the slope <inline-formula><mml:math id="inf295"><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>⁢</mml:mo><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow><mml:mn>20</mml:mn></mml:mfrac></mml:mrow></mml:math></inline-formula> is closer to 0:<disp-formula id="equ11"><label>(11)</label><mml:math id="m11"><mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>⁢</mml:mo><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>⁢</mml:mo><mml:mstyle displaystyle="true"><mml:mfrac><mml:mn>20</mml:mn><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mfrac></mml:mstyle></mml:mrow></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula></p><fig id="app2fig1" position="float"><label>Appendix 2—figure 1.</label><caption><title>Schematic of the effect of smoothing on the ability to estimate when <inline-formula><mml:math id="inf296"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo mathvariant="normal">=</mml:mo><mml:mn mathvariant="normal">1</mml:mn></mml:mrow></mml:math></inline-formula>.</title><p>The true <inline-formula><mml:math id="inf297"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> is indicated by the black solid line, the black dashed line shows a linear approximation of the smoothed <inline-formula><mml:math id="inf298"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula>. Instead of crossing 1 at <inline-formula><mml:math id="inf299"><mml:msub><mml:mi>t</mml:mi><mml:mn mathvariant="normal">0</mml:mn></mml:msub></mml:math></inline-formula>, this line crosses 1 at <inline-formula><mml:math id="inf300"><mml:mrow><mml:msub><mml:mi>t</mml:mi><mml:mn mathvariant="normal">0</mml:mn></mml:msub><mml:mo mathvariant="normal">+</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:math></inline-formula>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71345-app2-fig1-v2.tif"/></fig><p>In <xref ref-type="table" rid="table1">Table 1</xref> we have listed some possible delay values, using <italic>R</italic><sub>0</sub> values spanning the range of values reported for SARS-CoV-2 (<xref ref-type="bibr" rid="bib5">Alimohamadi et al., 2020</xref>). The delay is positive if <inline-formula><mml:math id="inf301"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> and <inline-formula><mml:math id="inf302"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mstyle></mml:math></inline-formula>, which was the case for most countries around the 1st lockdown. In general, these numbers can be considered a ‘worst-case’ scenario: when the true underlying <inline-formula><mml:math id="inf303"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> changes more gradually than considered here, the smoothing introduced by our pipeline will have a smaller effect.</p><p>Note that these calculations specifically refer to the point estimate. The estimates may stop being significantly above the threshold already earlier, especially when the confidence interval is wide and the slope is close to 0.</p><table-wrap id="app2table1" position="float"><label>Appendix 2—table 1.</label><caption><title>The effect of smoothing on the ability to estimate when <inline-formula><mml:math id="inf304"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo mathvariant="normal">=</mml:mo><mml:mn mathvariant="normal">1</mml:mn></mml:mrow></mml:math></inline-formula>.</title><p>These values were calculated using <xref ref-type="disp-formula" rid="equ11">Equation 11</xref>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom"><italic>R</italic><sub>0</sub></th><th align="left" valign="bottom"><italic>R</italic><sub>1</sub></th><th align="left" valign="bottom"><inline-formula><mml:math id="inf305"><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>⁢</mml:mo><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula></th><th align="left" valign="bottom"><inline-formula><mml:math id="inf306"><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>⁢</mml:mo><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>(per day)</th><th align="left" valign="bottom">Delays (days)</th></tr></thead><tbody><tr><td align="char" char="." valign="bottom">6.0</td><td align="char" char="." valign="bottom">0.0</td><td align="char" char="." valign="bottom">3.0</td><td align="char" char="." valign="bottom">–0.30</td><td align="char" char="." valign="bottom">6.7</td></tr><tr><td align="char" char="." valign="bottom">3.0</td><td align="char" char="." valign="bottom">0.0</td><td align="char" char="." valign="bottom">1.5</td><td align="char" char="." valign="bottom">–0.15</td><td align="char" char="." valign="bottom">3.3</td></tr><tr><td align="char" char="." valign="bottom">3.5</td><td align="char" char="." valign="bottom">0.5</td><td align="char" char="." valign="bottom">2.0</td><td align="char" char="." valign="bottom">–0.15</td><td align="char" char="." valign="bottom">6.7</td></tr><tr><td align="char" char="." valign="bottom">2.5</td><td align="char" char="." valign="bottom">0.5</td><td align="char" char="." valign="bottom">1.5</td><td align="char" char="." valign="bottom">–0.10</td><td align="char" char="." valign="bottom">5.0</td></tr><tr><td align="char" char="." valign="bottom">3.3</td><td align="char" char="." valign="bottom">0.9</td><td align="char" char="." valign="bottom">2.1</td><td align="char" char="." valign="bottom">–0.12</td><td align="char" char="." valign="bottom">9.2</td></tr><tr><td align="char" char="." valign="bottom">1.8</td><td align="char" char="." valign="bottom">0.8</td><td align="char" char="." valign="bottom">1.3</td><td align="char" char="." valign="bottom">–0.05</td><td align="char" char="." valign="bottom">6.0</td></tr></tbody></table></table-wrap></sec><sec sec-type="appendix" id="s9-2"><title>A concrete example to illustrate the overlapping block bootstrap method</title><table-wrap id="app2table2" position="float"><label>Appendix 2—table 2.</label><caption><title>Residuals and their corresponding days of the week.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Day of the week</th><th align="left" valign="bottom">Mon</th><th align="left" valign="bottom">Tue</th><th align="left" valign="bottom">Wed</th><th align="left" valign="bottom">Thu</th><th align="left" valign="bottom">Fri</th><th align="left" valign="bottom">Sat</th><th align="left" valign="bottom">Sun</th></tr></thead><tbody><tr><td align="left" valign="bottom">Residuals</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>e</italic><sub>1</sub></td><td align="left" valign="bottom"><italic>e</italic><sub>2</sub></td><td align="left" valign="bottom"><italic>e</italic><sub>3</sub></td><td align="left" valign="bottom"><italic>e</italic><sub>4</sub></td><td align="left" valign="bottom"><italic>e</italic><sub>5</sub></td><td align="left" valign="bottom"><italic>e</italic><sub>6</sub></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>e</italic><sub>7</sub></td><td align="left" valign="bottom"><italic>e</italic><sub>8</sub></td><td align="left" valign="bottom"><italic>e</italic><sub>9</sub></td><td align="left" valign="bottom"><italic>e</italic><sub>10</sub></td><td align="left" valign="bottom"><italic>e</italic><sub>11</sub></td><td align="left" valign="bottom"><italic>e</italic><sub>12</sub></td><td align="left" valign="bottom"><italic>e</italic><sub>13</sub></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>e</italic><sub>14</sub></td><td align="left" valign="bottom"><italic>e</italic><sub>15</sub></td><td align="left" valign="bottom"><italic>e</italic><sub>16</sub></td><td align="left" valign="bottom"><italic>e</italic><sub>17</sub></td><td align="left" valign="bottom"><italic>e</italic><sub>18</sub></td><td align="left" valign="bottom"><italic>e</italic><sub>19</sub></td><td align="left" valign="bottom"><italic>e</italic><sub>20</sub></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>e</italic><sub>21</sub></td><td align="left" valign="bottom"><italic>e</italic><sub>22</sub></td><td align="left" valign="bottom"><italic>e</italic><sub>23</sub></td><td align="left" valign="bottom"><italic>e</italic><sub>24</sub></td><td align="left" valign="bottom"><italic>e</italic><sub>25</sub></td><td align="left" valign="bottom"><italic>e</italic><sub>26</sub></td><td align="left" valign="bottom"><italic>e</italic><sub>27</sub></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>e</italic><sub>28</sub></td><td align="left" valign="bottom"><italic>e</italic><sub>29</sub></td><td align="left" valign="bottom"><italic>e</italic><sub>30</sub></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><p>We illustrate the overlapping block bootstrap method with block length <inline-formula><mml:math id="inf307"><mml:mrow><mml:mi>b</mml:mi><mml:mo>=</mml:mo><mml:mn>10</mml:mn></mml:mrow></mml:math></inline-formula> in a small example. Let <inline-formula><mml:math id="inf308"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>30</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> denote residuals corresponding to the days of the week as shown in <xref ref-type="table" rid="table2">Table 2</xref>.</p><p>We first randomly sample a block of 10 consecutive residuals from <inline-formula><mml:math id="inf309"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>30</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>. Say the sampled residuals are <inline-formula><mml:math id="inf310"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>4</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>12</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>. Since the first residual <italic>e</italic><sub>1</sub> of the original residuals corresponds to a Tuesday, we then take the longest part of <inline-formula><mml:math id="inf311"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>4</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>12</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> such that the first residual corresponds to Tuesday. In this case, we keep <inline-formula><mml:math id="inf312"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>8</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>9</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>12</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>.</p><p>The length of the sequence of re-sampled residuals is now only 5, which is less than the desired total length 30, so we have to sample again. We randomly sample a second block of 10 consecutive residuals from <inline-formula><mml:math id="inf313"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>30</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>. Say the sampled residuals are now <inline-formula><mml:math id="inf314"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>19</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>20</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>28</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>. Since the last residual <italic>e</italic><sub>12</sub> of the first set of re-sampled residuals corresponds to a Saturday, we take the longest part of <inline-formula><mml:math id="inf315"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>19</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>20</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>28</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> such that the first residual corresponds to a Sunday. In this case, we keep <inline-formula><mml:math id="inf316"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>20</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>21</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>28</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>. We then glue it to the previously sampled residuals and obtain <inline-formula><mml:math id="inf317"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>8</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>9</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>12</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>20</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>21</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>28</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> with length 14. Since this is less than the desired length 30, we need to sample again.</p><p>So we randomly sample a third block of 10 consecutive residuals from <inline-formula><mml:math id="inf318"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>30</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>. Say the re-sampled residuals are <inline-formula><mml:math id="inf319"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>10</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>. Since the last residual <italic>e</italic><sub>28</sub> of the kept residuals corresponds to a Monday, we take the longest part of <inline-formula><mml:math id="inf320"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>10</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> such that the first residual corresponds to a Tuesday. In this case, we keep <inline-formula><mml:math id="inf321"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>10</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>. We then glue it to the previously kept residuals and obtain <inline-formula><mml:math id="inf322"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>8</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>9</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>12</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>20</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>21</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>28</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>10</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>. Its length is 24, which is less than the original length of 30, so we keep going.</p><p>We randomly sample a fourth block of 10 consecutive residuals from <inline-formula><mml:math id="inf323"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>30</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>. Say the sample residuals are <inline-formula><mml:math id="inf324"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>17</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>18</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>26</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>. Since the last residual <italic>e</italic><sub>10</sub> of the kept residuals corresponds to a Thursday, we take the longest part of <inline-formula><mml:math id="inf325"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>17</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>18</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>26</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> such that the first residual corresponds to Friday. In this case, we keep <inline-formula><mml:math id="inf326"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>18</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>19</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>26</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>. We then glue it to the previously kept residuals and obtain <inline-formula><mml:math id="inf327"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>8</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>9</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>12</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>20</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>21</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>28</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>10</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>18</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>19</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>26</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>. Note that its length is 33 which is larger than the original length of 30, so we cut the last three residuals <inline-formula><mml:math id="inf328"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>24</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>25</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>26</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula>.</p><p>This means that we obtain <inline-formula><mml:math id="inf329"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>8</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>9</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>12</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>20</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>21</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>28</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>10</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>18</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>19</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">…</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>e</mml:mi><mml:mn>23</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> as our set of block bootstrapped residuals.</p></sec></sec></app><app id="appendix-3"><title>Appendix 3</title><fig id="app3fig1" position="float"><label>Appendix 3—figure 1.</label><caption><title>Performance of our method on simulated scenarios with differing slopes.</title><p>(<bold>A</bold>) The specified <inline-formula><mml:math id="inf330"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> trajectory (black line; see Methods) was used to simulate a trajectory of reported cases (with Swiss case observation noise) 100 times. From each trajectory we estimated <inline-formula><mml:math id="inf331"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> (yellow boxplots), and constructed a 95% confidence interval (purple boxplots of the lower/upper endpoint). We varied the time it took to change from one <inline-formula><mml:math id="inf332"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> value to the next, <inline-formula><mml:math id="inf333"><mml:mrow><mml:mi>t</mml:mi><mml:mo mathvariant="normal">∈</mml:mo><mml:mrow><mml:mo mathvariant="normal" stretchy="false">{</mml:mo><mml:mn mathvariant="normal">7</mml:mn><mml:mo mathvariant="normal">,</mml:mo><mml:mn mathvariant="normal">14</mml:mn><mml:mo mathvariant="normal">,</mml:mo><mml:mn mathvariant="normal">28</mml:mn><mml:mo mathvariant="normal" stretchy="false">}</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> (columns). Larger values of <inline-formula><mml:math id="inf334"><mml:mi>t</mml:mi></mml:math></inline-formula> correspond to less abrupt changes. (<bold>B</bold>) The fraction of simulations where the true <inline-formula><mml:math id="inf335"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> value was within the 95% confidence interval. The dashed red line indicates the nominal 95% coverage. (<bold>C</bold>) The root mean squared relative error for every time point. (<bold>D</bold>) The fraction of simulations where we estimate <inline-formula><mml:math id="inf336"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> is significantly above or below one, depending on the true value of <inline-formula><mml:math id="inf337"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula>. We see that the method closely tracks the true <inline-formula><mml:math id="inf338"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> in all scenarios, although the error is greater for steeper slopes. In the case of steeper changes in <inline-formula><mml:math id="inf339"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> the overall size of the epidemic is also smaller, which explains the larger confidence intervals.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71345-app3-fig1-v2.tif"/></fig><fig id="app3fig2" position="float"><label>Appendix 3—figure 2.</label><caption><title>Performance of our method, modified to skip the smoothing step in the pipeline, on simulated scenarios with observation noise.</title><p>The specified <inline-formula><mml:math id="inf340"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> trajectory (black line; see Methods) was used to simulate a trajectory of reported cases (with varying country-specific noise profiles; rows) 100 times. From each trajectory we estimated <inline-formula><mml:math id="inf341"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> (yellow boxplots), and constructed a 95% confidence interval (purple boxplots of the lower/upper endpoint). Contrary to our normal pipeline, the observations were not smoothed prior to the deconvolution and <inline-formula><mml:math id="inf342"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimation. We see that the estimates are highly variable.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71345-app3-fig2-v2.tif"/></fig><fig id="app3fig3" position="float"><label>Appendix 3—figure 3.</label><caption><title>Performance of our method on simulated scenarios with observation noise.</title><p>The columns differ in the method used to construct confidence intervals: EpiEstim reports the 95% HPD of EpiEstim on the original data, estimateR refers to our method, Quantiles and Reverse Quantiles use the 5 and 95% quantiles of the estimated <inline-formula><mml:math id="inf343"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> to construct the CIs. (<bold>A</bold>) The specified <inline-formula><mml:math id="inf344"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> trajectory (black line; see Methods) was used to simulate a trajectory of reported cases (with varying country-specific noise profiles; rows) 100 times. From each trajectory we estimated <inline-formula><mml:math id="inf345"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> (yellow ribbons represent the estimated mean ± sd across 100 simulations), and constructed a 95% confidence interval (purple ribbons represent the mean ± sd of the estimated lower/upper endpoint). (<bold>B</bold>) The fraction of simulations where the true <inline-formula><mml:math id="inf346"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> value was within the 95% confidence interval. The dashed red line indicates the nominal 95% coverage.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71345-app3-fig3-v2.tif"/></fig><fig id="app3fig4" position="float"><label>Appendix 3—figure 4.</label><caption><title>Performance of our method on simulated scenarios with varying population size, using confidence intervals from EpiEstim.</title><p>(<bold>A</bold>) We specified a constant <inline-formula><mml:math id="inf347"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo mathvariant="normal">∈</mml:mo><mml:mrow><mml:mo mathvariant="normal" stretchy="false">{</mml:mo><mml:mn mathvariant="normal">0.8</mml:mn><mml:mo mathvariant="normal">,</mml:mo><mml:mn mathvariant="normal">1</mml:mn><mml:mo mathvariant="normal">,</mml:mo><mml:mn mathvariant="normal">1.5</mml:mn><mml:mo mathvariant="normal" stretchy="false">}</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> value (black line; rows) to simulate a trajectory of reported cases (with Swiss case observation noise) 100 times. From each trajectory we estimated <inline-formula><mml:math id="inf348"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> (yellow boxplots), and constructed a 95% confidence interval (purple boxplots of the lower/upper endpoint). The simulated scenarios had differing initial incidence of <inline-formula><mml:math id="inf349"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mn mathvariant="normal">0</mml:mn></mml:msub><mml:mo mathvariant="normal">∈</mml:mo><mml:mrow><mml:mo mathvariant="normal" stretchy="false">{</mml:mo><mml:mn mathvariant="normal">10</mml:mn><mml:mo mathvariant="normal">,</mml:mo><mml:mn mathvariant="normal">100</mml:mn><mml:mo mathvariant="normal">,</mml:mo><mml:mn mathvariant="normal">1000</mml:mn><mml:mo mathvariant="normal">,</mml:mo><mml:mn mathvariant="normal">5000</mml:mn><mml:mo mathvariant="normal">,</mml:mo><mml:mn mathvariant="normal">10000</mml:mn><mml:mo mathvariant="normal" stretchy="false">}</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> infections per day (columns). In the top row, <inline-formula><mml:math id="inf350"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>&lt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mstyle></mml:math></inline-formula> so the epidemic is decreasing. In the middle row, <inline-formula><mml:math id="inf351"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo mathvariant="normal">=</mml:mo><mml:mn mathvariant="normal">1</mml:mn></mml:mrow></mml:math></inline-formula>, the epidemic is constant, and in the bottom row, <inline-formula><mml:math id="inf352"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mstyle></mml:math></inline-formula>, the epidemic is increasing. The bias at the start is due to the initialisation of the simulation. (<bold>B</bold>) The fraction of simulations where the true <inline-formula><mml:math id="inf353"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> value was within the 95% confidence interval. The dashed red line indicates the nominal 95% coverage. We see that the EpiEstim coverage strongly declines with increased epidemic size.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71345-app3-fig4-v2.tif"/></fig><fig id="app3fig5" position="float"><label>Appendix 3—figure 5.</label><caption><title>Performance of our method on simulated scenarios with varying population size, using the Union of EpiEstim and Block bootstrap 95% confidence intervals.</title><p>(<bold>A</bold>) We specified a constant <inline-formula><mml:math id="inf354"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo mathvariant="normal">∈</mml:mo><mml:mrow><mml:mo mathvariant="normal" stretchy="false">{</mml:mo><mml:mn mathvariant="normal">0.8</mml:mn><mml:mo mathvariant="normal">,</mml:mo><mml:mn mathvariant="normal">1</mml:mn><mml:mo mathvariant="normal">,</mml:mo><mml:mn mathvariant="normal">1.5</mml:mn><mml:mo mathvariant="normal" stretchy="false">}</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> value (black line; rows) to simulate a trajectory of reported cases (with Swiss case observation noise) 100 times. From each trajectory we estimated <inline-formula><mml:math id="inf355"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> (yellow boxplots), and constructed a 95% confidence interval (purple boxplots of the lower/upper endpoint). The simulated scenarios had differing initial incidence of <inline-formula><mml:math id="inf356"><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mn mathvariant="normal">0</mml:mn></mml:msub><mml:mo mathvariant="normal">∈</mml:mo><mml:mrow><mml:mo mathvariant="normal" stretchy="false">{</mml:mo><mml:mn mathvariant="normal">10</mml:mn><mml:mo mathvariant="normal">,</mml:mo><mml:mn mathvariant="normal">100</mml:mn><mml:mo mathvariant="normal">,</mml:mo><mml:mn mathvariant="normal">1000</mml:mn><mml:mo mathvariant="normal">,</mml:mo><mml:mn mathvariant="normal">5000</mml:mn><mml:mo mathvariant="normal">,</mml:mo><mml:mn mathvariant="normal">10000</mml:mn><mml:mo mathvariant="normal" stretchy="false">}</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> infections per day (columns). In the top row, <inline-formula><mml:math id="inf357"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>&lt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mstyle></mml:math></inline-formula> so the epidemic is decreasing. In the middle row, <inline-formula><mml:math id="inf358"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo mathvariant="normal">=</mml:mo><mml:mn mathvariant="normal">1</mml:mn></mml:mrow></mml:math></inline-formula>, the epidemic is constant, and in the bottom row, <inline-formula><mml:math id="inf359"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>&gt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mstyle></mml:math></inline-formula>, the epidemic is increasing. The bias at the start is due to the initialisation of the simulation. (<bold>B</bold>) The fraction of simulations where the true <inline-formula><mml:math id="inf360"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> value was within the 95% confidence interval. The dashed red line indicates the nominal 95% coverage. We see that for a wide range of infection incidences, our 95% confidence interval is informative and covers the true value of <inline-formula><mml:math id="inf361"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71345-app3-fig5-v2.tif"/></fig><fig id="app3fig6" position="float"><label>Appendix 3—figure 6.</label><caption><title>Performance of our method on simulated scenarios using a fixed shift versus the deconvolution to infer infection incidence.</title><p>The fixed shift method shifts the observations back by the mean of the delay distribution (here assumed to correspond to confirmed cases). (<bold>A</bold>) The specified <inline-formula><mml:math id="inf362"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> trajectory (black line; see Methods) was used to simulate a trajectory of reported cases (with Swiss case observation noise) 100 times. From each trajectory we estimated <inline-formula><mml:math id="inf363"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> (yellow boxplots), and constructed a 95% confidence interval (purple boxplots of the lower/upper endpoint). (<bold>B</bold>) The fraction of simulations where the true <inline-formula><mml:math id="inf364"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> value was within the 95% confidence interval. The dashed red line indicates the nominal 95% coverage. The average coverage in this scenario was 0.90 with deconvolution and 0.78 with the fixed shift. (<bold>C</bold>) The root mean squared relative error for every time point. The average (cumulative) RMSE in this scenario was 0.0706 (25.4) with deconvolution and 0.0726 (26.6) with the fixed shift.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71345-app3-fig6-v2.tif"/></fig><fig id="app3fig7" position="float"><label>Appendix 3—figure 7.</label><caption><title>Performance of our method on simulated scenarios with misspecified delay distributions.</title><p>When estimating <inline-formula><mml:math id="inf365"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula>, we misspecified the mean of the delay distribution (5.5 for symptom-onset to case confirmation) by the numbers above the columns. (<bold>A</bold>) The specified <inline-formula><mml:math id="inf366"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> trajectory (black line; see Methods) was used to simulate a trajectory of reported cases (with Swiss case observation noise) 100 times. From each trajectory we estimated <inline-formula><mml:math id="inf367"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> (yellow boxplots), and a 95% confidence interval (purple boxplots of the lower/upper endpoint). (<bold>B</bold>) The fraction of simulations where the true <inline-formula><mml:math id="inf368"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> value was within the 95% confidence interval. The dashed red line indicates the nominal 95% coverage. The average coverage in this scenario was 0.72, 0.85, 0.88, 0.90, 0.90, 0.89, 0.82, 0.69 from –5 to 10. (<bold>C</bold>) The root mean squared relative error for every time point. The average (cumulative) RMSE in this scenario was 0.0989 (36.0), 0.0807 (29.2), 0.0746 (26.9), 0.0706 (25.4), 0.0701 (25.2), 0.0726 (26.0), 0.0909 (32.3), 0.134 (47.0) from –5 to 10.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71345-app3-fig7-v2.tif"/></fig><fig id="app3fig8" position="float"><label>Appendix 3—figure 8.</label><caption><title>Performance of our method on simulated scenarios with time-varying delay distributions.</title><p>The observations were simulated with a time-varying delay distribution for (<bold>A,B,C</bold>) confirmed cases, or (<bold>D,E,F</bold>) deaths (see Methods), and then estimated with (right column) or without (left column) taking the time-varying distributions into account. (<bold>A, D</bold>) The specified <inline-formula><mml:math id="inf369"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> trajectory (black line; see Methods) was used to simulate a trajectory of reported cases or deaths (with Swiss case observation noise) 100 times. From each trajectory we estimated <inline-formula><mml:math id="inf370"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> (yellow boxplots), and a 95% confidence interval (purple boxplots of the lower/upper endpoint). (<bold>B, E</bold>) The fraction of simulations where the true <inline-formula><mml:math id="inf371"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> value was within the 95% confidence interval. The dashed red line indicates the nominal 95% coverage. For the cumulative cases, the average coverage in this scenario was 0.89 without and 0.89 with time variation. For the deaths, the average coverage was 0.83 without and 0.92 with time variation. (<bold>C, F</bold>) The root mean squared relative error for every time point. For the cumulative cases, the average (cumulative) RMSE was 0.0728 (26.2) without and 0.0783 (28.5) with time variation. For the deaths, the average (cumulative) RMSE was 0.113 (39.5) without and 0.0861 (30.8) with time variation.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71345-app3-fig8-v2.tif"/></fig></app><app id="appendix-4"><title>Appendix 4</title><fig id="app4fig1" position="float"><label>Appendix 4—figure 1.</label><caption><title>Stability of <inline-formula><mml:math id="inf372"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates at present.</title><p>We estimated <inline-formula><mml:math id="inf373"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> through time repeatedly on 4 scenarios. With each new iteration, we added one new data point at present. Each <inline-formula><mml:math id="inf374"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> trajectory is presented with its own colour. Purple trajectories are iterations for which the last known case data point was furthest in the past, yellow trajectories are trajectories for which the last known case data point was closest to the present. In each panel and for each <inline-formula><mml:math id="inf375"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> trajectory, 100 simulation replicates were aggregated. The median of mean estimates are presented with lines and medians of upper and lower bounds of 95% confidence intervals are shown with translucent ribbons. For each scenario, two panels are presented. Each time the right panel correspond to raw estimates and the left panel corresponds to the same estimates with the last 4 <inline-formula><mml:math id="inf376"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> values removed from each <inline-formula><mml:math id="inf377"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> trajectory. (<bold>A</bold>) Stable <inline-formula><mml:math id="inf378"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula>. (<bold>B</bold>) Gradual increase in <inline-formula><mml:math id="inf379"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula>. (<bold>C</bold>) Gradual decrease in <inline-formula><mml:math id="inf380"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula>. (<bold>D</bold>) Abrupt decrease in <inline-formula><mml:math id="inf381"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71345-app4-fig1-v2.tif"/></fig><fig id="app4fig2" position="float"><label>Appendix 4—figure 2.</label><caption><title>Mean delay in Switzerland between onset of symptoms and reporting.</title><p>For each date, the mean is taken over the last 300 reports with known symptom onset date, based on line list data from the FOPH. For early dates, before 300 reports are available, the mean is taken over the first 300 reports.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71345-app4-fig2-v2.tif"/></fig><fig id="app4fig3" position="float"><label>Appendix 4—figure 3.</label><caption><title>Comparison of the <inline-formula><mml:math id="inf382"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates with or without accounting for known symptom onset dates and for time-variability on reporting delays.</title><p>The comparison is based on time series of confirmed cases in Switzerland, from line list data provided by the FOPH. Both the inclusion of known symptom onset dates and of the time-variability of reporting delay distributions have an effect on the Re estimates, in particular for early estimates in this case. The fraction of cases with known symptom onset date has drastically reduced since November 2020, hence the overlap in curves with and without symptom onset data for later dates. For each trajectory the point estimate is shown with a line, and the translucent ribbon indicates the 95% confidence interval.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71345-app4-fig3-v2.tif"/></fig><fig id="app4fig4" position="float"><label>Appendix 4—figure 4.</label><caption><title>Effective reproductive number estimates with or without accounting for known imports.</title><p>The comparison is based on time series of confirmed cases in Switzerland, from line list data provided by the FOPH. The analysis ignoring imports is unbiased if the number of imports equals the number of exports. Since the analysis accounting for imports is not accounting for exports, the results are a lower limit for the effective reproductive number. Very few imported cases were reported since November 2020, hence the complete overlap in the curves after that date. For each trajectory the point estimate is shown with a line, and the translucent ribbon indicates the 95% confidence interval.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71345-app4-fig4-v2.tif"/></fig></app><app id="appendix-5"><title>Appendix 5</title><fig id="app5fig1" position="float"><label>Appendix 5—figure 1.</label><caption><title>Square root and log transformations to stabilise the variance of residuals.</title><p>Each row corresponds to the results of observations from Switzerland (CHE), China (CHN), France (FRA), New Zealand (NZL) and the United States (USA), respectively. The first and last two plots correspond to the result of square root transformation and log transformation, respectively.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71345-app5-fig1-v2.tif"/></fig><fig id="app5fig2" position="float"><label>Appendix 5—figure 2.</label><caption><title>Autocorrelation function (ACF) and partial autocorrelation function (PACF) plots of the observations from five different countries.</title><p>In each row, the two plots are the ACF and PACF plots of the observations from Switzerland (CHE), China (CHN), France (FRA), New Zealand (NZL) and the United States (USA), respectively.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71345-app5-fig2-v2.tif"/></fig><fig id="app5fig3" position="float"><label>Appendix 5—figure 3.</label><caption><title>Autocorrelation function (ACF) and partial autocorrelation function (PACF) plots of observations from Switzerland and the fitted ARIMA model.</title><p>The two plots on the upper row are the ACF and PACF plots of the observations from Switzerland. The two plots on the lower row are the ACF and PACF plots of the residuals of the fitted ARIMA model.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71345-app5-fig3-v2.tif"/></fig><fig id="app5fig4" position="float"><label>Appendix 5—figure 4.</label><caption><title>Simulated observations with and without noise.</title><p>The upper row shows the real observations from Switzerland (twice the same). The other four rows show simulated observations, the left column shows simulations without the noise term (<inline-formula><mml:math id="inf383"><mml:msub><mml:mover accent="true"><mml:mi>D</mml:mi><mml:mo mathvariant="normal" stretchy="false">~</mml:mo></mml:mover><mml:mi>t</mml:mi></mml:msub></mml:math></inline-formula> in Section 4.7), and the right the simulated observations with the noise term (<inline-formula><mml:math id="inf384"><mml:msub><mml:mi>D</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math></inline-formula> in Section 4.7).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71345-app5-fig4-v2.tif"/></fig><fig id="app5fig5" position="float"><label>Appendix 5—figure 5.</label><caption><title>Estimated <inline-formula><mml:math id="inf385"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> with different smoothing windows.</title><p>For each trajectory the point estimate is shown with a yellow line, and the purple ribbon indicates the 95% confidence interval.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71345-app5-fig5-v2.tif"/></fig><fig id="app5fig6" position="float"><label>Appendix 5—figure 6.</label><caption><title>Estimated <inline-formula><mml:math id="inf386"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> with different block sizes.</title><p>The ribbons indicate the 95% confidence interval.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-71345-app5-fig6-v2.tif"/></fig></app><app id="appendix-6"><title>Appendix 6</title><sec sec-type="appendix" id="s10"><title>SI 50 analysis</title><p>Reference date: first day the stringency index exceeded 50 (<inline-formula><mml:math id="inf387"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>S</mml:mi><mml:mi>I</mml:mi><mml:mo>&gt;</mml:mo><mml:mn>50</mml:mn></mml:mrow></mml:mstyle></mml:math></inline-formula>).</p><p>The 42 included countries: Algeria, Andorra(*), Australia, Austria, Belgium, Canada, Chile, Croatia, Czech Republic, Denmark, Egypt, Estonia, Finland, France, Germany, Greece, Iceland, Indonesia, Iran, Ireland, Israel, Japan, South Korea(*), Lebanon, Malaysia, Mexico, Netherlands, Norway, Philippines, Poland, Portugal, Saudi Arabia, Singapore, Slovenia, Spain, Switzerland, Tajikistan(*), Thailand, United Arab Emirates, United Kingdom, United States, Vietnam.</p><p>A star indicates the country was not included in the <inline-formula><mml:math id="inf388"><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo>⁢</mml:mo><mml:mi>S</mml:mi><mml:mo>⁢</mml:mo><mml:mi>I</mml:mi></mml:mrow></mml:math></inline-formula> analysis (e.g. because the biggest jump in SI took place prior to the first possible <inline-formula><mml:math id="inf389"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimate).</p><p>For 37/42 countries the <inline-formula><mml:math id="inf390"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimate was above one prior to the reference date, and significantly so for 35/42. The countries that reached <inline-formula><mml:math id="inf391"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>&lt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mstyle></mml:math></inline-formula> prior to the reference date were Andorra (17 days prior), Australia (2 day prior), Denmark (3 days prior), Japan (359 days prior), and Vietnam (3 days prior).</p><sec sec-type="appendix" id="s10-1"><title><inline-formula><mml:math id="inf392"><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo>⁢</mml:mo><mml:mi>S</mml:mi><mml:mo>⁢</mml:mo><mml:mi>I</mml:mi></mml:mrow></mml:math></inline-formula> analysis</title><p>Reference date: date of the biggest 7 day increase in the SI.</p><p>The 45 included countries: Algeria, Australia, Austria, Belarus(*), Belgium, Canada, Chile, Colombia(*), Croatia, Czech Republic, Denmark, Egypt, Estonia, Finland, France, Germany, Greece, Iceland, Indonesia, Iran, Ireland, Israel, Japan, Lebanon, Malaysia, Mexico, Netherlands, New Zealand(*), Norway, Philippines, Poland, Portugal, Russia(*), Saudi Arabia, Serbia(*), Singapore, Slovenia, Spain, Switzerland, Thailand, Turkey(*), United Arab Emirates, United Kingdom, United States, Vietnam.</p><p>A star indicates the country was not included in the <inline-formula><mml:math id="inf393"><mml:mrow><mml:mi>S</mml:mi><mml:mo>⁢</mml:mo><mml:mi>I</mml:mi><mml:mo>⁢</mml:mo><mml:mn>50</mml:mn></mml:mrow></mml:math></inline-formula> analysis (e.g. because <inline-formula><mml:math id="inf394"><mml:mrow><mml:mrow><mml:mi>S</mml:mi><mml:mo>⁢</mml:mo><mml:mi>I</mml:mi></mml:mrow><mml:mo>=</mml:mo><mml:mn>50</mml:mn></mml:mrow></mml:math></inline-formula> was never reached).</p><p>For 41/45 countries the <inline-formula><mml:math id="inf395"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimate was above one prior to the reference date, and significantly so for 38/45. The countries that reached <inline-formula><mml:math id="inf396"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>&lt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mstyle></mml:math></inline-formula> prior to the reference date were Australia (3 days prior), Denmark (4 days prior), Germany (4 days prior), and Vietnam (10 days prior).</p><table-wrap id="app6table1" position="float"><label>Appendix 6—table 1.</label><caption><title>Investigating the relation between the date of ‘lockdown’ and the date that the estimated <inline-formula><mml:math id="inf397"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> dropped below 1.</title><p>The first three columns contain the same information as the first four columns of the main text <xref ref-type="table" rid="table1">Table 1</xref>. The last two columns are analogous to the third (‘<inline-formula><mml:math id="inf398"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mi>R</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>&lt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mstyle></mml:math></inline-formula> based on confirmed cases’) but are based on <inline-formula><mml:math id="inf399"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates for hospitalisations and deaths respectively. For each of these observation types, we used our method to determine when the <inline-formula><mml:math id="inf400"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimate first dropped below 1, and for which dates the corresponding 95% confidence interval contained 1. Further, we used news reports to determine when a country implemented stay-at-home orders (a ‘lockdown’). Based on our <inline-formula><mml:math id="inf401"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates for confirmed cases, Denmark, Germany, the Netherlands, and Slovenia had 95% confidence intervals that included or were below one before a nationwide lockdown was implemented. For <inline-formula><mml:math id="inf402"><mml:msub><mml:mi>R</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></inline-formula> estimates based on COVID-19 deaths, there are also four: Denmark, the Netherlands, Poland, and the United Kingdom. See Appendix 2 for smoothing related caveats.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Country</th><th align="left" valign="bottom">Lockdown</th><th align="left" valign="bottom"><inline-formula><mml:math id="inf403"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mi>R</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>&lt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mstyle></mml:math></inline-formula> based on Confirmed cases</th><th align="left" valign="bottom"><inline-formula><mml:math id="inf404"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mi>R</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>&lt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mstyle></mml:math></inline-formula> based on Deaths</th><th align="left" valign="bottom"><inline-formula><mml:math id="inf405"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mi>R</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>&lt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mstyle></mml:math></inline-formula> based on Hospitalisations</th></tr></thead><tbody><tr><td align="left" valign="bottom">Austria</td><td align="char" char="ndash" valign="bottom">16–03</td><td align="char" char="ndash" valign="bottom">20–03 [20-03, 20-03]</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Belgium</td><td align="char" char="ndash" valign="bottom">18–03</td><td align="char" char="ndash" valign="bottom">30–03 [25-03, 03-04]</td><td align="char" char="ndash" valign="bottom">26–03 [24-03, 26-03]</td><td align="char" char="ndash" valign="bottom">25–03 [24-03, 25-03]</td></tr><tr><td align="left" valign="bottom">Denmark</td><td align="char" char="ndash" valign="bottom">18–03</td><td align="char" char="ndash" valign="bottom">10–03 [10-03, 20-06]</td><td align="char" char="ndash" valign="bottom">22–03 [18-03, 07-01]</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Finland</td><td align="char" char="ndash" valign="bottom">16–03</td><td align="char" char="ndash" valign="bottom">02–04 [29-03, 30-04]</td><td align="char" char="ndash" valign="bottom">07–04 [25-03, 11-04]</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">France</td><td align="char" char="ndash" valign="bottom">17–03</td><td align="char" char="ndash" valign="bottom">27–03 [23-03, 07-04]</td><td align="char" char="ndash" valign="bottom">24–03 [22-03, 26-03]</td><td align="char" char="ndash" valign="bottom">27–03 [25-03, 26-03]</td></tr><tr><td align="left" valign="bottom">Germany</td><td align="char" char="ndash" valign="bottom">22–03</td><td align="char" char="ndash" valign="bottom">18–03 [17-03, 19-03]</td><td align="char" char="ndash" valign="bottom">31–03 [23-03, 04-04]</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Ireland</td><td align="char" char="ndash" valign="bottom">27–03</td><td align="char" char="ndash" valign="bottom">08–04 [04–04, 15–04]</td><td align="char" char="ndash" valign="bottom">05–04 [31-03, 09-04]</td><td align="char" char="ndash" valign="bottom">06–04 [06–04, 26–04]</td></tr><tr><td align="left" valign="bottom">Italy</td><td align="char" char="ndash" valign="bottom">10–03</td><td align="char" char="ndash" valign="bottom">18–03 [17-03, 19-03]</td><td align="char" char="ndash" valign="bottom">14–03 [01–03, 29–05]</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Netherlands</td><td align="char" char="ndash" valign="bottom">23–03</td><td align="char" char="ndash" valign="bottom">05–04 [22-03, 10-04]</td><td align="char" char="ndash" valign="bottom">22–03 [19-03, 02-04]</td><td align="char" char="ndash" valign="bottom">26–03 [24-03, 26-03]</td></tr><tr><td align="left" valign="bottom">Norway</td><td align="char" char="ndash" valign="bottom">14–03</td><td align="char" char="ndash" valign="bottom">21–03 [17-03, 24-03]</td><td align="char" char="ndash" valign="bottom">25–03 [18-03, 08-04]</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Poland</td><td align="char" char="ndash" valign="bottom">25–03</td><td align="char" char="ndash" valign="bottom">02–04 [31-03, 17-04]</td><td align="char" char="ndash" valign="bottom">09–04 [24-03, 01-12]</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Portugal</td><td align="char" char="ndash" valign="bottom">16–03</td><td align="char" char="ndash" valign="bottom">28–03 [23-03, 15-04]</td><td align="char" char="ndash" valign="bottom">28–03 [21-03, 12-04]</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Romania</td><td align="char" char="ndash" valign="bottom">24–03</td><td align="char" char="ndash" valign="bottom">06–04 [31-03, 29-04]</td><td align="char" char="ndash" valign="bottom">17–04 [25-03, 28-04]</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Russian Federation</td><td align="char" char="ndash" valign="bottom">30–03</td><td align="char" char="ndash" valign="bottom">04–05 [01–05, 08–05]</td><td align="char" char="ndash" valign="bottom">18–05 [14-05, 12-12]</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Slovenia</td><td align="char" char="ndash" valign="bottom">20–03</td><td align="char" char="ndash" valign="bottom">23–03 [13-03, 26-03]</td><td align="char" char="ndash" valign="bottom">26–03 [20–03, ≥03-05-2021]</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Spain</td><td align="char" char="ndash" valign="bottom">14–03</td><td align="char" char="ndash" valign="bottom">26–03 [25-03, 26-03]</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sweden</td><td align="left" valign="bottom"/><td align="char" char="ndash" valign="bottom">01–04 [06–03,≥03-05-2021]</td><td align="char" char="ndash" valign="bottom">05–04 [13–03,≥03-05-2021]</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Switzerland</td><td align="char" char="ndash" valign="bottom">17–03</td><td align="char" char="ndash" valign="bottom">22–03 [20-03, 22-03]</td><td align="char" char="ndash" valign="bottom">21–03 [18-03, 23-03]</td><td align="char" char="ndash" valign="bottom">18–03 [16-03, 18-03]</td></tr><tr><td align="left" valign="bottom">Turkey</td><td align="char" char="ndash" valign="bottom">21–03</td><td align="char" char="ndash" valign="bottom">08–04 [01–04, 13–04]</td><td align="char" char="ndash" valign="bottom">04–04 [31-03, 06-04]</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">United Kingdom</td><td align="char" char="ndash" valign="bottom">24–03</td><td align="char" char="ndash" valign="bottom">30–03 [28-03, 20-04]</td><td align="char" char="ndash" valign="bottom">25–03 [24-03, 25-03]</td><td align="char" char="ndash" valign="bottom">29–03 [27-03, 29-03]</td></tr></tbody></table></table-wrap><table-wrap id="app6table2" position="float"><label>Appendix 6—table 2.</label><caption><title>News and public resources used to determine when a country implemented the first non-pharmaceutical interventions, and a nationwide lockdown.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Country</th><th align="left" valign="bottom">First Measure</th><th align="left" valign="bottom">Lockdown</th><th align="left" valign="bottom">URL</th></tr></thead><tbody><tr><td align="left" valign="bottom">Austria</td><td align="char" char="ndash" valign="bottom">10–03</td><td align="char" char="ndash" valign="bottom">16–03</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://mrc-ide.github.io/covid19estimates/">https://mrc-ide.github.io/covid19estimates/</ext-link>#/interventions</td></tr><tr><td align="left" valign="bottom">Belgium</td><td align="char" char="ndash" valign="bottom">10–03</td><td align="char" char="ndash" valign="bottom">18–03</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://mrc-ide.github.io/covid19estimates/">https://mrc-ide.github.io/covid19estimates/</ext-link>#/interventions</td></tr><tr><td align="left" valign="bottom">Denmark</td><td align="char" char="ndash" valign="bottom">12–03</td><td align="char" char="ndash" valign="bottom">18–03</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://mrc-ide.github.io/covid19estimates/">https://mrc-ide.github.io/covid19estimates/</ext-link>#/interventions</td></tr><tr><td align="left" valign="bottom">Finland</td><td align="char" char="ndash" valign="bottom">16–03</td><td align="char" char="ndash" valign="bottom">16–03</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/COVID-19_pandemic_in_Finland#Response_by_sector">https://en.wikipedia.org/wiki/COVID-19_pandemic_in_Finland#Response_by_sector</ext-link></td></tr><tr><td align="left" valign="bottom">France</td><td align="char" char="ndash" valign="bottom">29–02</td><td align="char" char="ndash" valign="bottom">17–03</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.politico.eu/article/europes-coronavirus-lockdown-measures-compared/">https://www.politico.eu/article/europes-coronavirus-lockdown-measures-compared/</ext-link></td></tr><tr><td align="left" valign="bottom">Germany</td><td align="char" char="ndash" valign="bottom">06–03</td><td align="char" char="ndash" valign="bottom">22–03</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.bundesregierung.de/breg-de/themen/coronavirus/besprechung-der-bundeskanzlerin-mit-den-regierungschefinnen-und-regierungschefs-der-laender-1733248">https://www.bundesregierung.de/breg-de/themen/coronavirus/besprechung-der-bundeskanzlerin-mit-den-regierungschefinnen-und-regierungschefs-der-laender-1733248</ext-link></td></tr><tr><td align="left" valign="bottom">Ireland</td><td align="char" char="ndash" valign="bottom">12–03</td><td align="char" char="ndash" valign="bottom">27–03</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/COVID-19_pandemic_in_the_Republic_of_Ireland#Containment_phase">https://en.wikipedia.org/wiki/COVID-19_pandemic_in_the_Republic_of_Ireland#Containment_phase</ext-link></td></tr><tr><td align="left" valign="bottom">Italy</td><td align="char" char="ndash" valign="bottom">22–02</td><td align="char" char="ndash" valign="bottom">10–03</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.politico.eu/article/europes-coronavirus-lockdown-measures-compared/">https://www.politico.eu/article/europes-coronavirus-lockdown-measures-compared/</ext-link></td></tr><tr><td align="left" valign="bottom">Netherlands</td><td align="char" char="ndash" valign="bottom">10–03</td><td align="char" char="ndash" valign="bottom">23–03</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.volkskrant.nl/nieuws-achtergrond/bijeenkomsten-tot-1-juni-verboden-burgemeesters-mogen-handhaven-met-forse-boetes~b41b8508/">https://www.volkskrant.nl/nieuws-achtergrond/bijeenkomsten-tot-1-juni-verboden-burgemeesters-mogen-handhaven-met-forse-boetes~b41b8508/</ext-link></td></tr><tr><td align="left" valign="bottom">Norway</td><td align="char" char="ndash" valign="bottom">12–03</td><td align="char" char="ndash" valign="bottom">14–03</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.euractiv.com/section/coronavirus/short_news/norway-update-covid-19/">https://www.euractiv.com/section/coronavirus/short_news/norway-update-covid-19/</ext-link></td></tr><tr><td align="left" valign="bottom">Poland</td><td align="char" char="ndash" valign="bottom">09–03</td><td align="char" char="ndash" valign="bottom">25–03</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.politico.eu/article/europes-coronavirus-lockdown-measures-compared/">https://www.politico.eu/article/europes-coronavirus-lockdown-measures-compared/</ext-link></td></tr><tr><td align="left" valign="bottom">Portugal</td><td align="char" char="ndash" valign="bottom">11–03</td><td align="char" char="ndash" valign="bottom">16–03</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.politico.eu/article/europes-coronavirus-lockdown-measures-compared/">https://www.politico.eu/article/europes-coronavirus-lockdown-measures-compared/</ext-link></td></tr><tr><td align="left" valign="bottom">Romania</td><td align="char" char="ndash" valign="bottom">21–02</td><td align="char" char="ndash" valign="bottom">24–03</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/COVID-19_pandemic_in_Romania">https://en.wikipedia.org/wiki/COVID-19_pandemic_in_Romania</ext-link></td></tr><tr><td align="left" valign="bottom">Russian Federation</td><td align="char" char="ndash" valign="bottom">25–03</td><td align="char" char="ndash" valign="bottom">30–03</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/COVID-19_pandemic_in_Russia">https://en.wikipedia.org/wiki/COVID-19_pandemic_in_Russia</ext-link></td></tr><tr><td align="left" valign="bottom">Slovenia</td><td align="char" char="ndash" valign="bottom">09–03</td><td align="char" char="ndash" valign="bottom">20–03</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/COVID-19_pandemic_in_Slovenia">https://en.wikipedia.org/wiki/COVID-19_pandemic_in_Slovenia</ext-link></td></tr><tr><td align="left" valign="bottom">Spain</td><td align="char" char="ndash" valign="bottom">10–03</td><td align="char" char="ndash" valign="bottom">14–03</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.elmundo.es/espana/2020/03/13/5e6b844e21efa0dd258b45a5.html">https://www.elmundo.es/espana/2020/03/13/5e6b844e21efa0dd258b45a5.html</ext-link></td></tr><tr><td align="left" valign="bottom">Sweden</td><td align="char" char="ndash" valign="bottom">11–03</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Switzerland</td><td align="char" char="ndash" valign="bottom">28–02</td><td align="char" char="ndash" valign="bottom">17–03</td><td align="left" valign="bottom">‘Verordnung 2 über Massnahmen zur Bekämpfung des Coronavirus (COVID-19)’</td></tr><tr><td align="left" valign="bottom">Turkey</td><td align="char" char="ndash" valign="bottom">12–03</td><td align="char" char="ndash" valign="bottom">21–03</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/COVID-19_pandemic_in_Turkey#Government_response">https://en.wikipedia.org/wiki/COVID-19_pandemic_in_Turkey#Government_response</ext-link></td></tr><tr><td align="left" valign="bottom">United Kingdom</td><td align="char" char="ndash" valign="bottom">12–03</td><td align="char" char="ndash" valign="bottom">24–03</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.bbc.com/news/uk-52012432">https://www.bbc.com/news/uk-52012432</ext-link></td></tr></tbody></table></table-wrap></sec></sec></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.71345.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Davenport</surname><given-names>Miles P</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03r8z3t63</institution-id><institution>University of New South Wales</institution></institution-wrap><country>Australia</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2020.11.26.20239368" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2020.11.26.20239368"/></front-stub><body><p>Understanding the trajectory of epidemic growth and predicting it in real-time is an important goal of epidemiological modelling. This work aggregates data from 170 countries in an effort to better understand how the effective reproduction number of SARS-CoV-2 spread evolved over time and across the world.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.71345.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Davenport</surname><given-names>Miles P</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03r8z3t63</institution-id><institution>University of New South Wales</institution></institution-wrap><country>Australia</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2020.11.26.20239368">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.medrxiv.org/content/10.1101/2020.11.26.20239368v1.full">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Estimation and worldwide monitoring of the effective reproductive number of SARS-CoV-2&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Miles Davenport as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) In addition to the stringency index, please incorporate mobility in selected countries where relevant data are available.</p><p>2) Moreover, please integrate additional data types, eg case series, hospitalizations and deaths, to estimate a single set of R_e (t), rather than separate analyses on each data stream.</p><p>3) Please address the uncertainty estimation procedure as queried by Reviewer #1.</p><p>Reviewer #1 (Recommendations for the authors):</p><p>1) Explain more for the simulation approach in the paper, such as why the noise should be computed in this way, instead of just based on the theoretical delay distribution from infection to death/hospitalization/reported, to simulate the input time series.</p><p>2) More simulations to validate the real-time property of the estimates of Rt</p><p>3) A potential framework that can use both time series for cases, hospitalization and death to jointly infer the infection time series.</p><p>The results are easy to be assessed and presented clearly, which is good. I am not sure how I can get the data and also the code to replicate the analysis. Ideally it should be available.</p><p>(Note from Ed: Data and code must be available to conform with <italic>eLife</italic> data policies)</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.71345.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) In addition to the stringency index, please incorporate mobility in selected countries where relevant data are available.</p></disp-quote><p>We have now integrated mobility data into our dashboard, similar to our stringency index and vaccination time series. We show both Apple and Google mobility data. All these traces can be downloaded and compared against our Re estimates. We have also incorporated this data into the empirical analysis of Figure 5 in the manuscript.</p><disp-quote content-type="editor-comment"><p>2) Moreover, please integrate additional data types, eg case series, hospitalizations and deaths, to estimate a single set of R_e (t), rather than separate analyses on each data stream.</p></disp-quote><p>We think it is a strength of our approach to show the different traces in parallel, as this allows direct comparison during periods where one trace may be more or less credible. We have revised the text to make clear early on that we estimate separate Re values, and what the advantages of this approach are.</p><disp-quote content-type="editor-comment"><p>3) Please address the uncertainty estimation procedure as queried by Reviewer #1.</p></disp-quote><p>We believe there was some misunderstanding here regarding the logic behind our simulation set-up. We have revised the corresponding method sections, specifically adding more information on why and how we incorporate observation noise into our simulations.</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>1) Explain more for the simulation approach in the paper, such as why the noise should be computed in this way, instead of just based on the theoretical delay distribution from infection to death/hospitalization/reported, to simulate the input time series.</p></disp-quote><p>We added more explanation about our simulation approach to the corresponding method section (lines 488-518). We found that simulated observations based only on the delay from infection to reporting did not show the same amount of variability as real case data from around the world. We added reporting noise to the simulations to be able to accurately assess the coverage of our method.</p><p>Please also refer to our answer to the public review above, for a more detailed overview of our simulation set-up.</p><disp-quote content-type="editor-comment"><p>2) More simulations to validate the real-time property of the estimates of Rt</p></disp-quote><p>As suggested, we performed an additional simulation study to investigate the accuracy and stability of the last possible Re estimate. We present this analysis in a new results paragraph (subsection &quot;Stability of Re estimates in an outbreak monitoring context&quot;; line 121) and Appendix 4 – Figure 1. This analysis emphasizes the need to be cautious with the most recent Re estimates when these values are directly policy relevant.</p><p>We revised the wording of our manuscript everywhere to replace the ambiguous &quot;near real-time&quot; by &quot;timely&quot;, and added text to highlight the delay between latest Re estimates and latest case observations.</p><disp-quote content-type="editor-comment"><p>3) A potential framework that can use both time series for cases, hospitalization and death to jointly infer the infection time series.</p></disp-quote><p>Please refer to our response to item #1 of the public review (for reviewer 1).</p><disp-quote content-type="editor-comment"><p>The results are easy to be assessed and presented clearly, which is good. I am not sure how I can get the data and also the code to replicate the analysis. Ideally it should be available.</p><p>(Note from Ed: Data and code must be available to conform with eLife data policies)</p></disp-quote><p>The information on data sources is provided in the Data subsection (4.6) of the Materials and methods section, with additional information in Supplementary File S1.</p><p>The information on software repositories is provided at the very end of the main text of the manuscript, in the Materials and methods section (subsection 4.8).</p><p>Specifically, the source code of the software pipeline is openly accessible at https://github.com/covid-19-Re/shiny-dailyRe, and the code necessary to reproduce the figures and analyses presented in this paper is available at https://github.com/covid-19-Re/paper-code.</p></body></sub-article></article>